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Upon treatment with a palladium catalyst and hydrogen gas in the presence of caesium 
carbonate, a wide range of exomethylenic allylic alcohols were found to afford their 
corresponding trisubstituted isomers. Although hydrogenation was an unavoidable 
competing pathway, careful monitoring of the reaction progress allowed the desired 




Asymmetric hydroboration reactions of a range of γ,δ-unsaturated methyl esters were 
found to afford their corresponding chiral 1,3-diols upon oxidation of the chiral 
organoborane intermediates, in a novel tandem reduction-hydroboration protocol. 
Alternatively, the chiral β-hydroxy ester product could be obtained by maintaining the 










1.1 Synthetic applications of alkenes 
Alkene bonds are a common structural feature of natural products and medicinally active 
compounds, as well as flavouring agents and perfume components.
1
 Due to their stability 
and high reactivity, they can also function as reliable and versatile synthetic intermediates.
2
 
The enormous number of one-step transformations of alkenes which are known (Figure 1) 
facilitates rapid access to almost any functional group. As a consequence, numerous 
methods for the synthesis of alkenes have been devised.
3
 Many methods exist for their 







 reactions all well established. In many cases, reversal 
of enantioselectivity can be readily achieved by using the opposite alkene geometric 
isomer, which is often significantly more convenient than preparation of a chiral 
catalyst/ligand in its antipodal form. A brief summary of the range of products that can be 
prepared using commonly employed alkene-functionalisation reactions is shown below in 
Figure 1. 
 
Figure 1. Selected one-step transformations of alkenes. 
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1.2 Protocols for the stereoselective synthesis of alkenes  
The simplest alkene syntheses are based on elimination of HX (where X = halogen or O) 







Scheme 1. Preparation of alkenes by E1 (eq 1), E2 (eq 2) and E1cB (eq 3) elimination reactions. 
 
Although these methods often utilise strongly acidic or basic conditions and can be poorly 
selective, they are simple and effective protocols for the preparation of simple alkenes, 
whilst the resulting product mixtures can potentially be purified by distillation. However, 
milder and more selective conditions are clearly desirable for the preparation of 
structurally complex alkenes that contain more sensitive functionality. An alternative 
method is to employ a two-step procedure involving initial conversion of an alcohol into a 
good leaving group, typically a tosylate or mesylate, followed by a base-induced 





Scheme 2. Alkene synthesis via mesylate formation followed by base-induced E1cB elimination. 
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A variety of other hydroxyl elimination methods which operate under relatively mild 
conditions have also been developed. For example, dehydration of secondary or tertiary 
alcohols can be carried out using the Burgess reagent – methyl N-
(triethylammoniumsulphonyl)carbamate.
11
 Initial attack of the alcohol functionality at the 
sulphur centre of the reagent occurs to displace its trialkylammonium fragment, followed 
by a rapid syn-elimination step that is initiated by β-deprotonation by the imide nitrogen. 
This type of elimination reaction was used during Holton’s elegant total synthesis of taxol 









 reported a mild procedure for the dehydration of primary alcohols to 
form the corresponding terminal alkenes via elimination of a selenide intermediate. 
Reaction of the hydroxyl group with (2-nitrophenyl)selenocyanate in the presence of 
tributylphosphine results in formation of a selenide that is then oxidised with hydrogen 






Scheme 4. The Grieco dehydration reaction. 
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Elimination reactions of amines have also been used for alkene synthesis, although they are 
less commonly encountered than their hydroxyl-based counterparts. The Hofmann 
elimination, first reported by Hofmann
15
 in 1851, consists of exhaustive methylation of an 
amino group with either methyl iodide or dimethyl sulphate, followed by base-induced 
elimination of the resultant quaternary ammonium salt under relatively harsh conditions 
(Scheme 5, eq 1).
16
 The Cope elimination reaction
17
 is a somewhat milder alternative, 
involving conversion of a tertiary amine into its corresponding N-oxide species, that is then 





Scheme 5. The Hofmann elimination (eq 1) and Cope elimination (eq 2) reactions. 
 
Alkenes can also be prepared via various fragmentation reactions, with the driving force of 
the reaction being provided by simultaneous formation of a carbonyl group.
19
 An early 
example was reported in 1952, by Eschenmoser,
20
 who reported base-catalysed elimination 
reactions of various β-hydroxyketones to afford δ,ε-unsaturated carboxylic acids (Scheme 
6, eq 1). Nowadays, these types of transformation are broadly classified as Grob
21
 
fragmentations and represent an efficient means of selectively preparing cyclic alkenes that 
contain remote functionality (Scheme 6, eq 2).
22





Scheme 6. Alkene synthesis via base-induced fragmentation reactions. 
 
Alkenes can also be prepared from diols in a highly stereospecific manner, via the Corey-
Winter
23
 olefination protocol. First reported in 1963, this two-step procedure allows the 
stereospecific conversion of vicinal diols into their corresponding alkenes, via formation of 
an intermediate cyclic thionocarbonate, followed by phosphorus-mediated syn-elimination 
of sulphur and CO2. An elegant example of this methodology was demonstrated in 
Mukaiyama’s total synthesis of taxol in 1999 (Scheme 7).24 
 
 
Scheme 7. A Corey-Winter olefination reaction. 
 
A potentially powerful strategy for alkene synthesis is the Shapiro reaction,
25
 which 
consists of treatment of tosylhydrazone derivatives of ketones with two equivalents of a 
20 
 
strong base, which results in a regioselective elimination reaction for formation of the 





Scheme 8. The Shapiro reaction. 
 
Alternatively, treatment of a hydrazone with iodine and DBN can afford a vinyl iodide 
product (Scheme 9),
27
 which can then be further elaborated via metal-catalysed cross-
coupling reactions as required. 
 
 
Scheme 9. The Barton vinyl iodide synthesis. 
 
A number of well-established methods for alkene synthesis are based on condensation 
reactions involving carbonyl compounds. These protocols generally involve 1,2-addition of 
the enolate of a ketone to the carbonyl functionality of either an aldehyde or ketone 
acceptor, followed by elimination of water to afford an α,β-unsaturated carbonyl product. 
An intramolecular variant of this type of aldol condensation reaction was utilised by 
Woodward
28





Scheme 10. An intramolecular aldol condensation reaction. 
 
The Henry reaction follows a similar pathway and involves condensation of the anion of a 
nitroalkane with an aldehyde or ketone to afford a 2-nitroalkene. This reaction was used to 










 utilises the enolate anion of a carboxylic acid anhydride as a 
nucleophile in a similar kind of condensation reaction. Reaction of the enolate of acetic 
anhydride, with a substituted benzaldehyde as the electrophilic partner, constitutes an 




Scheme 12. The Perkin reaction. 
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Another variant of the aldol condensation reaction is the Knoevenagel condensation.
32
 An 
active methylene compound is first deprotonated, followed by 1,2-addition of the stabilised 
anion to an aldehyde or ketone and then elimination of water. This reaction has been used 
as a key step in the commercial production of the antimalarial drug lumefantrine (Scheme 
13, eq 1).
33
 The use of a malonate-derived anion as the nucleophile can allow for the 
selective preparation of γ,δ-unsaturated carboxyl compounds, via the subsequent loss of an 
acid group by decarboxylation (vide infra) (Scheme 13, eq 2). 
 
 
Scheme 13. Knoevenagel condensation reactions. 
 
A well-established strategy for alkene synthesis is the Wittig reaction,
34
 which consists of 
addition of a phosphorus-derived ylide to either an aldehyde or ketone, followed by 
elimination of phosphine oxide and alkene bond formation. The reaction is most efficient 
with aldehydes, although the product alkene is often formed as a mixture of geometric 
isomers (Scheme 14, eq 1).
35
 However, if the ylide is stabilised by an electron-withdrawing 
group, the reversible nature of the reaction ensures that the alkene bond is formed with 

















The Horner-Wadsworth-Emmons variant of the Wittig olefination utilises a stabilised, 
phosphonate-derived ylide, and typically proceeds with an excellent level of 
stereoselectivity for the (E)-alkene product (Scheme 15).
37
 In addition, the phosphorus 
byproduct is a water-soluble phosphate ester, which, unlike triphenylphosphine oxide, is 
easily separated from the post-reaction mixture on work-up.  
 
 
Scheme 15. Horner-Wadsworth-Emmons olefination reaction. 
 
Another limitation of the Wittig reaction arises from its relatively s low reaction rate with 
ketones, with enolisation competing with the carbonyl addition, potentially resulting in 
epimerisation of adjacent stereocentres or enolate condensation reactions.
38
 This led to the 
development of the Lombardo methylenation reaction (Scheme 16, eq 1),
39
 whereby a 
highly nucleophilic species is prepared via addition of TiCl4 to a suspension of zinc dust in 
a THF solution of dibromomethane, which reacts rapidly with aldehydes and ketones to 
afford their corresponding methylenated products. The remarkable functional group 
tolerance and non-basicity of the reagent permits its use in the presence of THP ethers, 
TBS ethers, acetals, esters, lactones, amides, carboxylic acids, unprotected alcohols and 
substrates containing potentially enolisable stereocentres. For example, this procedure was 







Scheme 16. The Lombardo methylenation reaction of ketones (eq 1) and an example of its use in natural 
product synthesis (eq 2). 
 
Alkene synthesis can also be achieved via reaction of α-silyl carbanions with carbonyl 
compounds, as discovered by Peterson
41
 in 1968. The reaction pathway depends strongly 
upon the coordinating ability of the metal counterion associated with the silyl anion, 
whereby relatively ionic alkoxides (e.g. Na, K) result in direct elimination of the 





 are electron-withdrawing groups. If the intermediate alkoxide-
metal bond is relatively covalent and stabilised, then it may be protonated upon aqueous 
work-up and isolated (Scheme 17, eq 1).
3
 Subsequent treatment with either acid or base 
then results in stereoselective alkene formation via elimination of the trialkylsilanol. 
Interestingly, each diastereomer of the β-hydroxysilane (syn/anti) affords the opposing 





Scheme 17. Peterson olefination reaction. 
26 
 
Although separation of the intermediate β-hydroxysilanes enables geometrically pure 
alkenes to be isolated, the inefficiency of this separation step has resulted in this 
methodology not finding widespread application in synthesis. Consequently, alternative 
methods for the stereoselective preparation of these types of silyl products have been 
developed. For example, Nozaki-Hiyama allylation of an aldehyde gave a β-hydroxysilane 
with excellent stereocontrol, which was followed by a Peterson-type elimination to afford a 





Scheme 18. Diastereoselective β-hydroxysilane formation, followed by Peterson elimination reaction. 
 
In 1991, a new one-pot preparation of alkenes from reactions of lithiated 2-benzothiazolyl 
sulphones with aldehydes or ketones was reported by Julia and co-workers.
44
 Initial 1,2-
addition of a sulphone-derived carbanion to a carbonyl group is followed by a cascade of 
reactions that ultimately results in alkene formation and elimination of sulphur dioxide 
(Scheme 19). Unfortunately, high stereoselectivities could only be achieved for a narrow 
range of substrates, whilst many lithiated benzothiazolyl sulphones were found to be 
unstable. An investigation into the effects of base, solvent polarity, heterocyclic sulphone 
and branching in the aldehyde and sulphone precursors was later undertaken by Kocienski 
and co-workers.
45
 They found that alkylated 1-phenyl-1H-tetrazol-5-yl sulphones delivered 
superior stereoselectivities when compared to other heterocyclic sulphones, with the 
geometric purity of the alkene product being maximised by the use of a potassium base and 





Scheme 19. Proposed mechanism of the Julia-Kocienski olefination. 
 
In general, formation of an (E)-alkene product is favoured; however, some combinations of 
solvent, base, sulphone and aldehyde can favour the (Z)-alkene. The Julia-Kocienski 
olefination thereby constitutes an effective alternative to the Wittig reaction for the 




Scheme 20. The Julia-Kocienski olefination reaction. 
28 
 
The transformation of esters and amides into their corresponding enol ethers and enamines 
cannot be achieved via Wittig or Julia olefination reactions. In order to carry out this type 
of conversion, a range of titanium-based reagents have been developed. For example, the 
titanium methylide complex Cp2Ti=CH2, generated in situ by thermal decomposition of 





Scheme 21. Methylenation of an imide carbonyl group using dimethyltitanocene. 
 
1,2-Disubstituted and terminal alkenes can also be prepared by the partial reduction of 
alkynes, where selectivity for either geometric isomer can be readily achieved by the use of 
appropriate reaction conditions. The semi-hydrogenation of internal alkyne substrates, 
using a transition metal-based catalyst and hydrogen gas can afford a (Z)-alkene product in 
up to 100% selectivity. The catalyst most often utilised for this purpose is known as the 
Lindlar catalyst,
50
 which is comprised of palladium metal deposited onto a calcium 
carbonate support that has been ‘poisoned’ by treatment with lead(II) acetate. The 
inclusion of small amounts of quinoline in the hydrogenation reaction mixture is also 
known to improve catalyst selectivity. This procedure was utilised during the synthesis of 
gem-difluorinated goniothalamins reported by Qing and co-workers (Scheme 22, eq 1).
51
 
Alternatively, the use of dissolving metal reductions can result in the selective formation of 
(E)-alkenes via a single electron transfer process. For example, the use of sodium metal in 
liquid ammonia with tert-butanol as a proton quench was reported to afford the desired 







Scheme 22. Alkene synthesis via the partial reduction of alkynes, to afford (Z)- or (E)-alkenes. 
 
Since the introduction of well-defined, stable, reactive and functional group tolerant 
metathesis catalysts, catalytic alkene metathesis has emerged as a powerful synthetic 
tool.
53
 In this unique reaction, two alkenes are effectively “stitched together” via an 
exchange of alkene substituents, thus facilitating the efficient and rapid generation of 
molecular complexity. A simplified mechanism for this type of cross-coupling reaction is 
shown in Scheme 23. 
 
Scheme 23. Mechanism of alkene cross-metathesis catalysed by a metal carbene, M=CH2. 
 
Alkene metathesis reactions can be broadly classified into three main classes: cross-
metathesis (CM), ring-opening metathesis (ROM) and ring-closing metathesis (RCM). 
Although the overall synthetic outcome of these processes can be achieved using other 
30 
 
synthetic methodology, the metathesis approach is often superior in terms of efficiency, 
selectivity and favourable byproduct formation (e.g., ethylene gas). For example, the cross-
metathesis of methyl vinyl ketone with various terminal dienes reported by Blechert
54
 
occurs readily to afford dienone products (Scheme 24), where the presence of both acid- 
and base-sensitive functionality in the substrate would preclude the use of many alternative 
preparations. 
 
Scheme 24. Cross-metathesis of methyl vinyl ketone with a terminal diene. 
Although cross-metathesis is a highly reliable method for C=C bond formation, the (E)-
alkene isomer is normally favoured due to the lower thermodynamic stability of (Z)-
alkenes.
55
 Examples of (Z)-selective cross-metathesis are mainly limited to substrates 





Hoveyda, Schrock and co-workers
58
 have recently reported the synthesis and impressive 
selectivity of a molybdenum-based catalyst 2, which was used for the (Z)-selective cross-
metathesis of either aliphatic or aromatic enol ethers with a range of terminal alkenes under 
kinetic control (Scheme 25). 
 
Scheme 25. Highly (Z)-selective cross-metathesis between enol ethers and terminal alkenes. 
31 
 
Where applicable, enantioselective variants of each class of metathesis reaction have been 
reported.
59
 In the following example of a ring-opening/cross-metathesis reaction, the chiral 
catalyst 3 efficiently discriminates between the enantiotopic ends of the substrate alkene to 




Scheme 26. Enantioselective ring-opening/cross-metathesis using a chiral ruthenium alkylidene complex. 
 
Ring-closing metathesis allows ready access to all ring sizes ≥5 and has thus found 
frequent application in the field of natural product synthesis.
61
 It also constitutes a highly 
versatile method for preparing medium-to-large ring systems. An illustrative example is 
the ring-closing metathesis step utilised by Boehringer Ingelheim for the multi-kilogram 
synthesis of BILN-2061,
62
 an antiviral drug candidate which has since been discontinued 
due to toxicity issues. This ring-closure reaction was catalysed by the second-generation 
Grubbs-Hoveyda catalyst 4, proceeding cleanly in high yield and with almost complete 
selectivity for the (Z)-alkene (Scheme 27). 
 
 
Scheme 27. Ring-closing metathesis reaction on a large scale. 
32 
 
A relatively new class of metathesis reaction is ring-rearrangement metathesis (RRM),
63
 
which consists of sequential ring-opening and ring-closing metathesis steps. The synthetic 
relevance of this reaction is demonstrated by its application to the first stereoselective total 
synthesis of (–)-trans-dendrochrysine, reported in 2007 by Blechert.64 The RRM substrate 
was prepared in several steps from cycloheptatrienone, whereupon the cycloheptene ring 
was smoothly transformed into a pair of dihydropyrrole units, with complete conservation 
of enantiopurity, using the Grubbs-Hoveyda second generation catalyst 1 (Scheme 28). 
 
Scheme 28. Synthesis of (–)-trans-dendrochrysine via a ring-rearrangement metathesis reaction. 
Another powerful method for the synthesis of cyclic alkenes is the Diels-Alder reaction,
65
 
which is a thermally allowed, [4+2] cycloaddition reaction between a diene and dienophile. 
This reaction has been frequently and consistently utilised for the synthesis of natural 
products, for example in Woodward’s 1956 synthesis of reserpine (Scheme 29, eq 1).
66
 
Enantioselective variants have since been developed, using various forms of 
organocatalysis
67
 or chiral Lewis-acidic transition metal-based catalysts.
68
 For example, 
the chromium(III) salen complex 5 was used to catalyse an enantioselective Diels-Alder 









It is clear from this brief discussion that a wide range of synthetic methodology has been 
developed for the stereoselective synthesis of alkene bonds in the presence of a wide range 
of chemical functionality. A less well exploited approach for the synthesis of alkenes 
involves the use of a transition metal catalyst to isomerise a pre-existing alkene bond, thus 
affording a new geometric or positional isomer; this area will now be comprehensively 















2. Alkene isomerisation strategies 
Alkene isomerisation reactions have often been encountered as undesired side-reactions 
during asymmetric catalytic hydrogenation
70
 or metathesis reactions,
71
 that have the 
potential to compromise enantioselectivity and promote the formation of byproducts. 
However, the deliberate and controlled isomerisation of a pre-existing alkene bond can 
potentially afford positional and geometric isomers that are difficult to prepare using 
conventional methodology. Established methods for carrying out this type of 











 However, there are many disadvantages 
associated with these methods due to functional group incompatibility with the harsh 
reaction conditions that are often required for isomerisation to occur. Photochemical 
methods have been applied to the (E)/(Z)-isomerisation of alkenes,
77
 but the success of this 
approach is substrate dependent, with mixtures of products often being produced. Although 
additional cycles of reaction and separation can result in high yields of a pure geometric 
isomer, this is a tedious process that is often unfeasible on a preparative scale. 
The use of transition metal-based catalysts offer several advantages over these more 
conventional methods, such as functional group tolerance, mild reaction conditions, 
product selectivity and tunability (e.g., where homogeneous catalysts are used, variation of 
ligands is possible). From an industrial perspective, catalytic processes are infinitely more 
desirable than those that employ reagents in stoichiometric quantities, as product 
separation is greatly simplified. This is especially advantageous for the synthesis of 
pharmaceutical compounds intended for human consumption, which must adhere to strict 
purity requirements. The use of a catalyst also results in significantly lower quantities of 
waste material being generated, leading to greater economic efficiency, particularly on a 
large scale. A quantitative isomerisation reaction can potentially furnish the desired 
product in a 100% atom-economical manner,
78
 which clearly adheres to the principles of 
green chemistry. 
The following literature review will now provide a focused overview of synthetically 
useful alkene isomerisation reactions that have been carried out using transition metal 
catalysts, beginning with a brief mechanistic discussion of transition metal-catalysed 
alkene isomerisation pathways. 
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2.1 Mechanisms of transition metal-catalysed alkene 
isomerisation 
The vast majority of alkene isomerisation reactions mediated by transition metal-based 
catalysts proceed via either of the following mechanisms: (1) Reversible addition-
elimination of a metal hydride species to an alkene functionality to give a 
thermodynamically more stable geometric or positional isomer, or (2) formation and 
rearrangement of a π-allylmetal hydride complex using a metal catalyst that contains at 
least two vacant coordination sites.
79,80 
A representative addition-elimination mechanism involving treatment of a terminal, linear 
alkene 6 with a generic metal hydride species LnM–H is shown in Scheme 30. A reversible 
hydrometalation reaction occurs via coordination of the alkene functionality of 6 to the 
metal followed by reversible syn-addition of a metal hydride species across the alkene 
bond. If addition occurs in an anti-Markovnikov fashion to afford intermediate 7, it will 
position the metal species at the terminal position, with subsequent elimination of the metal 
hydride species resulting in reversion to starting alkene 6. However, a Markovnikov 
addition pathway will afford intermediate 8 that can either eliminate a metal hydride 
species to afford starting material 6, or undergo an alternative hydrogen elimination 
pathway from its 3-position to afford a 2-alkenyl product 9. Elimination of the metal 
hydride species 8 can occur via syn-periplanar conformers leading to either an (E)- or (Z)-
alkene, with any of the less stable (Z)-isomer formed being isomerised to its (E)-isomer by 
further rounds of addition-elimination reactions of metal hydride species. Further 
reversible addition-elimination reaction of M–H species may also occur to afford new 
positional alkene isomers such as 11, via pathways that are particularly favoured if the new 
alkene product 11 is conjugated to an electron-withdrawing group or aromatic ring. 
 
Scheme 30. Addition-elimination mechanism of transition metal-catalysed alkene isomerisation. 
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An alternative π-allylmetal hydride mechanism for alkene isomerisation is shown in 
Scheme 31. Initial complexation of alkene 6 to the catalyst MLn is followed by reversible 
hydride abstraction from the allylic position of the complex to afford a π-allylmetal 
hydride species 12. The allyl fragment of this intermediate can readily interconvert 
between syn- and anti-conformations, with the position of the equilibrium being dependent 
on steric factors and/or nature of the ligands coordinated to the metal centre. 
Intramolecular delivery of hydride to the terminal end of the allyl fragment can then occur, 
which results in migration of the alkene bond to afford an internal prop-2-enyl alkene 
bond, with an (E)-13 isomer generally predominating under thermodynamic control. The 
alkene bond of 13 can also undergo further isomerisation reactions, however when the 
alkene contains a good allylic leaving group (e.g., acetate, halide) then competing reactions 





Scheme 31. The π-allylmetal hydride mechanism of transition metal-catalysed alkene isomerisation. 
 
Differentiation between these two mechanisms is often difficult, although this has been 
achieved by studying reactions of appropriately labelled substrates.
82
 For example, 
isomerisation of a deuterated 1-alkene 14-d2 with a metal catalyst that proceeds via a π-
allylmetal hydride mechanism would result in clean transfer of deuterium to the termini of 
the 2-alkene product 15-d2 (Scheme 32, eq 1).
83
 Further evidence may also be obtained 
through carrying out crossover experiments
84
 as no intermolecular migration of deuterium 
between 14 and 16-d2 would be expected for a π-allylmetal hydride mechanism, however a 
reversible metal hydride addition mechanism would be expected to result in some 







Scheme 32. Eq 1: Isomerisation of a deuterium-labelled substrate that proceeds via a π-allylmetal hydride 
mechanism; Eq 2: Isomerisation of a deuterium-labelled substrate that proceeds via a reversible metal 
















2.2 (E)/(Z)-Isomerisation of alkenes 
Many of the synthetically useful alkene bond forming reactions discussed in the previous 
chapter can result in olefinic products as unwanted mixtures of (E)- and (Z)- geometric 
isomers that are difficult to separate. Although variants of these methodologies have been 
developed that proceed with high levels of stereocontrol,
42,86,87 
the availability of 
isomerisation protocols that enable the selective conversion of (Z)-alkenes into their 
thermodynamically more stable (E)-isomers can improve the efficiency of many of these 
protocols. It is known that alkene isomers can be interconverted via treatment with certain 
transition metal complexes, thus providing a mild method for isomerisation of (Z)-olefins 
to their corresponding (E)-isomers in both acyclic and medium/large ring systems. These 
isomerisation protocols only produce good yields of (E)-alkenes if competing alkene 
migration pathways can be efficiently suppressed, otherwise complex mixtures of 
positional isomers are also produced.
88,89
 Consequently, good yields of (E)-geometric 
isomers are generally only obtained for isomerisation of (Z)-aryl-substituted alkenes, or 
(Z)-α,β-unsaturated carbonyl compounds, where conjugation ensures that the position of 
the alkene bond is retained in the product. 
Palladium(II) complexes have proven to be the most widely used class of catalyst for 
carrying out (Z)-/(E)- isomerisation reactions, with Giles and co-workers reporting the first 
synthetically useful protocol in 1990.
90
 They employed a series of Wittig reactions to 
prepare mixtures of (E)/(Z)-aryl-alkenes (predominantly (Z)-) (18-23, Scheme 33) that 
were subsequently isomerised into their corresponding (E)-isomers in good yield using a 
catalytic amount of PdCl2(MeCN)2 in CH2Cl2 or CDCl3 at 35 °C. However, application of 
this isomerisation procedure to a mixture of (E)- and (Z)-4-octene was not successful, 
resulting in competing alkene migration reactions occurring to afford a complex mixture of 
regioisomeric octenes. In 2002, Spencer and co-workers
91
 further explored the use of 
PdCl2(MeCN)2 (10 mol%) as a catalyst for the isomerisation of various (Z)-aryl-alkenes, a 
(Z)-α,β-unsaturated ketone and a (Z)-alkene containing a quaternary allylic centre (Scheme 
34), reporting >85% isolated  yields of their corresponding (E)-alkenes in all cases. 
However, propenylbenzene 32, which has a CF3-substituent in its para-position, failed to 





Scheme 33. PdCl2(MeCN)2 catalysed (Z)-to-(E) isomerisation of substituted styrenes. 
 
 
Scheme 34. Scope of PdCl2(MeCN)2 catalysed (Z)-to-(E) isomerisation reaction. 
 
Spencer and co-workers have proposed that alkene isomerisation proceeds via reversible 
addition of PdCl2(MeCN)2 to an alkene bond to give a carbocation intermediate 34 that 
rotates around its central carbon-carbon σ-bond to provide a pathway for interconversion 





Scheme 35. Carbocation mechanism for PdCl2(MeCN)2-catalysed (E)/(Z)-isomerisation reactions of 3-
substituted (Z)-1-arylpropenes. 
 
However, this mechanism does not explain the ability of this class of catalyst to isomerise 
aryl-allyl substrates to their corresponding prop-2-enyl regioisomers. Therefore, we 
propose these type of (Z)/(E)-isomerisation reactions are likely to facilitated by a palladium 




Scheme 36. Formation of a palladium hydride species. 
 
This palladium complex and the bis(benzonitrile) analogue [PdCl2(PhCN)2] have since 
been frequently utilised to isomerise mixtures of (Z)- and (E)-arylalkenes that were 






Figure 2. Mixtures of (E)/(Z)-alkenes that were subsequently isomerised to their corresponding (E)-isomers 
using PdCl2(MeCN)2 or PdCl2(PhCN)2.
92,93,94,95,96,97,98 
[a] The isomerisation reaction was carried out in refluxing benzene. 
 
Palladium(II) complexes have also been used to catalyse multiple (Z)/(E)-isomerisation 
reactions of polyenes, enabling access to geometric isomers that would otherwise be 
difficult to obtain.  Baldwin  and  co-workers  have  elegantly employed palladium-
catalysed isomerisation reactions of conjugated polyenes as a key transformation in their 
biomimetic syntheses of bicyclic cyclobutane derived frameworks (Scheme 37).
99,100,101
 
For example, they showed that PdCl2(MeCN)2 could be used to generate an equilibrating 
mixture of isomeric tetraalkenes from an isomerically pure (E,E,E,E)-tetraene precursor 
37, with the (E,Z,Z,E)-isomer 38 possessing the required alkene geometry to undergo a 
series of tandem electrocyclization reactions to afford the desired bicyclic [4.2.0] 





Scheme 37. PdCl2(MeCN)2 mediated isomerisation results in formation of (E,Z,Z,E)-tetraene 38 that reacts 
via a series of electrocyclic ring closure reactions to afford bicyclobutane 40. 
 
Other isomerisation protocols have recently been developed for the selective conversion of 
(Z)-alkenes into their corresponding (E)-isomers that are proposed to proceed via 
palladium(0) intermediates. Isomerisation of a range of (Z)-aryl-substituted alkenes and 
(Z)-α,β-unsaturated esters was achieved using a catalytic quantity of palladium(II) acetate 
in the presence of tributyltin hydride and triethylamine (Scheme 38).
102
 Although the 
highest conversions were obtained for substituted styrene derivatives, good yields were 
also achieved with substrates containing non-conjugated alkene bonds. Particularly 
impressive was the selective conversion of (Z)-4-decene to (E)-4-decene in 75% isolated 




Scheme 38. Palladium-catalysed isomerisation of (Z)-alkenes using Bu3SnH as a co-catalyst. 
[a] 22% yield of a terminal alkene arising from elimination of the terminal hydroxyl group also formed. 
[b] 15% yield of internal and terminal alkenes also formed upon elimination of acetate. 
 
The reaction pathway for these isomerisation reactions is proposed to involve tributyltin 
hydride mediated reduction of Pd(OAc)2 to afford a palladium(0) species that inserts into a 
tin-hydrogen bond to afford a palladium hydride species Bu3SnPdH (Scheme 39). 
Hydropalladation of the (Z)-alkene coordinated complex 42 then occurs to form 
alkylpalladium species 43, with rotation around its carbon-carbon bond and subsequent β-
hydrogen elimination affording the more thermodynamically stable alkene (E)-41, with 
regeneration of palladium hydride species Bu3SnPdH completing the catalytic cycle. 
 
 
Scheme 39. Proposed mechanism of palladium-catalysed isomerisation of (Z)-alkenes in the presence of 





 has recently described the application of a highly effective low loading 
palladium(0) catalytic system comprised of a 1:1:1 ratio of Pd(dba)2, P(
t
Bu)3, and 
isobutyryl chloride for the isomerisation of double bonds with excellent functional group 
tolerance. It was shown that this highly promising protocol generates a catalytically active 
palladium hydride species in situ, that cleanly isomerises the alkene fuctionalities of (Z)-
stilbene (44a), dimethyl maleate (44b) and (Z)-α,β-unsaturated ester 44c to afford their 
corresponding (E)-isomers in >95% isomeric purity, respectively (Scheme 40). 
 
 
Scheme 40. (Z)-to-(E)  isomerisations  of  some  representative  alkenes  using  an  in-situ  generated,  bulky  
palladium hydride  catalyst. 
 
Finally, a rare example of the selective isomerisation of an (E)-alkene to its less 
thermodynamically stable (Z)-alkene counterpart was reported in 2009 by Zaera.
104
 
Treatment of (E)-2-butene with a supported platinum catalyst, consisting largely of 
tetrahedral platinum nanoparticles featuring exposed (111) facets, resulted in selective 
formation of (Z)-2-butene. Although a practically useful synthetic procedure was not 
reported, the fact that such contra-thermodynamic selectivity could be achieved has 
significant implications. 
In conclusion, transition metal catalysis offers great potential for carrying out (Z)-to-(E) 






2.3 Isomerisation of substituted alkenes  
2.3.1 Isomerisation of monosubstituted alkene substrates 
Hydrated rhodium(III) chloride (the anhydrous form is not isomerisation active) has been 
extensively used to isomerise a wide variety of alkenes featuring different substitution 
patterns and functional groups. Upon heating in an alcoholic solvent, typically ethanol, a 
rhodium hydride species is generated according to the following equation:
105,106 
 
CH3CH2OH + RhCl3 → HRhCl2 + HCl + CH3CHO 
 
The rhodium hydride species thus formed is a highly reactive alkene isomerisation catalyst, 
with selected examples of isomerisation reactions of terminal alkenes that contain a wide 
range of functional groups shown in Table 1. 
 
Table 1. Examples of rhodium trichloride-catalysed isomerisation reactions of monosubstituted alkenes to 
their disubstituted counterparts. 
Entry Substrate Product, yield, (E):(Z) Reaction conditions Ref. 
1 
  
RhCl3.3H2O (0.3 mol%), 
EtOH, 20 °C, 2 h 
107 
  92%, >9:1   
2 
  
RhCl3.3H2O (0.3 mol%), 
EtOH, 20 °C, 2 h 
107 
  93%, 4:1   
3 
  
RhCl3.3H2O (8 mol%), 
EtOH, 70 °C, 8 h 
108 
  89%, 9:1   
4 
  
RhCl3.3H2O (1 mol%), 
PrOH, 95 °C, 10 h 
109 
  60%, (E) only   
46 
 
Entry Substrate Product, yield, (E):(Z) Reaction conditions Ref. 
5 
  
RhCl3.3H2O (5 mol%),   
EtOH, 45 °C, 4 h 
110 
  96%, 10:1   
6 
  
RhCl3.3H2O (cat.),  
PhMe-MeOH (5:1),  
70 °C, 3 h 
111 










EtOH, Δ, 3.5 h 
113 
 R = MeO, Me,  
CO2Me, NO2  




MeOH, 70 °C, 10 h 
114 
  94%   
10 
  
RhCl3.3H2O (2 × 5 mol%), 
EtOH, reflux, 2 h 
115 
  99%   
11 
  
RhCl3.3H2O (5 mol%), 
EtOH, 80 °C, 3 h 
116 




EtOH, reflux, 20 h 
117 
  77%   
47 
 
Entry Substrate Product, yield, (E):(Z) Reaction conditions Ref. 
13 
  
RhCl3.3H2O (10 mol%), 
K2CO3 (18 mol%),  
EtOH, reflux, 2.5 h 
118 
  91%   
14 
  
RhCl3.nH2O (3 mol%),   
EtOH, 70 °C, 6 h 
119 
  100%   
15 
  
RhCl3.3H2O (11 mol%), 
K2CO3 (1.0 equiv.),          
EtOH, 60 °C, 2 h 
120 
  76%, 10:1   
16 
  
RhCl3.3H2O (7 mol%),          
EtOH, reflux, 24 h 
121 
  46%   
17 
  
RhCl3.3H2O (cat.),  
EtOH, 100 °C, 30 m 
122 
  91%   
18 
  
RhCl3.3H2O (3 mol%),          
H2SO4, EtOH, reflux, 2 h 
123 
  95%, 1:3   
 
Many other transition metal-based catalysts have been utilised for the isomerisation of 
monosubstituted alkenes to selectively afford 1-propenyl products. Selected examples 
where rhodium-, ruthenium-, iridium-, palladium-, platinum- and cobalt-derived catalysts 






Table 2. Further examples of transition metal-catalysed isomerisation of monosubstituted alkenes to their 
disubstituted counterparts. 
Entry Substrate Product, yield, (E):(Z) Reaction conditions Ref. 
1 
  
5% Rh/Al2O3 or Rh/C           
(1 mol% Rh),                              
conc. HCl(aq) (10 equiv.), 
EtOH-H2O (1:1), 
90 °C, 24 h 
124 
  95%, 1:2.6   
     
2 
  
RhCl(PPh3)3 (cat.),        
EtOH-H2O, Δ, 5 h 
125 
  80%, 8:1   
3 
  
RuCl2(PPh3)3 (2 mol%), 
iPr2NEt (8 equiv.),       
toluene, 130 °C, overnight 
126 
  83%   
4 
  
Grubbs’ II  (20 mol%),                      
TrNH(Allyl) (2.0 equiv.),                   
iPr2NEt (1.0 equiv.),    
toluene, reflux, 15 h 
127
  81%, ~2:1   
5 
  
Grubbs’ II (5 mol%), 
TMSOCH=CH2               
(10 equiv.),               
CH2Cl2, reflux, 7 h 
128 
  100%, 2.3:1   
6 
  
Grubbs’ II (5 mol%), 
TMSOCH=CH2                
(10 equiv.),              
toluene, reflux, 15 h 
129 
  ~100%   
     
49 
 




CH2Cl2, 35 °C, 72 h 
130 
 R = Me, iPr, Bn 81 – 94%   
8 
  
PdCl2(MeCN)2 (5 mol%), 
CH2Cl2, reflux, 4 h 
131 
  86%   
9 
  
[(dppb)Pt(C6F5)(H2O)]OTf   
(1 mol%),                          
CHCl3, 50 °C, 12 h 
132 




+ (2 mol%),      
50:1 CH2Cl2:acetone 
133 
  98%   
11 
  
[Ir(PPh2Me)2(COD)]PF6       
(10 mol%),                         
pre-treated with H2,         
THF, rt, 48 h  
134 




[Ir(PPh2Me)2(COD)]PF6     
(10 mol%),                      
pre-treated with H2,      
THF, rt, 48 h 
134 
  89%, (E) only   
13 
  
[Ir(PPh2Me)2(COD)]PF6       
(10 mol%),                         




 87%   
50 
 
Entry Substrate Product, yield, (E):(Z) Reaction conditions Ref. 
14 
  
[Ir(PPh2Me)2(COD)]PF6       
(10 mol%),                         
THF, rt, 2 h 
135 








CoCl2 (5 mol%),      
IMes.HCl (5 mol%),                  
Me2PhSiCH2MgCl             
(0.5 equiv.),                  
dioxane, 50 °C, 6 h 
 
136 







CoCl2 (10 mol%),      
IMes.HCl (10 mol%),                  
Me2PhSiCH2MgCl             
(1.0 equiv.),                  
dioxane, 100 °C, 8 h 
 
136 







CoCl2 (10 mol%),      
IMes.HCl (10 mol%),                  
Me2PhSiCH2MgCl             
(1.0 equiv.),                  
dioxane, 100 °C, 8 h 
 
136 




 have recently explored the reactivity of Grubbs’ second 
generation-derived ruthenium hydride complex 46 for the isomerisation of alkenes (see 
Scheme 41, below). Formation of the active catalytic species 46 was achieved in situ upon 
heating a methanolic suspension of 45 and substrate to 60 °C.
138,139
 An alkene 
concentration of 0.075 M resulted in the occurrence of competing self-dimerization and 
cross-metathesis side-reactions being minimised. Initially, a range of substituted 
allylbenzenes 47a-e and the 2-allylindole derivative 47f were converted to their 
corresponding 1-propenyl isomers with high selectivity for their (E)-isomers (Scheme 41). 
A range of substituents in the aromatic ring were tolerated and excellent levels of 
conversion were observed, with isomerisation proceeding in less than three hours. 
51 
 
Importantly, attempts to isomerise substrates that contain coordinating functional groups, 
such as 47d/47e, using conventional catalysts  such as RhCl3.3H2O, RhCl(PPh3)3, or 
RuH2(PPh3)4 resulted in no isomerisation occurring. 
 
Scheme 41. Isomerisation of aryl-allyl derivatives. 
The isomerisation of a variety of carbonyl containing allyl derivatives (49) to 1-propenyl 
products (50) was also investigated, with these substrates reacting more slowly to afford 
(E)-alkenes in high yields (Scheme 42). In all cases, no further migration of the double 
bond to form conjugated alkenes was observed. The isomerisation catalyst is sufficiently 
sensitive to steric demands in order to selectively furnish 2-alkene isomers, thus allowing 
facile access to α-1-propenyl carbonyl compounds that are difficult to obtain using other 
types of methodology. 
 
Scheme 42. Isomerisation of α-C-allyl carbonyl derivatives. 
52 
 
Isomerisation of terminal alkenes to their disubstituted counterparts using this catalyst 
system has recently been demonstrated for natural product synthesis. Willis
140
  and co-
workers isomerised an O-TBS protected homoallylic alcohol 51a to its corresponding 1-
propenyl derivative 51b for use as an intermediate in the total synthesis of (–)-clavosolide 
D (Scheme 43, eq 1). Hanessian
141
 and co-workers have also reported isomerisation of 52a 
(Scheme 43, eq 2) as part of their total synthesis of L-(+)-noviose. 
 
Scheme 43. Selective alkene isomerisation reactions mediated by thermally activated Grubbs’ 2nd generation 
ruthenium carbene. 
The isomerisation of a range of allylbenzene derivatives to their corresponding 1-propenyl 
products, using a polymer-supported iridium catalyst 53, was reported by Ley
142
 and co-
workers in 2002 (Scheme 44). The isomerisation reactions proceed smoothly in THF at 
room temperature under gentle agitation, with simple filtration and removal of solvent 
affording the isomerised 1-propenyl products 55a-f. A range of substrates were isomerised 
with high levels of (E)-selectivity, although electron-deficient aromatic derivatives proved 
more difficult to isomerise. 
 
Scheme 44. Isomerisation of allylbenzene derivatives using a polymer-supported iridium catalyst. 
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The isomerisation of aryl-allyl derivatives to form their corresponding 1-propenylbenzenes 
represents an “idealised” isomerisation reaction, due to the strong thermodynamic 
preference for the conjugated isomer and the lack of opportunity for further migration of 
the double bond. Numerous essential oils are rich in aryl-substituted allylbenzenes and 
their 1-propenyl isomers are often used as flavourings, perfumery compounds, or for the 
manufacture of fine chemicals.
143
 An illustrative example is the conversion of estragole 
(57a, see Scheme 45 below) to anethole (57b), which has been carried out on an industrial 
scale using stoichiometric amounts of sodium or potassium hydroxide at 200 °C, resulting 
in an approximately 60% conversion to anethole, with a maximum (E):(Z) ratio of 
82:18.
132,144
 Unfortunately, the (Z)-isomer is considered toxic and has an unpleasant odour 
and taste, with a maximum permitted level of 1% for human use, thus necessitating further 
purification.
145
 A recent promising report from Jasra
144
 described highly selective 
isomerisation of both eugenol (56a) and estragole (57a), catalysed by RuCl2(PPh3)3. The 
respective (E)-1-propenyl isomers, (E)-isoeugenol (56b) and (E)-anethole (57b), were 
formed with >95% (E)-selectivity in almost quantitative yield (Scheme 45). Interestingly, 
the catalyst functioned efficiently at < 0.1 mol% loading and could be re-used up to five 
times in both cases, with no significant drop in either yield or stereoselectivity. 
 
 
Scheme 45. Ruthenium-catalysed isomerisation of essential oil-derived allylbenzenes. 
 
Deuterium-labelled compounds can function as useful mechanistic probes for both 
synthetic and biological applications, therefore a variety of methods for carrying out H–D 
exchange reactions at carbon centres have been devised.
146
 As transition metal-catalysed 
isomerisation of alkenes usually occurs via C–H bond cleavage and reformation, the 
introduction of an external source of deuterium atoms into these isomerisation reactions 
can be used for the deuteration of alkene-containing substrates. However, where H–D 
exchange has been carried out, it is often incomplete and/or poorly regioselective. 
Following up on previous work
147
 on alkene isomerisation using a novel ruthenium-based 
“alkene zipper” catalyst 58 (see Scheme 47), Grotjahn148 has reported an effective method 
54 
 
for H–D exchange of alkenes under mild conditions. Inclusion of D2O in the acetone-d6 
reaction solvent resulted in efficient levels of deuteration at the alkene carbons, as well as 
nearby sp
3
 carbon centres (Scheme 46). 
 
Scheme 46. Reactions carried out in acetone-d6 with enough deuterium oxide so as to provide 20 D per 
exchangeable H present. The number in brackets indicates the percentage of the theoretical amount (95%) of 
deuterium. 
[a] At rt with 2 mol% catalyst; [b] At 70 °C with 5 mol% catalyst; [c] At rt with 5 mol% catalyst. 
 
Deuteration of the substrate alkenes is thought to occur according to the mechanism 
outlined below (Scheme 47), where further deuterium incorporation is facilitated by H–D 
exchange of the protonated imidazolium ligand. 
 
Scheme 47. Proposed mechanism of isomerisation and deuteration. 
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2.3.2 Isomerisation of 1,2-disubstituted alkene substrates 
A landmark early report describing alkene isomerisation reactions of 1,2-disubstituted 
alkenes using catalytic quantitites of RhCl3.3H2O was published by Grieco
149
 in 1976. 
Conversion of Δ2-cycloalkenones 59 (n = 0, 1, 2, 3) to their more substituted isomers 60, 
was found to occur upon treatment with 2 – 3 mol% RhCl3.3H2O at 100 °C in absolute 
ethanol (Scheme  48). 
 
 
Scheme 48. Isomerisation of α,β-unsaturated cycloalkenones into their more substituted isomers, catalysed 
by rhodium(III) chloride trihydrate in ethanol. 
 
The observation that Δ1,2-octalone 61 could not be isomerised to the Δ4,5-octalone  62 
(Scheme  49, eq 1) suggested that the reaction occurs via rhodium-catalysed isomerisation 
of the double bond around the ring. Strong evidence for this hypothesis was obtained by 
treating cyclohexenone 63 with RhCl3.3H2O in CH3OD at 100 °C, with multiple ring 
protons of the isomerised product 64 found to have undergone deuterium exchange 
(Scheme 49, eq 2). 
 
 
Scheme 49. Eq 1: Alkene isomerisation through a quaternary carbon centre is not possible; Eq 2: Isotopic 




It was also demonstrated that the alkene bond to be isomerised could be exocyclic to a ring 
system, with dihydrocarvone 65 and 3-isopropenylcyclohexanone 68 being isomerised to 
their corresponding conjugated enones (Scheme 50), although in the former case a 7:1 
mixture of the positional isomers 66 and 67 were obtained in 90% yield. 
 
 
Scheme 50. Rhodium-catalysed isomerisation of 3-(2-propenyl)cyclohex-2-enones to their conjugated 
isomers. 
 
The limitation of this methodology is reached when the energy of a transition state leading 
to an alkene isomerisation product is too high, or is not favoured by the catalyst/reaction 
conditions. For example, an attempt to isomerise γ,δ-unsaturated enone 70 to the more 
stable α,β-unsaturated octalone 71 resulted in the δ,ε-unsaturated isomer 72 being 
unexpectedly isolated in 90% yield (Scheme 51). 
 
 
Scheme 51. Unexpected regioselectivity during rhodium-catalysed isomerisation of a γ,δ-unsaturated 
decalone. 
 
Rhodium(III) chloride in its hydrated form has since been frequently used for the 
conversion of a wide variety of disubstituted alkene-containing substrates into their more-
57 
 
substituted alkene isomers, with reactions generally being carried out in an alcoholic 
solvent, such as ethanol (see Table 3 for selected examples).  
 
Table 3. Selected examples of RhCl3-catalysed alkene isomerisation to the more substituted isomer. 














RhCl3.nH2O (10 mol%), 
EtOH, 80 °C, 16 h 
 
151 
  96%   
 
  3[a] 
  
 




                     93          :         7   





RhCl3.nH2O (10 mol%), 
EtOH, reflux, 18 h 
 
153 
 96% ee 100%, 55% ee   
[a] The isomerisation protocol was performed upon a crude elimination reaction product comprising a mixture 
of γ,δ- and δ,ε-unsaturated isomers in a ratio of 82:18, respectively.  
Alkene bond migration may be used as a useful strategy for accessing late stage alkene 
intermediates that are less easily prepared than their isomeric counterparts. Towards this 
end, Jauch
154
 employed a range of catalysts to mediate isomerisation of homoallylic ether 
73 to its allylic ether 74 (Scheme 52). The use of RhCl3.3H2O, IrCl3.3H2O, 
RhH(CO)(PPh3)3 or RhCl(PPh3)3 resulted in isomerisation of the alkene through two C–C 
bonds to afford enol ether 75 as the major product. Although an intermediate trisubstituted 
alkene 74 was initially observed, it was shown to be further isomerised to 75 before all of 
58 
 
the starting material 73 was consumed. Interestingly, further experiments identified 
Vaska’s complex, [Ir(PPh3)2(CO)Cl] as a catalyst that readily mediated the first 
isomerisation reaction, but was slower to catalyse the second isomerisation reaction. The 
use of 50 mol% of [Ir(PPh3)2(CO)Cl] in a mixed toluene:ethanol solvent (4:1, v/v) at 70 °C 
for six hours was found to afford the most favourable equilibrium mixture of 73/74/75 that 
were isolated in a ratio of 46:50:4, respectively. 
 
 

















2.3.3 Isomerisation of 1,1'-disubstituted alkene substrates 
Isomerisation of exocyclic methylenic alkenes to their respective endocyclic trisubstituted 
isomers has been widely used during synthesis and there are many different catalysts 
capable of achieving this transformation. Therefore, this reaction constitutes a convenient 
method of accessing trisubstituted alkenes that are often difficult to prepare by other 
routes, without recourse to multiple synthetic steps. 
A common strategy employed for the synthesis of natural products involves the use of a 
methylene-Wittig reaction to afford an exo-methylene cyclohexane derivative followed by 
subsequent exo-endo double-bond isomerisation using RhCl3.3H2O.
155,156,157
 A 
representative example of this approach is shown for the synthesis of the tetracyclic core of 




Scheme 53. Synthesis of a 1-methylcyclohexene fragment from its corresponding cyclohexanone via a 
methylene Wittig/isomerisation sequence. 
 
Further selected examples of the wide range of rhodium-catalysed isomerisation reactions 
that have been used to convert substrates with exomethylenic alkene bonds to their 








Table 4. Further examples of transition metal-catalysed isomerisation of 1,1'-disubstituted alkenes to their 
tri- or tetrasubstituted counterparts. 










RhCl3.3H2O (cat.),     



















EtOH, reflux, 24 h 
 
161 





RhCl3.nH2O (5 mol%),      
EtOH, 75 °C, 7 h 
 
162 





RhCl3.nH2O,              
EtOH, 75 °C, 5 h 
 
163 
  100%   
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Entry Substrate Product, yield Reaction  conditions Ref. 














RhCl3.3H2O (20  mol%), 









RhCl3.nH2O (30 mol%),   









RhCl3.3H2O (6 mol%), 
EtOH-H2O (10:1), 
reflux, 24 h 
 
167 





RhCl3.3H2O (cat.),     
EtOH-H2O (1:1),            
100 °C, 2 h 
 
168 





RhCl3.nH2O (10 mol%),   
EtOH-H2O (10:1),            
60 – 65 °C, 19 h 
 
169 









  72%   
62 
 





RhCl3.3H2O  (15  mol%),  
EtOH,  reflux 
 
171 





RhCl3.3H2O  (15  mol%),  
EtOH,  reflux, 3.5 h 
 
172 











  83%   
16 
  
[RhCl(PPh3)3] (10 mol%), 
Et3SiH (5 mol%),      
toluene, reflux 
174 





RhCl3.3H2O (5 mol%), 
EtOH, reflux, 15 h 
 
175 









RhCl3.3H2O (5 mol%), 
EtOH, rt, 1 h,                 




 (E)-endo:(Z)-endo:exo  = 
1:0.08:0.88 






EtOH, reflux, 24 h 
 
177 





 reported the development of palladium(II)- and nickel(II)-catalysed 
stereoselective  isomerisations of 1,1'-disubstituted alkenes and terminal alkenes to afford 
their corresponding trisubstituted and disubstituted alkenes, respectively  (Scheme 54, eqs 
1 and 2). Following the observation of unexpected byproducts arising from substrate 
isomerisation during asymmetric hydrovinylation reactions of 1,1'-disubstituted alkenes, 
conditions were optimised in order to maximise the yield of isomerised product. The 
established alkene isomerisation catalysts, [Ir(COE)Cl]2 and the thermally activated 
Grubbs’ 2nd generation metathesis catalyst (45), were found to be ineffective for 
isomerisation of either 80 or 82a under their reported conditions of operation. 
 
 
Scheme 54. Isomerisation of 1-methylenetetralin (80a) and 1-(2-phthalimidoethyl)styrene (82a). 
 
With optimised conditions in hand, [(allyl)PdCl]2 was used to catalyse isomerisation of a 
range of 2-arylbutenes 80b-e to their corresponding trisubstituted species in excellent 
yields and with generally high stereoselectivities (Scheme 55). 
 
Scheme 55. Palladium-catalysed isomerisation of 1,1´-disubstituted alkenes. 
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2.3.4 Isomerisation of trisubstituted and tetrasubstituted alkene 
substrates 
Isomerisation reactions of substrates containing tri- and tetrasubstituted alkenes have been 
less frequently reported and normally involve formation of conjugated alkene products. 
Wilkinson’s catalyst [RhCl(PPh3)3] in combination with a substoichiometric quantity of 
triethylsilane has been used to isomerise α-alkylidenelactones and α-alkylidene 
cycloalkanones to their corresponding internal tetrasubstituted olefinic isomers.
179
 
Attempts to carry out rhodium-catalysed hydrosilylation of α-alkylidenebutyrolactone 82 
were found to result in formation of a significant amount of the isomerised alkene product 
83 (Table 5, entry 1). This reaction was not observed in the absence of triethylsilane, 
suggesting its direct involvement in the isomerisation process.  Subsequent repetition of 
the reaction using a catalytic quantity of triethylsilane afforded isomerised lactone 83 as 
the major product (entry 2). 
 
Table 5. Hydrosilylation and isomerisation of α-alkylidenebutyrolactone 82. 
 
 
Entry Conditions Yield/% (83:84)[a] 
              1 RhCl(PPh3)3 (0.7 mol%),  
Et3SiH (50 equiv.) 
        80 (1:3) 
              2 RhCl(PPh3)3 (3 mol%),  
Et3SiH (7 mol%) 
      93 (100:0) 




The isomerisation reaction was proposed to occur via sequential hydrosilylation-
dehydrosilylation mediated by a trialkylsilylrhodium-hydride species that is formed from 
oxidative addition of rhodium into the Si–H bond of triethylsilane (Scheme 56). 
Hydrosilylation occurs when an excess of triethylsilane is employed; however, when the 
concentration of triethylsilane is low, dehydrosilylation of intermediate 86 can occur via 
elimination of either Ha or Hb to afford the thermodynamically favoured trisubstituted 
alkene isomer. 
 
Scheme 56. Proposed mechanism of rhodium-catalysed alkene isomerisation reactions in the presence of 
triethylsilane. 
 
Subsequent optimisation of this isomerisation reaction established its general applicability 













Table 6. RhCl(PPh3)3/Et3SiH-catalysed isomerisation of  unsaturated lactones and ketones. 




1 89: R1, R2 = CH2 90 99 




3 93: R = (CH2)2CH3, X = O 94 94 








8 99: R1 = R2 = Bn, R3 = Me 100 94 
9 101: R1, R2 = CH2, R
3 = Me 102 94 




Pyridone 103 was prepared via an aldol condensation reaction and isomerised into its 
trisubstituted derivative 104 in 80% yield via treatment with RhCl(PPh3)3, triethoxysilane 





Scheme 57. Rhodium-catalysed isomerisation of an aldol condensation product. 
 
Alkene isomerisation reactions have also been used to increase the proportion of a 
positional isomer formed in a non-selective alkene bond forming reaction prior to 
chromatographic purification. For example, Paquette
181
 reported the use of rhodium(III) 
chloride trihydrate to equilibrate a mixture of diastereomeric alkenes obtained from an 




Scheme 58. Equilibration of an isomeric mixture of alkenes using rhodium(III) chloride trihydrate. 
Rhodium(III) chloride trihydrate has also been utilised for the isomerisation of a range of 
trisubstituted alkenes to afford their corresponding di-, tri- or tetrasubstituted isomers, with 




Table 7. Further examples of rhodium-catalysed isomerisation reactions of trisubstituted alkene substrates. 
Entry Substrate Product, yield Reaction conditions Ref. 
1 
  
RhCl3.3H2O (cat.),         
EtOH, reflux, 30 m 
182 
  (yield not stated)   
2 
  
RhCl3.3H2O (7 mol%),  
EtOH-H2O (10:1),         
reflux, 3.5 d 
183 
  50%   
3 
  
RhCl3.3H2O (10 mol%),  
EtOH, 100 °C, 16 h 
184 
  83%   
4 
  
RhCl3.3H2O (10 mol%),  
benzene-EtOH (4:1),         
reflux, 28 h 
185 
  99%, α,β:β,γ = 2:1   
5 
  
RhCl3.3H2O (23 mol%),  
EtOH, reflux, 24 h 
186 










































RhCl3.3H2O (8 mol%),  
EtOH, reflux, 3 h 
187 
  90%   
7 
  
RhCl3.3H2O (cat.),         
EtOH, reflux, 24 h 
188 
  53%   
 
Positional isomerisation reactions of tetrasubstituted alkenes have been reported less 
frequently, with protocols normally involving formation of conjugated alkenes, or relief of 
steric strain. For example, a 5:1 mixture of β,γ- and α,β-unsaturated polycyclic enones was 
treated with rhodium(III) chloride trihydrate to afford the conjugated enone isomer in 70% 
isolated yield, during Smith’s 1992 synthesis of (+)-paspalicine (Scheme 59).189 
 
Scheme 59. Isomerisation of a tetrasubstituted alkene during the synthesis of (+)-paspalicine. 
 
A synthesis of giberellins (+)-GA1 and (+)-GA3, reported in 1995 by De Clereq,
190
 also 
features rhodium-catalysed isomerisation of a tetrasubstituted alkene (Scheme 60), with the 
isomerisation equilibria being driven by relief of transannular strain. 
 




The process of isoaromatisation
191
 involves the net movement of unsaturation within a 
molecular framework that results in formation of an aromatic system. This can occur, for 
example, in a cyclohexadienyl ring, where migration of a third exocyclic double bond 
occurs to complete an aromatic sextet. Most commonly, migration of a single alkene bond 
into a cyclohexenone system is followed by an irreversible keto-enol tautomerisation to 
afford a phenolic product. For example, attempts to hydrogenate carvone often result in 
contamination of the saturated ketone product by variable amounts of the isomeric phenol 
formed from competing isomerisation reactions.
192,193
 For example, hydrogenation of (–)-
carvone (106) using a polymer-supported palladium catalyst resulted in 70% 
hydrogenation to carvomenthone (107), with the remaining 30% of starting material being 
isomerised to form carvacrol (108, Scheme 61).
194
 This reflects the ease with which 
palladium-hydride species can induce alkene isomerisation as well as the strong 
thermodynamic preference for the formation of aromatic rings. 
 
 
Scheme 61. Hydrogenation of (–)-carvone 106, accompanied by isoaromatisation. 
 
In 1974, Blum and co-workers
195
 reported some preliminary results concerning the ability 
of various homogeneous transition metal catalysts (i.e., IrCl(CO)(PPh3)2, RhCl(PPh3)3 and 
RuCl2(PPh3)3) to isomerise diarylidenecyclohexanones to their corresponding phenols at 
250 °C. Good yields of substituted phenols were obtained in most cases (Scheme 62), 
although the presence of an ortho-methoxy group led to a reduced yield of its 
corresponding phenol (52%), whilst the presence of an ortho-chloro substituent effectively 







Scheme 62. Isoaromatisation of bis(arylmethylene)cyclohexanones catalysed by IrCl(CO)(PPh3)2. 
Monitoring the iridium-catalysed reaction of 2,6-dibenzylidenecyclohexanone (109a) by 
1
H NMR spectroscopy revealed that its conversion to a phenol occurs by sequential exo-
endo isomerisation of the arylidene double bonds to form intermediates 111 and 112, 
followed by thermal tautomerisation to afford 2,6-dibenzylphenol 110a (Scheme 63). 
 
Scheme 63. Intermediates formed during the iridium-catalysed isoaromatisation of 2,6-





 reported isoaromatisation of cyclohexenones and their corresponding 
oximes under relatively mild conditions, catalysed by treatment with 10 – 15 mol% 




Table 8. Formation of substituted phenols and anilines via RhCl3-catalysed isoaromatisation. 

























[a] Reagents and conditions, entries 1 – 5: RhCl3.3H2O (10 mol%), EtOH, 100 °C, 8 h; entries 6 – 8: 
RhCl3.3H2O (15 mol%), K2CO3 (1.4 equiv.), EtOH, 100 °C, 30 h. 
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More recently, substituted 2-cyclohexenones featuring a second exocyclic double bond 
have been constructed using ring-closing metathesis reactions, followed by 





Scheme 64. The RCM-isoaromatisation strategy for the synthesis of substituted phenols. 
 
A range of conditions previously used for the isomerisation of alkene bonds were screened, 
using model substrate 114, which resulted in [RhCl(COD)]2 and caesium carbonate (1 
equiv.) in aqueous dioxane (60 °C) being identified as the catalyst system of choice. These 
optimised reaction conditions were applied for the isoaromatisation of several highly 
substituted 6-methylidene-2-cyclohexenones, affording the corresponding phenols in good 
to excellent yields (Scheme 65). 
 
 






2.5 N-Allyl isomerisation 
The isomerisation of N-allylamines to afford enamines or amino groups is one of the most 
synthetically important double-bond migration reactions catalysed by transition-metal 
complexes, whose synthetic applications have been extensively reviewed.
199
 Briefly, the 
resultant (E)-enamine products can be isolated as potentially useful synthetic intermediates 
in good yield using a range of different transition  metal catalysts (see Table 9 for selected 
examples). 
Table 9. Transition metal-catalysed isomerisation of N-allylamines to their corresponding enamines. 
 








trans-Mo(N2)2(dppe)2             
(10 mol%),                            
toluene, 110 °C, 2 h 
 
200 








[Rh(BINAP)(COD)]ClO4        
(1 mol%),                               
H2, THF-d8, 60 °C, 23 h 
 
201 








[Rh(BINAP)(COD)]ClO4         
(1 mol%),                               
H2, THF-d8, 60 °C, 23 h 
 
198 








[Rh(BINAP)(COD)]ClO4         
(1 mol%),                               
H2, THF-d8, 60 °C, 23 h 
 
198 








[Fe(CO)5] (10 mol%) + hv,                                                                         
hexane, 20 °C, 15 h 
 
202 








[CoH(N2)(PPh3)3] (1 mol%),                                         
THF, 80 °C, 15 h 
 
203 
  100%, (E) only   
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Transition metal-catalysed isomerisation of N-allyl species has also been applied as a 
strategy for selective N-deprotection of N-allylic amines, amides and lactams. For example, 
treatment of N-allyl tertiary amines with Wilkinson’s catalyst has been reported by Davies 
and co-workers
204
 for the synthesis of enantiopure β-amino esters (Scheme 66, eq 1). 
Alternatively, a highly chemoselective N-deallylation reaction in the presence of an O-allyl 
ether, mediated by Grubbs’ ruthenium carbene has been reported by Alcaide205 for the 
synthesis of enantiopure indolizidines (Scheme 66, eq 2). 
 
 
Scheme 66. Transition metal-catalysed methods of chemoselective N-allylamine deprotection. 
 
Although the chemoselectivity displayed by Grubbs’ ruthenium carbene complex is 
impressive, this catalyst is known to undergo competing metathesis reactions when applied 
to the isomerisation of N,N-diallyl species.
206
 However, some ruthenium complexes have 
been developed for exhaustive deallylations of both N,N-diallylaniline and N,N-diallyl-4-
nitroaniline, as well as for a large range of N-allylamides, heterocycles, primary and 







Scheme 67. Tandem ruthenium-catalysed isomerisation-hydrolysis protocol for deprotection of N-allyl 
compounds. 
 
A one-pot isomerisation-oxidative deprotection protocol for N-allylamides was reported by 
Shuto and co-workers,
208
 using the well-known alkene isomerisation catalyst 
[RuCl(CO)H(PPh3)3] for the isomerisation step. A range of amides were efficiently 
deprotected in good to excellent overall yields, with the procedure being applied to the 
synthesis of various dipeptides (Scheme 68). 
 
 
Scheme 68. One-pot ruthenium-catalysed isomerisation-oxidative deprotection of N-allylamides. 
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Alternatively, N-allylamides can be deprotected upon heating with palladium(II) 
trifluoroacetate in the presence of a diphosphine ligand and water, as reported by Tokunaga 





Scheme 69. Palladium-mediated hydrolytic cleavage of N-allylamides. 
 
Various asymmetric isomerisation reactions of prochiral allylic amines have been reported, 
with rhodium being the transition-metal most often employed for this purpose,
210
 such as 
the famous asymmetric isomerisation of N,N-diethylgeranylamine that is used as a key step 




Scheme 70. The Takasago process for the asymmetric synthesis of (–)-menthol. 
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2.6 Isomerisation of O-allyl and S-allyl compounds 
2.6.1 O-Allyl ethers 
In 2007, Kuźnik and Krompiec published a short but comprehensive review of alkene bond 
migration in O-allyl systems, catalysed by transition metal complexes.
212
 Examples of 
isomerisation reactions of allylic ethers, allyl silyl ethers, allylic carboxylates and allylic 
acetals, tandem metathesis and Claisen rearrangement reactions involving isomerisation of 
O-allylic substrates, were also described. This review also includes a thorough discussion 
of various mechanistic and stereoselectivity models that have been developed to explain 
the outcome of these isomerisation reactions. 
In 1973, Corey
213
 reported the first transition-metal catalysed isomerisation of O-allyl 
ethers, followed by hydrolysis with dilute aqueous hydrochloric acid, as a chemoselective 
method for their deprotection (Scheme 71). The isomerisation reaction was carried out by 
heating the allyl ether with Wilkinson’s catalyst RhCl(PPh3)3 in aqueous ethanol, in the 
presence of DABCO to prevent catalyst poisoning due to aldehyde formation. Under these 
reaction conditions other alcohol protecting groups, such as benzyl ethers, aryl ethers, alkyl 
ethers and esters, remain unaffected. Previous methods for the deprotection of allyl ethers 
involved the use of strong acids, oxidation with SeO2,
214
 or treatment with strong base
215
 to 
form enol ethers which were subsequently hydrolysed or oxidised. 
  
 
Scheme 71. Deprotection of allyl ethers via isomerisation to their corresponding enol ethers. 
 
An early example of stereoselective allyl ether isomerisation with respect to alkene 
geometry was reported by Felkin,
216
 in 1978. Hydrogen activation of the cationic iridium 
complex [Ir(PPh2Me)2(COD)]PF6 resulted in a catalyst which was found to selectively 
79 
 
isomerise various O-allyl ethers to (E)-1-propenyl ethers (Scheme 72). Particularly 
impressive features of this reaction are the excellent (E):(Z) ratios of the products obtained 
(>30:1), the low catalyst loading required, the extremely mild conditions and short reaction 
times. However, it appears to be limited to primary allylic ether substrates, since attempted 
isomerisation of secondary allylic ethers under the same conditions resulted in no reaction, 
even at 65 °C. 
 
 
Scheme 72. Isomerisation of allyl ethers to enol ethers catalysed by [Ir(PPh2Me)2(COD)]PF6 at room 




H2]allyl methyl ether (cf. 129a) was shown to afford the (E)-1-
propenyl methyl ether (cf. 130a) with deuterium incorporated at C3 and C1 of the allyl 
group, but not at C2. This strongly implies that isomerisation occurs via formation of a π-
allyliridium hydride intermediate, as shown in Scheme 73. It appears that there is sufficient 
steric demand to ensure that the catalyst can only form a π-allyl complex with a syn 
configuration, whose hydrogen atoms occupy ‘endo’ positions. Such an intermediate can 




Scheme 73. Mechanism of allyl ether isomerisation via formation of a π-allyliridium hydride species. 
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The reaction has often been utilised for the removal of O-allyl protecting groups, via 







cleavage of the resultant 1-propenyl ethers. For example, this procedure was recently used 
by Bittman
221
 in order to isomerise O-allyl ether 131 during the synthesis of an unnatural 




Scheme 74. Highly (E)-selective iridium-catalysed isomerisation of an allyl ether during total synthesis. 
 
A complimentary, highly (Z)-selective isomerisation procedure for allylic acetals and 
ethers was reported by Frauenrath, in 1998.
222
 Treatment of a range of substrates with 4 
mol% NiCl2(dppb), activated with an equimolar quantity of LiEt3BH led to formation of 
the corresponding (Z)-1-propenyl species with excellent stereocontrol, with the exception 
of 3-buten-2-yl ether 133d which afforded a 75:25 mixture of (Z)- and (E)-isomers, 
respectively (Scheme 75). 
 
 




The original method introduced by Corey
213
 has since been used extensively for the 
selective deprotection of O-allyl ethers, particularly for applications in carbohydrate 
chemistry,
223,224,225,226,227
 and for the preparation of 1-propenyl ethers as substrates for 
Diels-Alder reactions.
228
 A recent report from Golding described the direct removal of a 
phenolic allyl ether using Corey’s conditions, without the need for an acidic hydrolytic 
work-up step.
229







have also been used to carry out the isomerisation of allyl ethers, prior to hydrolytic 
cleavage of the resulting 1-propenyl ethers. 
In 1996, Boons
233
 reported a modification of Corey’s protocol
213
 for the isomerisation of 
O-allyl glycosides to form novel glycoside donors. Pre-treatment of Wilkinson’s catalyst 
with 1.5 equivalents of n-BuLi in THF afforded a catalyst which efficiently isomerised a 
range of allylic glycosides to their vinylic counterparts, without the requirement for a 
DABCO additive (Table 10). The reduction of allyl ethers to n-propyl ethers, which had 
previously been found to occur
234,235,236 
using Wilkinson’s catalyst via transfer of hydrogen 
from the alcohol solvent was also avoided. The active catalyst is likely to be RhH(PPh3)3, 
formed via replacement of the chloride ligand with a butyl group that then undergoes β-
hydrogen elimination. Independent preparation of this complex revealed that it possessed 















Table 10. Isomerisation of allyl ethers and glycosides using modified Wilkinson catalyst. 
 












































 135g 136g  
[a] (E):(Z) ratios of products were not stated in the original publication. 
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This method has since evolved into a routine procedure for the selective removal of allylic 
ethers in carbohydrate chemistry,
237,238,239




A modified version of Corey’s protocol,213 where the DABCO additive was substituted 
with DBU, was reported by Hirama
242
 for the synthesis of the ABCD ring system of 
ciguatoxin, whereby allylic ether 137 was isomerised to its corresponding enol ether 138 
(Scheme 76, eq 1). A similar reaction was also utilised by Hirama
243
 as part of the 
synthesis of a trans-fused polycyclic ether skeleton (Scheme 76, eq 2). 
 
 





 reported that Grubbs’ second generation metathesis catalyst (45) could 
be used to carry out isomerisation reactions of allyl/homoallyl ethers and N-allyl amines, 
with full N/O-deprotection mediated by subsequent acid-catalysed hydrolysis (Scheme 77). 
By omission of the hydrolysis step, certain classes of vinyl ether (and enamine) could be 
isolated, whilst the procedure is also applicable to homoallylic ethers. 
 
Scheme 77. Isomerisation-deprotection of (homo)allyl ethers and allyl amines using Grubbs’ second 
generation metathesis catalyst. 
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 reported greatly improved 
enantioselectivities for the asymmetric desymmetrisation of cyclic allyl acetal 141a, using 
chiral nickel(II) complexes, to afford a vinyl acetal in up to 98% ee (Table 11, entry 7). 
Acceptable ee’s of 90% were obtained for analogous acetals featuring isopropyl and n-
butyl substituents using the same nickel(II) catalyst. 
 
Table 11. Asymmetric isomerisation of 4,7-dihydro-1,3-dioxepin 141a using (R,R)-(+)-CHIRAPHOS- and 
(R,R)-(–)-Me-DuPHOS-modified nickel complexes. 
 





THF 20 100(71)/48 67 
2 
 
THF 20 100/48 73 
3  THF –40 100(83)/72 82 
4 
 
Toluene 20 80/96 85 
5 
 
Toluene 20 100/2.5 80 
6  Toluene –20 100/48 92 





2.6.2 O-Allyl silyl ethers 
Transition metal-catalysed isomerisation of allyl silyl ethers constitutes an efficient route 
to silyl enol ethers, that avoids the use of a stoichiometric amount of a strong base. It also 
enables access to both geometric isomers, thus expanding the synthetic utility of these 
synthetically useful enolate equivalents. 
In 1979, Suzuki
247
 reported that treatment of allyl silyl ethers with [RuH2(PPhMe2)4], 
[RuH2(PPh2H)4], [RuH2(PPh2Me)4] or [RuH2(PPh3)4] complexes resulted in isomerisation 
to afford mixtures of (Z)- and (E)-silyl enol ethers. Almost two decades later, 
Miyaura
248,249
 applied [Ir(PMePh2)2(COD)]PF6 for the isomerisation of allyl silyl ethers to 
afford their corresponding silyl enol ethers in higher yields with better (E):(Z) ratios, under 
milder conditions. Isomerisation reactions of primary silyl ethers were found to favour 
formation of their (E)-isomer, with selectivities well above 90% in most cases (Table 12). 
For secondary silyl ethers, the (E):(Z) ratios were found to be more modest, although 
substrates featuring branched alkyl groups in their allylic 2-positions yielded cis-enol 



















Table 12. Isomerisation of primary and secondary allyl silyl ethers (143). 
 
                     [Ir(COD)(PMePh2)2]                   [Ir(COD)2]PF6/2PPr3 
Entry Allyl silyl ether (143)     Yield (%)        (E):(Z)      Yield (%)  (E):(Z) 
1 
 
78 99:1 74 99:1 
2 
 
84 97:3 92 99:1 
3 
 
91    
4 
 
87 94:6   
5 
 
76 98:2 77 96:4 
6 
 
<10  85 88:12 
7 
 
84 68:32   
8 
 
96 96:4 95 63:37 
9 
 
  83 12:88 
10 
 
  93 1: >99 
11 
 
trace  96 1: >99 
 
Exploiting the discovery of the ability of (arene)chromium tricarbonyl complexes to 
catalytically isomerise conjugated dienes
250
 at room temperature via a 1,5-hydrogen shift 
pathway, Shibasaki
251
 developed a procedure for the synthesis of silyl dienol ethers 145 for 
use as substrates in Diels-Alder reactions (Table 13). 
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Table 13. Synthesis and isomerisation of various [(silyloxy)methyl]butadiene derivatives. 
 




































2.6.3 Isomerisation-Claisen Rearrangement (ICR) 
The Claisen rearrangement of allyl vinyl ethers constitutes a valuable synthetic strategy for 
the preparation of γ,δ-unsaturated aldehydes and ketones,
252
 although preparation of the 
required allyl vinyl ether substrates is often difficult. A convenient and versatile method 
for their preparation consists of transition metal-catalysed isomerisation of diallyl ethers to 
form allyl vinyl ethers, followed by a thermal [3,3] sigmatropic rearrangement. The term 
isomerisation-Claisen rearrangement (ICR) reaction has been coined to describe this 
process, an early example of which was reported in 1977 by Salomon.
253
 A series of 
unsymmetrical diallyl ethers 147a-i were treated with 0.1 mol% RuCl2(PPh3)3 at 200 °C in 
the absence of solvent (Table 14), with regioselective 1,3-hydrogen migration and 
subsequent Claisen rearrangement of the resulting allyl vinyl ethers leading to the 
formation of γ,δ-unsaturated carbonyl compounds 148a-i. 
Table 14. ICR reactions of substituted bis(allyl) ethers 147a-i. 
 






   1 
  
1 92 89 
           147a        148a    
   2 
 
 
1 90 99 
           147b        148b    
   3 
  
1.5 71 100 
 
          147c        148c    
   4 
  
3 56 70[a] 
 
          147d        148d    
89 
 






   5 
 
 
1.5  95 
           147e        148e    
   6 
 
 
1.5 84 93 
           147f        148f    
   7 
 
 
4 80 92 
           147g        148g    
   8 
 
 
2 78 83 
           147h        148h    
   9 
 
 
4 55 100 
           147i        148i    
[a] Also isolated: Δ3-cyclopentenyl methylallyl ether and methylallyl alcohol. 
 
Clearly, in the cases of diallyl ethers 147g/147h, only one of the two alkenes present 
migrates to form an allyl vinyl ether, that then rearranges to afford a single product. The 
products observed from ICR reactions of diallyl ethers 147a-f correlate with the order of 
relative reactivity for alkene migration, which is generally considered to be: 
monosubstituted > 1,2-disubstituted > 1,1'-disubstituted > trisubstituted, reflecting the 
stabilities of the parent alkene. In the case of ether 147i, which features two 
monosubstituted alkenes, isomerisation of the α-methylallyl ether is disfavoured to a 
surprisingly large extent, with the two competing rearrangement products 148i  and 148i′ 





Scheme 78. Competing products formed from an isomerisation-Claisen rearrangement of a diallyl ether 147i. 
 
Modifications to the diallyl ether isomerisation-Claisen rearrangement (ICR) protocol have 
since been reported that proceed at significantly reduced reaction temperatures. For 
example, Ishii
254
 reported an iridium-catalysed ICR procedure in 2000, using a PCy3 co-
catalyst and reaction temperatures of 100 °C. Although these protocols allow facile access 
to γ,δ-unsaturated carbonyl compounds from easily prepared allyl homoallyl or bis(allyl) 
ethers, in all cases the products were obtained as diastereoisomeric mixtures. Chiral 
information is normally faithfully transcribed during [3,3] sigmatropic rearrangements due 
to the six-membered transition states through which they occur. Non-selective 
isomerisation reactions that form mixtures of (E)- and (Z)-vinylic ether isomers were 
therefore proposed to be responsible for the formation of diastereoisomeric syn/anti 
mixtures in these Claisen-rearrangement reactions. 
Highly diastereoselective ICR reactions have been developed by Nelson and co-workers,
255
 
who reported the first syn-selective example in 2003. The catalyst [Ir(PCy3)3]BPh4 was 
used for the stereoselective isomerisation-rearrangement of a range of diallyl ethers, 
forming their corresponding syn-2,3-dialkyl-4-pentenal derivatives with excellent levels of 
diastereocontrol (Scheme 79). Ether substrates bearing a variety of substituents at their 
carbinol (R
3
) and allylic (R
2
) positions gave their corresponding Claisen products with 








Scheme 79. Syn-selective ICR reactions of substituted bis(allyl) ethers. Isolated yields are reported for the 
primary alcohols derived from iBu2AlH reduction of the initial aldehyde products 150a–l. 
 
The high (E)-selectivity that is characteristic of iridium-catalysed allyl ether isomerisations 
allowed (E,E)/(E,Z)-mixtures of diallyl ethers 149e and 149i to be converted into 
rearrangement products with excellent levels of syn-selectivity. The synthetic utility of this 
method was demonstrated by its application for the asymmetric synthesis of (+)-calopin 









 reported anti-selective ICR reactions of several allyl vinyl ethers that 
are complimentary to their syn-selective thermal counterparts. By combining the 
established iridium(I)-catalysed diallyl ether isomerisation reaction with palladium(II)-
catalysed Claisen-rearrangement, a range of anti-2,3-disubstituted-4-pentenals could be 
formed with consistently high selectivities (Scheme 81). This protocol was also extended 
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to ICR reactions of chiral diallyl ethers (155f-h), with minimal erosion of their 
stereochemical purity during the rearrangement step. In contrast to the thermally induced 
Claisen rearrangement, control of vinyl ether geometry was not a pre-requisite for the 
formation of a stereodefined product. Vinyl ethers which were prepared as mixtures of (E)- 
and (Z)-isomers (156e-f) reliably delivered anti-products, presumably due to the reaction 
conditions facilitating facile interconversion of these geometric isomers. 
 
Scheme 81. Anti-selective ICR reactions of substituted bis(allyl) ethers. 
[a] Isolated yields over two steps. 
[b] Reactions carried out using enantioenriched diallyl ethers 155f-h proceeded with 97-99% retention of 
chirality to afford aldehydes 157f (84% ee), 157g (86% ee) and 157h (92% ee). 
The anti-selectivity of the palladium(II)-catalysed rearrangement was rationalised by a 
bidentate mode of coordination of the substrate to the metal centre, leading to a boat-like 
transition state (Figure 3) and subsequent transfer of chirality to the products. 
 
Figure 3. Postulated mechanism for Pd(II)-catalysed Claisen rearrangements. 
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2.6.4 Isomerisation of S-allyl sulphides and sulphoxides 
Isomerisation of S-allylic compounds to their corresponding vinylic species is not normally 
carried out using transition metal catalysts, due to rapid poisoning of the catalyst. 
However, a rare example of transition metal-catalysed isomerisation of S-allylic 
compounds to their 1-propenyl counterparts using RuCl(CO)(PPh3)3 was reported in 2003 
by Kuźnik.
258
 Attempted isomerisation of phenyl allyl, ethyl allyl and diallyl sulphide 
substrates resulted in very little isomerisation occurring due to competitive carbon-sulphur 
bond cleavage and the formation of catalytically inactive species. The best yields of 
isomerised products were obtained using tert-butyl allyl sulphide and trityl allyl sulphide 
(Scheme 82, eqs 1 and 2, respectively) where the steric bulk surrounding the sulphur atom 
is likely to inhibit coordination to the ruthenium centre. Allylic sulphones (Scheme 82, eqs 
3 and 4) also gave comparatively good yields for formation of their corresponding vinylic 
isomers, probably due to the absence of donatable electron lone pairs at sulphur. For those 
substrates that undergo isomerisation, high levels of conversion to the (Z)-isomer were 
observed, with selectivity decreasing over time, implying that (Z)/(E) isomerisation was 
occurring after the initial double bond migration. However, immediately terminating the 
reaction when >99% of the starting material had been consumed enabled isomerised 
products to be obtained in high geometric purity. 
 
 




2.6.5 Isomerisation of allylic alcohols to carbonyl compounds 
A recent review of allylic alcohol isomerisation, that also includes coverage of 1,3-
rearrangement reactions and propargylic alcohol isomerisations, has been published by 
Gimeno.
259





 The transition-metal catalysed isomerisation reactions of allylic 
alcohols constitutes a potentially convenient shortcut to carbonyl compounds, whose 
preparation might otherwise require a two-step sequential oxidation/reduction protocol 
(Scheme 83). This conversion is achieved via a one-step internal redox reaction, enabling 
the use of expensive and/or toxic oxidising reagents to be avoided. 
 
 
Scheme 83. Isomerisation of allylic alcohols represents a convenient shortcut to carbonyl compounds.262 
 
Two main mechanisms have been proposed for this reaction (Scheme 84); firstly, 
sequential addition-elimination of a metal-hydride species, M–H, to form an enol which 
subsequently tautomerises. Alternatively, association of the alkene bond with a metal 
centre bearing two vacant coordination sites is followed by formal oxidative addition of a 
C–H bond to yield a π-allylmetal hydride species, that undergoes reductive elimination to 
form a coordinated enol that tautomerises to its keto form upon decomplexation from the 
metal centre. Because the carbonyl compound is thermodynamically more stable than the 






Scheme 84. (a) π-Allylmetal hydride mechanism. (b) Metal-hydride addition-elimination mechanism.           
(S = 2e- vacant site or labile ligand).143 
 
A representative example of this type of isomerisation occurred during an attempt to carry 
out the hydroxyl-directed hydrogenation of the alkene bond of 158 with Crabtree’s catalyst 
(Scheme 85). Instead of alkene hydrogenation occurring, the use of this catalyst resulted in 
stereoselective isomerisation of the allylic alcohol 158 to afford aldehyde 159, which was 





Scheme 85. OH-directed isomerisation of allylic alcohol 158 to afford lactol 160. 
 
Recent challenges addressed in this area have been broadening the substrate scope of 
catalysts and the development of enantioselective reactions. In 2006, Crochet
262
 reported 
the use of a ruthenium phosphite catalyst to isomerise a range of trisubstituted allylic 
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alcohols that were known to be particularly unreactive toward previously described 
catalyst systems (Table 15). Mono- and disubstituted allylic alcohols were also converted 
to carbonyl compounds, in ~99% yield, at ambient temperatures and low catalyst loadings. 
 
Table 15. Isomerisation of different types of substituted allylic alcohols. 
 
Entry Substrate T (°C) Time (m) Yield (%) TOF (h-1) 
1 
 
35 5 99 238 
2 
 
75 10 99 494 
3 
 
35 10 99 119 
4 
 
35 5 97 233 
5 
 
35 35 99 34 
6 
 
35 50 99 24 
7 
 
35 25 99 48 
 
An example of asymmetric allylic alcohol isomerisation was reported by Fu
264,265
  in 2001 
(Scheme 86), which constituted a significant improvement upon the previous best results 







Scheme 86. Asymmetric allylic alcohol isomerisation. Aldehydes 163a-f derived from their corresponding 




 has reported high levels of stereoselectivity during asymmetric 
redox isomerisation of primary allylic alcohols to aldehydes, using iridium-based catalysts 
(Scheme 87). The lower ee’s obtained from isomerisation of the (Z)-allylic alcohols 166g 
and 166h were shown to be a consequence of a competing (E)/(Z)-isomerisation pathway. 
 





 has also reported greatly improved selectivity, towards (Z)-configured and 
aliphatic allylic alcohols, using an analogous iridium-based catalyst 168 (Scheme 88). 
 
 





















 reported the synthesis and reactivity of ruthenium(II) complex 58 as a 
catalyst capable of mediating multiple isomerisation reactions (see Table 16, below). A 
range of analogous complexes were screened, with 58 found to be the best catalyst, which 
efficiently isomerised a range of both functionalized and unfunctionalized alkene 
substrates at low catalyst loadings, affording (E)-alkenes in high purity. Scheme 89 depicts 
the proposed mechanism of the catalyst’s activity: the first step in the catalytic cycle 
involves displacement of an acetonitrile ligand by the substrate alkene, with the basic 
nitrogen of the imidazole ligand then deprotonating its allylic position to afford 169. 
Transfer of a proton from nitrogen to either end of the allyl moiety then either reforms the 




Scheme 89. Mechanistic hypothesis for the isomerisation activity of 58. 
 
Although most reactions were not optimised, the remarkable ability of 58 to isomerise a 
variety of heterofunctionalised alkene-derivatives, with high levels of (E)-selectivity and at 
low catalyst loadings, is summarised in Table 16. Particularly impressive is the double 
isomerisation of diallyl ether (entry 2), with neither Claisen rearrangement of the 
intermediate allyl vinyl ether, or detectable amounts of the (E,Z)-species being present. 
This provides ready access to a relatively unexplored class of compounds which had 
previously been prepared as mixtures using strong base.
269
 Unsaturated alcohols were also 
100 
 
efficiently isomerised to afford their corresponding saturated carbonyl compounds via 
tautomerisation of an intermediate enol species (entries 6, 7, 9–12). 
 
Table 16. Scope and limitations of catalyst 58. 




Time Yield  
(%) 
1   2 25 15  m 95 
2 
  
2 25 40  m 96 
3 
  
2 25 4  h 75[b] 
4 
  
2 25 26  h 70:30[a] 
5 
  
2 25 4  d 61[b] 
6 
  
2 70 1  h 95 
7 
  
2 70 1  h 97 
8 
  
5 70 4  h 90 
9 
  
5 70 4  h 84 
10 
  
5 70 4  h 97 
11 
  
20 70 3.6  d 91 
12 
  
30 70 3  d 81 
[a] Equilibrium ratio reached from either side within 2 – 4 h using 2 mol% of 58 at 70 °C. 





 reported the effect of the presence of an ortho-phenol group upon the 
course of palladium-catalysed isomerisation reactions of alkenyl side chains. Treatment of 
substituted phenol 171a with 10 mol% of palladium(II) chloride and iron(III) chloride 
resulted in formation of an isomeric alkene 172a in 92% yield (Scheme 90). The same 
reaction conditions, when applied to 171b, that lacks a hydroxyl group, failed to afford 
more than trace amounts of the corresponding trisubstituted alkene 172b, instead resulting 
in migration of the alkene bond through just one bond to form 173b. 
 
 
Scheme 90. The influence of an ortho-phenol hydroxyl group on palladium-catalysed alkene isomerisation 
reactions. 
 
Tandem Heck coupling-alkene isomerisation to form carbonyl compounds has been 
frequently reported as a result of reactions between allylic
271
 or homoallylic alcohols
272
 and 
aryl halides. After formation of the cross-coupled product, a palladium hydride species 
mediates isomerisation of the alkene bond by reversible hydropalladation and β-hydrogen 
elimination. Subsequent formation of an enol, which rapidly tautomerises to the 
corresponding carbonyl compound, can act as an efficient thermodynamic sink to produce 
ketones or aldehydes as major products. However, this process is comparatively rare for 
reactions involving longer-chain alkenols, where products of partial isomerisation and/or 
regioisomeric coupling products are often obtained in significant amounts.
273
 The 
formation of ketone products via Heck-coupling of non-allylic alcohols with a range of 
aryl bromides, reported by Crawley
274
 in 2009, is a particularly efficient example of this 
type of reaction (Scheme 91). 
 




As part of investigations into preparing libraries of nonsteroidal agonists of the farnesoid X 
receptor, Heck reactions between an aryl bromide 175 and γ-hydroxyalkene 174 were 
carried out to afford a range of bis-aryl ketones 176 (Scheme 92). The isomerisation 
reaction proved to be less efficient when the alkenyl chain was shortened, forming 
numerous positional isomers arising from partial isomerisation. 
 
 
Scheme 92. Palladium-catalysed tandem Heck-isomerisation reactions. 
[a] Significant amounts of positional isomers formed. 
 
The ability of RuClH(CO)(PPh3)3 to isomerise a double bond out of conjugation with an 
electron-withdrawing group and into conjugation with another electron-withdrawing group 
was reported in 2000, by Mori and co-workers.
275
 Initially, treatment of α,β-unsaturated 
ester 177 with 1.7 mol% of RuClH(CO)(PPh3)3 in refluxing toluene for two hours was 
found to result in quantitative conversion to a mixture of non-conjugated isomers 178 
(Scheme 93). This result was surprising because alkene isomerisation usually results in 
conversion of a less thermodynamically stable isomer into a more stable one, with α,β-
103 
 




Scheme 93. Deconjugative isomerisation of an α,β-unsaturated ester catalysed by RuClH(CO)(PPh3)3. 
 
In order to exploit this result for the formation of other types of functionalised alkenes, 
isomerisation reactions of terminally functionalised α,β-unsaturated esters were carried out. 
A series of α,β-unsaturated esters containing a terminal silyl ether substituent were found 
to selectively afford their corresponding silyl enol ethers via isomerisation reactions 
mediated by the ruthenium catalyst, although the yield generally decreased with increasing 
length of the alkyl chain linker (Table 17).  
 
Table 17. Effect of chain length on the isomerisation of 179 to 180. 
 
Entry Substrate n Time (h) Yield of 180 
(%) 
(E):(Z) 
1 179a 0 2 97 1:2.1 
2 179b 1 2 94 1:2.2 
3 179c 2 2 80 1:2.2 
4 179d 3 2 85 1:2.2 
5 179e 4 4 78 1:2.0 




In order to probe the scope and limitation of this reaction, a range of α,β-unsaturated 
carbonyl compounds featuring various electron-withdrawing groups at their termini were 
synthesised and subjected to the same reaction conditions (Table 18). Isomerisation was 
found to proceed smoothly in each case, forming a benzyl enol ether (entry 1), conjugated 
enyne (entry 2) and styrene derivative (entry 3) via alkene isomerisation of the parent α,β-
unsaturated esters. Isomerisations of an α,β-unsaturated amide (entry 4) and ketone (entry 
5) were also successful, although in the latter case extended reaction times were necessary, 
presumably due to the strong coordinating properties of its carbonyl group. 
Table 18. Isomerisation of α,β-unsaturated carbonyl compounds.[a] 
 























































 179k 180k   
[a] Starting material was recovered in 23% yield. 
[b] (E,E)/(Z,E) of 180i = 2.2/1. 
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This unusual type of isomerisation-deconjugation reaction has since been utilised by 
Nishida
276
 and co-workers during the course of their synthesis of the reported structure of 
fistulosin (184a/184b, Scheme 94).
277
 Treatment of α,β-unsaturated ester 182 with 
RuClH(CO)(PPh3)3 (10 mol%) in refluxing toluene resulted in deconjugation of the alkene 
from the ester functionality to afford N-tosyl-enamine 183 in high yield. 
 
 















Transition metal-catalysed isomerisation reactions of alkenes are a potentially powerful 
class of reactions which we believe are underexploited in organic synthesis. The above 
review is intended to give a concise account of the range of synthetically relevant alkene 
isomerisation reactions that have been carried out using transition metal catalysts. In the 
following chapter, I will now discuss my own work in this area, namely the palladium-
catalysed isomerisation of exomethylenic alcohols to afford their corresponding 
trisubstituted isomers. This reaction is unique because, in all other reported cases, 
migration of the alkene bond of an allylic alcohol results in formation of its corresponding 
saturated aldehyde or ketone. In the third chapter, strategies for the migration of a 
trisubstituted alkene bond with the simultaneous creation of a new stereogenic centre are 
described. In this case a chiral organoborane reagent, rather than a transition metal, was 
utilised. Although this novel approach for the creation of alkenes featuring chiral 
substituents proved not to be feasible, it did lead to the development of a novel strategy for 















3. Isomerisation of exomethylenic allylic 
alcohols 
This chapter describes my investigations into the synthetic utility of a novel palladium 
catalysed isomerisation reaction that converts exomethylenic allylic alcohols into their 
corresponding allylic alcohol isomers. 
3.1 Introduction and previous work 
As part of an investigation carried out by a previous member of the Bull group employing 
hydroxyl-directed catalytic hydrogenation reactions for the asymmetric synthesis of chiral 
α-methyl aldehydes,278 authentic samples of aldol diastereomers 187a and 187b were 
required. It was found that treatment of exomethylenic allylic alcohol 185 in IPA with 
Pd/C (3 mol% Pd) under one bar of hydrogen for three hours did not afford the expected 
diastereomeric hydrogenated products 187a/187b, but instead gave the isomerised 
trisubstituted (E)-allylic alcohol 186 in >95% yield (Scheme 95). Neither prolonged 
reaction times nor increased hydrogen pressure (up to 5 bar) were found to significantly 
alter the product distribution. No reaction occurred in the absence of either the palladium 
catalyst or hydrogen gas, and substitution of palladium(II) acetate for Pd/C also gave the 
same product ratio of isomerised alcohol 186 to hydrogenated alcohols 187a/187b. A 
variety of solvents were then screened but the only effect observed was the extent of 
substrate conversion, which roughly corresponded to the polarity of the solvent employed. 
These results were unexpected, since palladium catalysts had been used previously to 
reduce the alkene functionality of a number of related allylic alcohols.
279
 Importantly, 
products arising from migration of the alkene towards the hydroxyl group to afford an 
intermediate enol species that could then tautomerise to the corresponding diastereometic 
ketones 188a/188b were not observed. This was particularly surprising since palladium-
catalysed isomerisation of allylic alcohols to their corresponding saturated carbonyl 







Scheme 95. Palladium-catalysed isomerisation of exomethylenic allylic alcohol 185 to afford trisubstituted 
(E)-allylic alcohol 186. 
 
The mechanism of this isomerisation reaction was subsequently investigated using 
palladium(II) acetate and deuterated reagents. Firstly, the reaction was performed using 
hydrogen gas in isopropanol-d8 as solvent, with deuterium incorporation into the 
isomerised product being limited to exchange of the hydroxylic proton (Scheme 96, eq 1). 
Secondly, the reaction was performed using deuterium gas in place of hydrogen, which 
afforded a somewhat reduced yield of the isomerised product, presumably due to a kinetic 




D NMR spectroscopic analysis showed that 








The mechanism of this isomerisation reaction was proposed as follows (Figure 4): Initial 
Markovnikov addition of palladium(II) deuteride across the alkene bond of 185 
incorporates the first equivalent of deuterium, with subsequent β-hydrogen elimination of 
the resulting palladium-alkyl species 189-d affording the monodeuterated trisubstituted 
(E)-allylic alcohol 190-d. The mixed palladium(II) hydride species then undergoes rapid 
exchange with the vast excess of molecular deuterium present to afford palladium(II) 
deuteride, which undergoes readdition across the alkene bond of 190-d to afford, after 
selective β-elimination of the hydrogen, the dideuterated product 186-d2. It should be noted 
that if the isomerisation reaction proceeded via an alternative π-allyl hydride mechanism 
then the formation of a mixture of isotopomeric products, each containing between one and 




Figure 4. Proposed mechanism of palladium-catalysed isomerisation of exomethylenic allylic alcohol 185 to 
afford trisubstituted (E)-allylic alcohol 186-d2. 
 
Exo-methylene isomerisation reactions of related allylic alcohol substrates have also been 
encountered as undesired side-reactions in hydrogenation reactions by Evans,
281
 who 
reported reduced diastereoselectivites during rhodium(I)-catalysed hydroxyl-directed 
hydrogenations of allylic alcohols  192 and 194 (Scheme 97). The formation of small 
amounts of ketonic byproducts 196a/196b, with the observation that hydrogenation of each 
allylic alcohol isomer results in opposite diastereocontrol, implied that a competing alkene 
110 
 
isomerisation pathway might be responsible. Prior reduction of the catalyst precursor with 
hydrogen gas to afford the catalytically active cationic rhodium(I) species, followed by 
addition of substrate 192 was found to result in extensive equilibration between the di- and 
trisubstituted isomeric allylic alcohols 192/194 and saturated ketones 196a/196b. 
Selectivity could be restored by increasing the hydrogen pressure, which effectively 
suppressed the isomerisation pathway. This effect was ascribed to a change in the rate-
determining step of the reaction, from addition of dihydrogen to the catalyst at low 
hydrogen pressure, to substrate coordination to the catalyst at high pressures of hydrogen. 
 
 
Scheme 97. Interconversion of alkenes 192 and 194 in situ causes low levels of diastereoselectivity in 











3.2 Optimisation of reaction conditions 
Building upon these observations, the initial aim of my project was to determine the 
general applicability of this isomerisation reaction and its potential for development into a 
standard synthetic procedure. Accordingly, my first task was to produce a series of allylic 
alcohols 198a-c as simplified analogues of 185 (Scheme 198). These compounds were 
easily synthesised from n-octanal via a Mannich-type elimination reaction
282
 to afford an 
α-methylene aldehyde 197 that was then treated with the appropriate Grignard reagent.
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Formation of these products was confirmed by the presence of diagnostic resonances of the 
exomethylenic (at δ 4.72–5.27) and secondary alcohol fragments (at δ 3.67–5.03) in their 
1
H NMR spectra. 
 
Scheme 98. Synthesis of exomethylenic allylic alcohols 198a-c from n-octanal. 
 
 
Scheme 99. Mechanism of the Mannich-elimination reaction. 
 
To our delight, it was found that allylic alcohol 198a was successfully isomerised to its 
trisubstituted counterpart 199a in 70% yield upon treatment with palladium(II) acetate and 
hydrogen gas in isopropanol (Scheme 100, eq 1). However, a large amount of the 
hydrogenated alcohol species syn- and anti-200a (30%) was also formed under these 
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conditions, which meant that the alkene bond of 198a was significantly more susceptible to 
hydrogenation in comparison to the alkene bond of the original aldol substrate 185. This 
was presumed to be due to the reduced steric bias of the carbinol methyl group of 198a. 
Similar product ratios were also obtained using various batches of palladium on carbon. 
Unfortunately, isomerisation experiments where a partial pressure of hydrogen was used 
(i.e. < 1 bar hydrogen, remainder nitrogen) in an attempt to suppress hydrogenation, whilst 
still allowing formation of a catalytically active palladium species, resulted in competing 
formation of enones 201a/202a (Scheme 100, eq 2). 
 
 
Scheme 100. Palladium(II) acetate-catalysed isomerisation reactions of allylic alcohol 198a.  
 
From an analytical perspective, the peaks corresponding to the alkene protons of enones 
201a/202a, the alkene and carbinol protons of the starting material 198a and the (E)/(Z)-
isomers of trisubstituted allylic alcohol 199a, as well as the carbinol proton of saturated 
alcohols syn-/anti-200a, were all well resolved in the 
1
H NMR spectrum of the crude 
reaction mixture (Figure 5). The 
1
H NMR spectra obtained from the crude products of all 
subsequent isomerisation reactions using different allylic alcohol substrates were also all 
well-resolved and easily interpretable. Further analysis of crude product mixtures of 





spectroscopy and mass spectrometry, as well as comparison with literature data where 
available. Unfortunately, chromatographic separation of the trisubstituted allylic alcohols 
from their corresponding saturated alcohol products was not successful, even when 






Figure 5. Representative 1H NMR spectrum (CDCl3) of the crude product of a partial isomerisation reaction 
showing resolved resonances corresponding to enones 202a (6.68 ppm) and 201a (5.78 and 6.02 ppm), 
trisubstituted allylic alcohols (E)-199a (5.43 ppm) and (Z)-199a (5.21 ppm), starting material 198a (4.83 and 
5.05 ppm) and hydrogenated alcohols syn-200a/anti-200a (3.70 ppm). 
 
Next, allylic alcohol 198b was treated with palladium(II) acetate and hydrogen gas (1 bar), 
with the presence of the more sterically demanding isopropyl group of the carbinol carbon 
being found to reduce the rate of the competing hydrogenation reaction, allowing 
formation of trisubstituted allylic alcohol 199b in slightly higher 79% yield (Scheme 101). 
 
Scheme 101. Palladium(II) acetate-catalysed isomerisation reaction of allylic alcohol 198b. 
 
The isomerisation reaction of allylic alcohol 198c also occurred readily to give 199c in 
55% yield, accompanied by the expected but nonetheless unwanted hydrogenated product, 
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200c. However, the observation of a new hydrocarbon product 205c in the 
1
H NMR 
spectrum of the crude post-reaction mixture was quite unexpected (Scheme 102). 
 
Scheme 102. Palladium(II) acetate-catalysed isomerisation reaction of allylic alcohol 198c. 
It was considered likely that protonation of the hydroxyl group from the alcohol solvent 
was responsible for palladium-mediated hydrogenation reactions having occurred to afford 
intermediate alkene species 203c and 204c that were then swiftly hydrogenated to give the 




Scheme 103. Formation of hydrocarbon 205c from allylic alcohols 198c/199c. 
It was found that formation of 205c could be suppressed either by substitution of aprotic 
ethyl acetate for isopropanol as solvent (Table 19, entry 2), or inclusion of caesium 
carbonate in the reaction mixture (entry 3). This latter protocol also resulted in an increase 
in the proportion of isomerised product formed, as well as a slightly higher (E):(Z) ratio. 
Table 19. Methods for suppression of the formation of hydrocarbon 205c during isomerisation of allylic 
alcohol 198c (see Scheme 103). 










(h)    
               199c      syn-/anti-200c            205c 
1 IPA 0 1 55 (9:1) 15 30 
2 EtOAc 0 1.5 83 (12:1) 7 10 
3 IPA 1 1 80 (14:1) 20 0 
[a] Values in parentheses denote (E):(Z) ratios. 
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From the results of these initial test reactions, 198a was identified as being the most 
reactive of the three substrates and also the most prone to hydrogenation at the expense of 
isomerisation. Therefore, this allylic alcohol was chosen as a model substrate for 
optimisation of the reaction conditions. Initially, a variety of protic, polar and non-polar 
solvents were screened and the reaction mixtures periodically analysed by 
1
H NMR 
spectroscopy in order to determine the amount of trisubstituted allylic alcohol present 
(Table 20). 
 
Table 20. Solvent screen for the palladium(II) acetate-catalysed isomerisation reaction of allylic alcohol 
198a. 
 







(m)     
              199a    syn-/anti-200a             201a             202a 
   1 IPA 20 70 (8:1) 30 0 0 
   2 MeOH 5 68 (7:1) 32 0 0 
   3 EtOH 15 63 (7:1) 37 0 0 
   4[b] t-BuOH 15 62 (7:1) 38 0 0 
   5 MeCN 3 79 (8:1) 21 0 0 
   6[c] THF 15 63 (7:1) 13 4 12 
   7[c] Acetone 10 56 (7:1) 13 6 8 
   8 PhMe 30 57 (5:1) 30 0 13 
   9 EtOAc 12 53 (5:1) 30 0 17 
   10[c] CH2Cl2 10 55 (7:1) 10 3 3 
[a] Numbers in parentheses denote (E):(Z) ratios; [b] reaction carried out at 28 °C; [c] remaining mass 
balance comprised of starting material 198a. 
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From the table, acetonitrile (entry 5) can clearly be identified as the best solvent that 
provides the highest selectivity towards isomerisation versus hydrogenation with an 
extremely short reaction time, followed by isopropanol which gives a greater proportion of 
hydrogenated product (entry 1). All other alcohols tested (entries 2–4) gave similar results 
to isopropanol, with a particularly fast reaction found to occur in methanol (entry 2). 
Interestingly, with the exception of acetonitrile, the oxidative side-reaction to afford ketone 
products was limited to aprotic solvents (entries 6–10). A correlation between hydrogen 
solubility, solvent polarity and selectivity toward isomerisation is also apparent. Firstly, the 
known order of increasing hydrogen solubility (at 298 K and 1 bar hydrogen pressure) in 
these solvents is as follows: MeCN < CH2Cl2 < THF < acetone < PhMe.
286
 Although this 
data was obtained at different pressures (>1 bar), another paper reports that the solubility 
of hydrogen in ethyl acetate is greater than in ethanol, which, in turn, is higher than that of 
methanol.
287
 Indeed, the solubility of hydrogen in n-alcohols (number of carbons = 1 – 4) 
is also known to increase with increasing alkyl chain length.
288
 The solubilities of 
hydrogen in ethyl acetate, toluene, isopropanol, ethanol and THF have also all been 
measured at a pressure of 10 bar.
289
 It can therefore be surmised that hydrogen solubility in 
my isomerisation reactions also increases in the following order: MeOH < EtOH < IPA < 
THF < PhMe < EtOAc. These trends indicate that selectivity for isomerisation over 
hydrogenation is favoured by a low solubility of hydrogen in the reaction solvent and a 
high solvent polarity. Acetonitrile and the alcoholic solvents follow this trend, although 
isopropanol outperforms methanol and ethanol which implies that other factors may be 
involved. Toluene, which was both the least polar and the worst solvent, has the second 
highest solubility of hydrogen and also the lowest polarity. The use of this solvent also 
resulted in the slowest rate of reaction, whilst the highest rates were observed in the most 
polar solvents methanol and acetonitrile. 
Next, using acetonitrile as solvent, the beneficial effect of the caesium carbonate additive 
upon the isomerisation of 198a was established. The presence of caesium carbonate was 
found to increase the proportion of trisubstituted allylic alcohol 199a relative to 
hydrogenated product 200a, whilst also improving the (E):(Z) ratio (Table 21). However, 
the overall reaction rate was observed to have decreased threefold. As the base is unlikely 
to interact directly with the catalyst, its most likely function is deprotonation of the 
hydroxyl group. The resulting alkoxide anions are likely to coordinate to the palladium 
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more strongly, deactivating its ability to catalyse the hydrogenation pathway relative to the 
isomerisation pathway. 
Table 21. Establishing the influence of Cs2CO3 upon the palladium-catalysed isomerisation reaction of 
allylic alcohol 198a. 
 








                 199a    syn-/anti-200a 
1 0 3 79 (8:1) 21 
2 1 9 84 (10:1) 16 
[a] Numbers in parentheses denote (E):(Z) ratios. 
  
Up until this point, the amount of palladium catalyst and the substrate concentration used 
had been arbritarily set at 10 mol% and 1.0 M, respectively. Upon independently varying 
each of these parameters, the ideal conditions for these isomerisation reactions were 
serendipitously found to be: 10 mol% Pd(OAc)2, H2 (1 bar), [substrate] = 1.0 M, Cs2CO3 
(1 equiv.), as shown in Table  22, entry 2. It was found that a catalyst loading of 5 mol% 
resulted in a much slower isomerisation reaction and the formation of a larger proportion 
of hydrogenated product (entry 1), whereas using 20 mol% palladium resulted in a slightly 
less selective reaction (entry 3). Altering the substrate concentration to either 0.5 or 2.0 M 









Table 22. Determination of optimum catalyst loading and substrate concentration.[a] 

















               199a  syn-/anti-200a 
  1[c] 5 1.0 15 32 (4:1) 14 
  2 10 1.0 9 84 (10:1) 16 
  3 20 1.0 9 79 (8:1) 21 
  4[c] 10 0.5 15 41 (7:1) 24 
  5[c] 10 2.0 9 45 15 
[a] All reactions carried out at room temperature in acetonitrile, with palladium(II) acetate (10 mol%) and 
caesium carbonate (1 equiv.); [b] numbers in parentheses denote (E):(Z) ratios; [c] remaining mass balance 
comprised of starting material 198a. 
 
A range of different palladium sources were then screened, with Pd(OH)2/C identified as 
the catalyst of choice, followed by PdCl2 (Table 23, entries 6 and 5, respectively). The 
satisfactory result obtained using Pd(OAc)2 (entry 1) demonstrates that this isomerisation 
reaction can be effectively carried out under either hetero- or homogeneous catalytic 
conditions. However, catalyst precursors featuring strongly coordinating ligands did not 
produce good results. For example, the use of Pd2(dba)3 resulted in a relatively slow and 
particularly unselective reaction to afford an approximately 50:50 mixture of isomerised 
and reduced products (entry 2), whereas no reaction was observed at all using Pd(PPh3)4. 
Experiments at low temperatures were also carried out with mixed results. The use of 
palladium(II) hydroxide on carbon at 0 °C was determined to be optimal, affording 
trisubstituted allylic alcohol 199a in 90% yield with an (E):(Z) ratio of 21:1 (entry 7). 
Lower temperatures were not found to be beneficial for this catalyst and merely increased 
the yield of the hydrogenated alcohols syn-/anti-200a. In contrast, Pd/C functioned most 
effectively at –10 °C to afford an 84% yield of the isomerised allylic alcohol (entry 4). The 
use of Pd/Al2O3 (5 wt%) or Lindlar’s catalyst as palladium sources in isomerisation 
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reactions of 198a (the latter with or without the inclusion of either quinoline or ethanethiol) 
did not significantly improve the selectivity toward isomerisation over hydrogenation. 
 
Table 23. Results of the palladium catalyst screen.[a] 








Time   
               199a   syn-/anti-200a 
1 Pd(OAc)2 20 9 m 84 (10:1) 16 
2 Pd2(dba)2 20 1 h 54 (7:1) 46 
3 Pd(PPh3)4 20 24 h                    no  reaction 
4 Pd/C –10 20 m 84 (8:1) 16 
5 PdCl2 20 20 m 87 (8:1) 13 
6 Pd(OH)2/C 20 10 m 88 (11:1) 12 
7 Pd(OH)2/C 0 15 m 90 (21:1) 10 
8 Pd/Al2O3 20 5 m 79 (9:1) 21 
[a] All reactions performed in acetonitrile under hydrogen (1 bar) with 10 mol% palladium catalyst and 
caesium carbonate (1.0 equiv.); [b] numbers in parentheses denote (E):(Z) ratios. 
 
With optimised reaction conditions in hand, alcohols 198a, 198b and 198c were all 
isomerised in high yield, with favourable (E):(Z) ratios (Table 24). As expected, the best 
result was achieved using 198b as substrate. However, the maximum 96% yield of 199b 
could not be improved further by performing the reaction at a lower temperature, with the 






Table 24. Isomerisation of allylic alcohols 198a-c under the optimised conditions: [Pd] (10 mol%), H2 (1 
bar), Cs2CO3 (1 equiv.), MeCN. 






Catalyst          
(10 mol%) 
 




(m)   










































              198c      
[a] Numbers in parentheses denote (E):(Z) ratios. 
 
The scope of this isomerisation reaction was further explored by the synthesis and 
isomerisation of three pyridyl-substituted allylic alcohols, 198d-f. Mannich-type α-
methylenation of n-butyraldehyde proceeded smoothly to afford ethacrolein 206 in good 
yield. Using a slightly modified literature protocol,
290
 an excess of each of the desired 
pyridyl-Grignard reagents were then prepared in situ from addition of a solution of 
isopropylmagnesium chloride in Et2O to the appropriate bromopyridine. Subsequent 
addition of ethacrolein 206 to a solution of the respective Grignard reagent gave the 
desired allylic alcohols 198d-f, in unoptimised 34 – 60% yields. 
 
 




An alternative route to allylic alcohol 198f, via lithiation of 2-bromo-1-butene,
291
 was also 
successful (Scheme 105). However, the vinylic bromide required for this route was 
relatively expensive and as a consequence the Grignard protocol is more favoured. 
 
 
Scheme 105. Synthesis of allylic alcohol 198f from pyridine-4-carboxaldehyde. 
 
The isomerisation reactions of allylic alcohols 198d-f were then carried out using the 
optimised conditions, although isopropanol was used as solvent due to their insolubility in 
acetonitrile. Surprisingly, allylic alcohol 198d (Table 25, entry 1) was preferentially 
hydrogenated rather than isomerised, affording its trisubstituted isomer in just 27% yield 
upon full conversion of starting material. The most rational explanation for this anomalous 
behaviour is that the ortho-pyridyl nitrogen can potentially coordinate the palladium metal 
and deliver it to the terminus of the alkene bond, with anti-Markovnikov addition of 
palladium hydride affording an intermediate which is unable to undergo isomerisation, 
only reversion to starting material or hydrogenation. In contrast, the 3- and 4-pyridyl 
substituted allylic alcohols (entries 2 and 3, respectively) underwent isomerisation 













Table 25. Palladium-catalysed isomerisation reactions of allylic alcohols 198d-f. 
 







































 198f  199f:  83 (10:1) syn-/anti-200f:  17 











3.3 Isomerisation to form tetrasubstituted allylic alcohols 
All of the isomerisation reactions described to date had produced trisubstituted alkene 
bonds; it was therefore decided to test the feasibility of isomerisation to form 
tetrasubstituted alkenes. Application of the Mannich-type α-methylenation and Grignard 
reactions (MeMgI, BnMgBr) to isovaleraldehyde proceeded without incident to afford 
alcohols 198g and 198h (Scheme 106). 
 
Scheme 106. Synthesis of allylic alcohols 198g/198h. 
Application of optimal isomerisation reaction conditions to allylic alcohols 198g/198h 
furnished their corresponding tetrasubstituted isomers 199g/199h in approximately 60% 
yields (Table 26). The slightly reduced yields of isomerisation products may be due to the 
added steric requirements of the syn-periplanar conformation required for β-hydride 
elimination (see Figure 6, below). 
Table 26. Palladium-catalysed isomerisation reactions of allylic alcohols 198g/198h. 
 
Entry Substrate Time      Product distribution (%) 
 





 198g  199g:  61 200g: 39 
 





 198h  199h:  58 200h:  42 
 
Figure 6. Steric interactions which may disfavour isomerisation to form a tetrasubstituted alkene. 
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3.4 Isomerisation to form conjugated allylic alcohols 
A conclusion that can be drawn about the processes occurring during these reactions is that 
the rate of isomerisation is fast relative to the hydrogenation pathway for both disubstituted 
and trisubstituted allylic alcohol substrates. If the rate constants for hydrogenation were 
comparable to those of isomerisation then very little, if any, isomerised products would be 
observed. This inspired the preparation of substrates where the alkene of the isomerised 
product might prove more resistant to hydrogenation, so that instead of an ‘A → B → C’ 
cascade occurring, a reaction manifold involving ‘A → B or C’ would predominate. The 
allylic alcohols 198i and 198j, easily synthesised in two steps from hydrocinnamaldehyde, 
seemed to fulfil this criterion since their isomerisation would lead to an allylic alcohol 199 




Scheme 107. Synthesis of allylic alcohols 198i/198j and their expected isomerisation products 199i/199j. 
 
Unfortunately, these substrates proved unexpectedly resistant to isomerisation and were 
instead gradually hydrogenated, with the amount of isomerised product present remaining 
consistently low throughout the reaction. The best result of only 13% yield of 
isomerisation product was obtained for alcohol 198i (Scheme 108). 
 
 




This outcome was in direct contradiction to the previous observations with allylic alcohols 
198a-c. Therefore, either (1) the products of isomerisation, with the alkene conjugated to 
the aromatic ring, were more readily hydrogenated; or (2) isomerisation of the starting 
material was slow in comparison to hydrogenation. In light of the fact that conjugated 
alkenes are known to be more thermodynamically stable than their isolated counterparts, 
the second explanation appears more reasonable.  
A possible explanation for the lack of isomerisation product observed was due to potential 
coordination of the aromatic ring to the palladium catalyst. For isomerisation to occur, a 
hydrogen atom must be delivered to the terminus of the alkene in the hydropalladation step 
of the catalytic cycle, with the disubstituted sp
2
-carbon atom coordinated to palladium 
(Figure 7, path a). Subsequent β-hydride elimination from the benzylic position then 
generates the isomerised product. However, coordination of palladium by the phenyl ring 
might result in a strained transition state that cannot adopt the correct geometry to undergo 
elimination from the benzylic position. Alternatively, formation of 210b might occur via a 
six-membered transition state, and this intermediate would only lead to regeneration of the 
starting material, or (irreversible) formation of the fully hydrogenated product 200i . 
 
 
Figure 7. Hypothesised mechanism for the reduction/isomerisation of 198i. 
 
The four-carbon chain homologues 198k/198l were prepared therefore from 4-
phenylbutanal (211) using our standard Mannich-elimination/Grignard protocol (Scheme 




Scheme 109. Synthesis of allylic alcohols 198k /198l. 
Both exomethylenic allylic alcohols 198k/198l underwent isomerisation upon treatment 
with a palladium catalyst and hydrogen gas, to afford their corresponding trisubstituted 
allylic alcohols 199k/199l  (Table 27). The use of palladium(II) chloride was found to be 
optimal for isomerisation of 198k and a slightly higher yield of isomerised product 199k 
was obtained by carrying out the reaction at 0 °C (entry 2). As expected, alcohol 198l , 
featuring a more sterically demanding isopropyl carbinol substituent, was found to afford a 
higher proportion of isomerised to reduced product (entry 3). However, the extent of 
isomerisation was low in comparison to the isopropyl-substituted allylic alcohol 198b, 
which featured an aliphatic side-chain that gave its trisubstituted isomer in 96% yield 
under equivalent conditions. As the respective steric demands imposed by the n-hexyl and 
2-(phenyl)ethyl chains would not be expected to differ significantly, an electronic effect 
due to aryl coordination to the catalyst may be responsible for the reduced ratio of 
isomerised to hydrogenated products. 
Table 27. Palladium-catalysed isomerisation reactions of allylic alcohols 198k /198l. 
 





























































 198l    199l:  75 (8:1) 200l:  25 
[a] Numbers in parentheses denote (E):(Z) ratios. 
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In order to determine whether substrates containing aromatic rings capable of coordinating 
to the palladium catalyst after the hydrometalation step might be generally problematic for 
this type of isomerisation reaction, the allylic alcohol 198m was synthesised from aldehyde 
197 and benzylmagnesium bromide (Scheme 110). 
 
 
Scheme 110. Synthesis of allylic alcohol 198m. 
 
Isomerisation of 198m under the conditions originally used to isomerise the methyl and 
isopropyl analogues (198a and 198b, respectively) yielded an approximately 60:40 mixture 
of isomerised and reduced products (Scheme 111, eq 1). Based on the relative steric 
demands of the methyl, isopropyl and benzyl groups, the yield of 199m observed was 
much lower than expected. This result once again implies that the presence of a relatively 
electron-rich aromatic ring that can coordinate to the metal centre is likely to adversely 
affect the selectivity towards isomerisation over hydrogenation. However, it should be 
noted that use of optimised conditions for this reaction resulted in 198m being isomerised 
in relatively good yield (Scheme 111, eq 2). 
 
 
Scheme 111. Palladium-catalysed isomerisation reactions of allylic alcohol 198m under unoptimised (eq 1) 





3.5 Isomerisation reactions of primary and tertiary 
allylic alcohols 
Since all of the substrates investigated to date were secondary allylic alcohols, it was then 
decided to investigate isomerisation of the primary alcohol 198n, that was easily 
synthesised by reduction of aldehyde 197 using LiAlH4 (Scheme 112). 
 
Scheme 112. Synthesis of primary allylic alcohol 198n. 
 
Contrary to expectations, isomerisation of this substrate (198n) was relatively slow, 
affording good yields of hydrogenated product 200n (Table 28, entry 1). The yield of 
isomerised trisubstituted allylic alcohol 199n could be raised by increasing catalyst loading 
(entry 2), but not by lowering the reaction temperature (entry 3). The detection of aldehyde 
213 in the crude product mixture implies that the more typical mode of allylic alcohol 
isomerisation occurs with this substrate, i.e. formation of an enol intermediate which 
tautomerises to afford an aldehyde. However, production of this aldehyde by oxidation of 
the hydrogenated alcohol 200n by the palladium catalyst cannot be totally ruled out. 
Table 28. Palladium-catalysed isomerisation reactions of primary allylic alcohol 198n. 
 
Entry [Pd(OH2/C] Temp. (°C) Time          Product distribution (%)
[a] 
    199n 200n 213 
   1 10 mol% 20 40 m 49 (4:1) 35 16 
   2 15 mol% 20 15 m 65 (4:1) 21 14 
   3 15 mol% 0 1 h 41 (3:1) 39 20 
[a] Numbers in parentheses denote (E):(Z) ratios. 
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It should be noted that a recent report from Sabitha and co-workers
292
 describes the use of 
hydrogen-activated Pd(OH)2/C for the isomerisation of a range of primary allylic alcohols 
to their corresponding saturated alcohols. The facile isomerisation of allylic alcohol 214 
(Scheme 113) demonstrates the ease with which this type of alcohol (i.e., 198n/199n) 
undergoes this kind of isomerisation reaction. However, when isomerisation of allylic 
alcohol 198a was attempted via pre-activation of a palladium catalyst, a similar mixture of 
oxidation and isomerisation products to that obtained in our studies of partial hydrogen 
pressures was observed (see Scheme 100, eq 2). 
 
 
Scheme 113. Isomerisation of a primary allylic alcohol to afford its corresponding saturated aldehyde; [a] the 
catalyst was pre-activated under 1 bar H2 for 30 m. 
 
The THP- (198o) and TBS-protected (198p) analogues of alcohol 198n were then 
synthesised (Scheme 114, eqs 1 and 2, respectively); these protecting groups were selected 
due to their ready removability and were intended to mimic the steric effect of a bulky 
substituent at the carbinol carbon. In the absence of electronic effects, this structural 
feature appeared to be critically important for achieving high levels of selectivity towards 
isomerisation over hydrogenation. 
 
 





This structural design was found to significantly suppress the hydrogenation pathway and 
afforded higher yields of isomerised products (Table 29). However, enol ethers 216o/216p 
were also formed as products of an unavoidable isomerisation side-reaction. The formation 
of these products also suggests that the saturated aldehyde 213 (Table 29) is formed via 
direct isomerisation of the allylic alcohol 198n and/or its trisubstituted isomer 199n. 
 
Table 29. Isomerisation of protected primary allylic alcohols. 
 
Entry Substrate Temp. 
(°C) 


















 198o   199o:  62 (4:1) syn-/anti-200o:  
15 


















 198o   199o:  70 (4:1) syn-/anti-200o:  
11 


















 198p   199p:  69 (4:1) syn-/anti-200p:  
23 
216p:  8 
[a] Numbers in parentheses denote (E):(Z) ratios. 
 
A tertiary alcohol 198q was also synthesised via oxidation of allylic alcohol 198a and 
treatment of the resulting ketone 201a with MeMgI. However, when this allylic alcohol 
was subjected to the optimised isomerisation conditions, the hydrogenated alcohol 200q 
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was formed as the major product in 64% yield with the isomerised product 199q being 
present in only 36% yield (Scheme 115). 
 
 














3.6 Isomerisation reactions of α,β-unsaturated carbonyl 
compounds   
It was proposed that the alkene bonds of an enone might be less susceptible to palladium-
catalysed hydrogenation than the corresponding allylic alcohol and as a consequence more 
isomerised product might be observed. Attempted isomerisation of the exomethylenic α,β-
unsaturated ketone 201a, which was prepared by oxidation of allylic alcohol 198a, resulted 
in formation of saturated ketone 217a as the major product, with the trisubstituted α,β-
unsaturated isomer 202a also present as a minor component in the crude reaction product 
(Scheme 116). When the same procedure was attempted with the corresponding aldehyde 
197, very little trisubstituted α,β-unsaturated aldehyde 218 was observed, with the 
corresponding saturated aldehyde 213 being formed as almost the sole product of the 
reaction (Scheme 117). This suggests that any alkylpalladium hydride species formed in 




Scheme 116. Palladium-catalysed isomerisation of exomethylenic α,β-unsaturated ketone 201a. 
 
 
Scheme 117. Palladium-catalysed isomerisation of α-methylene aldehyde 197. 
 
The poor results obtained in these reactions discouraged any extension of this study to 
equivalent isomerisation reactions of the corresponding exomethylenic α,β-unsaturated 
carboxylic acids and esters. 
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3.7 Isomerisation reactions of exomethylenic 
hydrocarbons   
The electronic nature of the functional group appeared to exert a significant influence upon 
the course of the palladium-catalysed isomerisation/hydrogenation reactions, and as a 
consequence we were interested to determine what would happen during the isomerisation 
reactions of simple hydrocarbon alkenes. The exomethylene-containing hydrocarbon 222a 
was synthesised via a methylene Wittig reaction on 2-decanone in 57% yield (Scheme 
118). Interestingly, when treated with 10 mol% Pd(OH)2/C and 1 bar of hydrogen gas, the 
product of isomerisation, 223a, was obtained in good yield after a short reaction time. 
Hydrogenation was still a competing pathway, and at longer reaction times the proportion 
of saturated hydrocarbon 224a became greater. However, as observed for allylic alcohols, 
this catalyst system carried out a relatively rapid isomerisation of exomethylene compound 
222a to afford its trisubstituted isomer 223a, whilst both di- and trisubstituted alkenes 
undergo comparatively slow hydrogenation reactions. Other internal alkene-containing 
isomers that could potentially have been formed from further migration of the double bond 
along the chain were not observed. 
 
 
Scheme 118. Synthesis and palladium-catalysed isomerisation of exomethylenic hydrocarbon 222a. 
 
Encouraged by this positive result, a pair of more sterically demanding analogues 
222b/222c were prepared, featuring ethyl and tert-butyl substituents in place of the methyl 





Scheme 119.  Synthesis  of  the  exo-methylene  hydrocarbon  series  of  substrates. 
 
When treated under the same isomerisation conditions as for 222a, the ethyl analogue 222b 
reacted more slowly to afford a mixture of saturated hydrocarbon 224b and the 





signals (Scheme 120). No other alkene-containing products, including the alternative 
positional isomer 225b, were detected in the 
1
H NMR spectrum of the crude reaction  
mixture. 
 
Scheme 120. Isomerisation of exomethylenic hydrocarbon 222b. 
 
Treatment of the tert-butyl substituted alkene 222c under the isomerisation reaction 
conditions afforded a mixture of alkane 224c and the trisubstituted alkenes (E)- and (Z)-
223c, although in a much higher isomeric ratio (Scheme 121). The reaction of this 
substrate occurred considerably more slowly, with only 50% substrate conversion being 
achieved after 24 hours. 
 




It is clear that a combination of palladium catalyst and hydrogen gas is capable of 
achieving selective isomerisations of exomethylene-containing substrates to their 
corresponding trisubstituted isomers, without further migration of the alkene bond 
occurring, under mild and simple reaction conditions. Good yields and high (E):(Z) ratios 
were observed for the isomerisation of the majority of allylic  alcohol substrates examined. 
Unfortunately, unavoidable competing hydrogenation reactions which proceed alongside 
the isomerisation result in significantly reduced yields, particularly if reaction progress is 
not closely monitored, resulting in mixtures of unsaturated and saturated products that are 
extremely difficult to separate by chromatography or distillation. The highest yields of 
isomerised products were obtained with substrates featuring the range of substitution 
patterns shown below, in Figure 8. When R
2
 = alkyl or R
3
 ≠ H, a larger proportion of 
hydrogenated alcohol products 200 were observed. Similarly, the isomerisation of a 






 = H, R
2
 = n-pentyl) afforded reduced 
yields of trisubstituted alkene products 199. Although yields of 51 – 80% were achieved 
with alcohols featuring homobenzyl substituents at position R
1
, the main pathway for 
hydrocinnamaldehyde-derived substrates (i.e. R
1
 = benzyl) was hydrogenation. 
 
 
Figure 8. Substrate substitution pattern exerts a dramatic influence upon the viability of palladium-catalysed 
isomerisation reactions. 
 
In the following chapter, I will now present results of my investigation into the novel use 
of chiral organoboranes in alkene isomerisation reactions and the development of an 
asymmetric hydroboration reaction of β,γ-unsaturated esters for the production of chiral 




4. Synthesis of chiral aldol products using 
asymmetric hydroboration reactions 
4.1 Introduction 
The addition of diborane to alkene bonds, known as hydroboration, was discovered in 1956 
by the late H. C. Brown,
293
 who subsequently devoted the rest of his career towards 
establishing the scope and applications of this reaction. During the course of his 
comprehensive exploration of the chemistry of organoboranes, it was established that (i) 
hydroboration of alkenes is essentially quantitative, proceeding in a cis anti-Markovnikov 
fashion to preferentially position the boron atom at the least substituted position; (ii) many 
other functional groups are tolerated; (iii) the reaction is reversible; and (iv) substitution of 
the boron atom of organoboranes with various heteroatom/alkyl groups occurs with 
retention of configuration. This last characteristic was largely responsible for 
organoboranes being established as highly versatile synthetic intermediates: they can be 













 or protonated with carboxylic acids
300
 to afford their formally 






Scheme 122. Synthetic transformations of organoboranes obtained via hydroboration of alkenes. 
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The majority of these substitution processes proceed with retention of configuration by the 
incoming group, which occupies the precise position previously occupied by the boron 
atom. The mechanism of an oxidative process that converts a chiral organoborane to its 
corresponding chiral alcohol is shown in Scheme 123.
301
 Bromination and iodination are 
notable exceptions, where displacement occurs with inversion of configuration at the 
carbon centre. These halogenation reactions of organoboranes are greatly accelerated by 
the presence of base, presumably due to the initial formation of an “ate” complex. 
Subsequent displacement of boron by the incoming halogen then results in clean inversion 




Scheme 123. Mechanism of organoborane oxidation with alkaline hydrogen peroxide. 
 
 









4.2 Alkene isomerisation reactions of organoboranes 
The reversible nature of the hydroboration of alkenes can potentially allow for a 
contrathermodynamic isomerisation of internal or endocyclic alkenes. For example, 
hydroboration of 1-ethylcyclohexene (226) readily affords a trans-organoborane 227, 
which, upon heating, undergoes isomerisation via sequential elimination/re-addition 
steps
302
 to position the boron at the terminus of the ethyl chain, thus reflecting the strong 
thermodynamic preference of boron to occupy the least sterically hindered position 
(Scheme 125). Addition of a molar excess of a higher boiling olefin to the reaction 
mixture, followed by heating, results in efficient displacement, thus enabling the 
isomerisation product vinylcyclohexane (229) to be distilled from the equilibrating 
mixture. Alternatively, the intermediate organoborane can be oxidised or aminated to 















4.3 Asymmetric hydroboration reactions 
Asymmetric hydroboration began with the discovery that the hydroboration product of α-
pinene, diisopinocampheylborane (Ipc2BH), was itself a highly stereoselective 
hydroboration reagent. Using optically pure (+)-Ipc2BH (>99% ee), the hydroboration-
oxidation of (Z)-2-butene afforded (R)-(–)-2-butanol in 98% ee (Scheme 126).2h,304  
 
 
Scheme 126. Asymmetric hydroboration-oxidation of (Z)-2-butene using (+)-Ipc2BH. 
 
Ipc2BH was subsequently found to hydroborate a wide range of (Z)-alkenes to afford, upon 
oxidation, the corresponding secondary alcohols with consistently high 
enantioselectivites.
305
 However, poorer selectivities were observed with the more sterically 
demanding (E)-1,2-disubstituted and trisubstituted olefins, with oxidation of the 
intermediate organoboranes affording their product alcohols in just 14 – 22% ee.306 For 
these classes of olefin substrate, the related monoisopinocampheylborane (IpcBH2) was 
more appropriate, with Brown demonstrating the conversion of a range of (E)-1,2-





Scheme 127. Asymmetric hydroboration of (E)-alkenes by IpcBH2 followed by oxidation. 
 
Trisubstituted alkyl olefins have also been subjected to asymmetric hydroboration, 
followed by oxidation, although the alcohols obtained showed only moderate 
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enantiopurities of 53 – 75% ee.308 However, superior enantioselectivities were obtained for 
the hydroboration of trisubstituted styrene derivatives that afforded chiral alcohol products 





Scheme 128. Asymmetric hydroboration of phenyl-substituted tertiary olefins by IpcBH2 followed by 
oxidation; alcohols 235c and 235d were derived from (E)-2-phenyl-2-butene and (Z)-2-phenyl-2-butene, 
respectively. 
 
Unfortunately, neither of these conveniently accessible reagents could hydroborate 1,1'-
disubstituted alkenes with a satisfactory level of enantioselectivity. To date, the highest 
enantioselectivities achieved for the hydroboration of this challenging substrate class have 
been reported by Soderquist,
310
 using chiral 10-substituted 9-borabicyclo[3.3.2]decane 
reagents. For example, hydroboration of α-methylstyrene 238 with borane (S)-237, 
followed by oxidation, afforded the corresponding primary alcohol 239 in 78% ee (Scheme 
129). In contrast, the equivalent reaction using IpcBH2 resulted in the formation of alcohol 










4.4 Tandem asymmetric hydroboration-isomerisation 
protocols 
It was proposed that combining enantioselective hydroboration of a trisubstituted 
arylalkene with contrathermodynamic isomerisation of an internal alkene bond to a 
terminal position might result in a one-pot hydroboration-isomerisation-substitution 
sequence being developed that could furnish products containing both a benzylic 
stereocentre and a remote functional group. Therefore, initial treatment of substituted 
styrene derivative 240 with IpcBH2 would be expected to proceed in a highly 
stereoselective manner to afford dialkylborane 241 (Scheme 130). This intermediate could 
then undergo thermal isomerisation to selectively position the boron atom at the terminus 




Scheme 130. Asymmetric hydroboration, followed by isomerisation for the synthesis of chiral primary 
alcohols containing benzylic stereocentres. 
 
Therefore, 2-(4-methoxyphenyl)-2-butene (245) was chosen as a test substrate, due to the 
good stereoselectivities previously reported for the IpcBH2-mediated hydroboration-







Scheme 131. Asymmetric hydroboration-oxidation of (E)-2-phenyl-2-butene (eq 1) and (Z)-2-phenyl-2-
butene (eq 2) with (–)-IpcBH2. 
 
However, addition of 4'-methoxyacetophenone to EtMgBr, followed by acid-catalysed 
dehydration of tertiary alcohol 244 resulted in a chromatographically inseparable 1:1 
mixture of its (E)- and (Z)-alkene isomers (Scheme 132). Therefore, a more selective 
preparation of geometrically pure trisubstituted arylalkenes was sought. 
 
 
Scheme 132. Preparation of alkene 245 via dehydration of its tertiary alcohol precursor 244. 
 
To this end, allylic alcohol (E)-246 was prepared via lithiation
312
 of 4-bromoanisole 
followed by addition of tiglic aldehyde. Sequential treatment of allylic alcohol (E)-246 
with NBS and a large excess of powdered NaOH afforded trisubstituted alkene (Z)-245 
(Scheme 133).
313
 The (Z)-geometry of 245 was confirmed by NOE measurements that 
showed interactions between the alkene proton and both alkenyl methyl groups, but not 





Scheme 133. Preparation of alkene (Z)-245. 
 
With the desired test substrate in hand, hydroboration-oxidation and hydroboration-
isomerisation-oxidation reactions were carried out under standard conditions
314
 using 
borane-dimethyl sulphide complex (BMS) in diglyme solvent, in order to obtain authentic 
racemic reference samples of the expected products syn-247 and 249 (Scheme 134, eqs 1 
and 2, respectively). 
 
Scheme 134. Hydroboration-oxidation and hydroboration-isomerisation-oxidation reactions of (Z)-245 using 
BMS. 
 
The initial hydroboration reaction proceeded with >99% regioselectivity (i.e., the 
alternative isomer 248 was not detected by 
1
H NMR spectroscopy), affording the expected 
alcohol syn-247 upon oxidation. Heating the hydroborated intermediate at 140 °C 
overnight, followed by oxidation, was found to afford a mixture of two products: the 
desired primary alcohol 249, formed from migration of boron to the terminal position, and 
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an isomeric primary alcohol which was determined to be 250. This compound presumably 
arises from Markovnikov-addition of borane to the starting alkene (Z)-245, followed by 
elimination to afford styrene 255 which is subsequently hydroborated in anti-Markovnikov 
fashion to form the observed primary alcohol 250 upon oxidation (Scheme 135). This was 
a disturbing observation since enantioselectivity would be severely compromised if such a 
pathway were to occur in an asymmetric hydroboration-isomerisation-oxidation reaction. 
However, the IpcBH2 reagent is significantly more sterically demanding than the 
dialkylboranes derived from BMS and (Z)-245 and it was reasoned that this might favour 
the desired isomerisation pathway to exclusively afford 249. 
 
 
Scheme 135. Alternative isomerisation pathways leading to primary alcohols 249 and 250. 
 
Following the method of Brown,
306
 the bis-adduct 2IpcBH2.TMEDA (257) was 
synthesised from commercially available (+)-α-pinene (Scheme 136). However, the 1H and 
11
B NMR spectra of the product obtained were not in agreement with the published data, 
although the product was found to afford the known isopinocampheol 258 upon oxidation 
with alkaline hydrogen peroxide. Consequently, an X-ray crystal structure of the product 
was acquired which confirmed its structure (Figure 9), whilst analysis of a commercially 




C NMR spectra and also the 




Scheme 136. Synthesis of 2IpcBH2.TMEDA (257) from (+)-α-pinene. 
 
 
Figure 9. X-Ray crystal structure of bis-monoisopinocampheylborane TMEDA complex (2IpcBH2.TMEDA, 







The initial asymmetric hydroboration reaction was carried out as follows: (–)-
monoisopinocampheylborane (259) was liberated from its TMEDA adduct, (–)-
2IpcBH2.TMEDA (257), via treatment of its THF solution with BF3.OEt2 (Scheme 137).
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Oxidation of the dialkylborane intermediate using alkaline hydrogen peroxide solution 
gave alcohol 247, which was purified by column chromatography and the enantiomeric 
excess (ee) determined to be >99% by chiral HPLC over an OD-H stationary phase. 
 
Scheme 137. Asymmetric hydroboration of alkene (Z)-245. 
 
The hydroboration-isomerisation-oxidation sequence was carried out in an analogous 
manner (Scheme 138). Upon completion of the asymmetric hydroboration step, a small 
aliquot was removed and worked up as described above in order to verify the 
enantioselectivity of this step (>99% ee). The remaining reaction mixture was then 
subjected to isomerisation conditions involving replacement of the THF solvent with 
diglyme, heating at 140 °C for 20 hours and subsequent oxidation with alkaline hydrogen 
peroxide. Three products were isolated via column chromatography: isopinocampheol 
(258) and the primary alcohols 249 and 250. Sadly, the ee of alcohol 249 was found to be 
only 5% via chiral HPLC analysis. 
 
Scheme 138. Asymmetric hydroboration-isomerisation-oxidation of alkene (Z)-245. 
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Therefore, it appears that the high reaction temperature required for the migration pathway 
to occur has resulted in the boron reagent undergoing migration along the length of the 
alkyl chain to afford essentially racemic product 249 under thermodynamic control. The 
isolation of primary alcohols 249 and 250, combined with the absence of any tertiary 
alcohol arising from oxidation of the intermediate organoborane 263 or any alkene-
containing species 261/264, confirms that the boron reagent preferentially resides at the 
two ends of the alkyl chain (Scheme 139). Therefore, all other species are short-lived 
intermediates which are present in vanishingly small concentrations at any given time. The 
rapid reversible addition of IpcBH2 to styrene (Z)-245 at 140 °C clearly provides a facile 
pathway to a racemic product under thermodynamic control. Furthermore, the isolation of 
alcohol 250 from this reaction clearly indicates that a tertiary organoborane species 263 
must also be reversibly formed under these conditions. This tertiary borane species can 
potentially eliminate to form two different trisubstituted alkenes, (E)-245 and (Z)-245, 
which in turn would then be hydroborated, isomerised and oxidised to afford opposing 
enantiomers of the primary alcohol 249. 
 
 
Scheme 139. Asymmetric hydroboration of alkene (Z)-245, followed by isomerisation and racemisation. 
 
In an attempt to develop more stereoselective conditions, it was then decided to monitor 
the enantiomeric purity of alcohol 249 and the product distribution of the hydroboration-
isomerisation reaction over time. Unfortunately, it was found that the ee of the small 
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amount of primary alcohol 249 produced was just 8% after one hour at 140 °C, with an 
essentially identical 3:1 ratio of the primary alcohols 249 and 250 being present. It was 
concluded that the use of this type of hydroboration-isomerisation protocol for the 


























4.5 Hydroboration of β,γ-unsaturated esters 
As the unselective nature of the organoborane isomerisation process to afford styrene 245 
was an inherent problem, rather than the level of asymmetric induction in the initial 
hydroboration step, the substrate was re-designed in an attempt to preserve the benzylic 
stereocentre of the product. It was reasoned that if the initial elimination step of an 
intermediate organoborane species 264 would afford a thermodynamically more stable 
alkene that was less susceptible to reaction with the borane reagent, then the 
stereochemical integrity of the benzylic centre might be retained (Scheme 140).  
 
 
Scheme 140. Asymmetric hydroboration and isomerisation of a suitably functionalised trisubstituted 
arylalkene. 
 
Our initial thoughts were that an alkene conjugated to a suitable electron withdrawing 
group could constitute a thermodynamic trap by withdrawing electron density from the 
isomerised alkene bond of 265, thus rendering it essentially unreactive toward 
hydroboration. A review of the literature revealed that electron-deficient alkenes such as 





Scheme 141. Hydroboration of an electron-deficient alkene. 
 
Alternative electron-withdrawing groups such as cyano or nitro that would disfavour 
hydroboration and confer synthetic versatility to the product were deemed unsuitable due 
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to their potential to undergo competing borane-mediated reduction pathways to afford 




Scheme 142. Borane-mediated reduction of cyano and α,β-unsaturated nitroalkene groups. 
However, borane-mediated reduction of the alkene substituents of α,β-unsaturated еster 
derivatives does not generally occur, therefore we considered using a strategy based on the 
reversible hydroboration of β,γ-unsaturated esters. Brown’s original investigations into the 
hydroboration reactions of unsaturated esters to afford their corresponding hydroxy esters 
appeared promising.
319,320
 In summary, addition of BH3.THF to ethyl 3-butenoate, 4-
pentenoate and 10-undecenoate esters followed by oxidative work-up gave their 
corresponding ω-hydroxy esters, with small amounts of secondary hydroxy ester and diol 
by-products also being isolated. Utilisation of the bulkier disiamylborane (Sia2BH) further 
increased the regioselectivity and, notably, did not result in any reduction of the ester 
functionality (Scheme 143, eq 1). However, in both cases attempted hydroboration of ethyl 
acrylate was found to afford a complex mixture of products (Scheme 143, eq 2), with 
essentially no β-hydroxy ester being produced. 
 
Scheme 143. Selective hydroboration of unsaturated esters to afford their corresponding ω-hydroxy esters 
(eq 1) and the anomalous reactivity of ethyl acrylate under hydroboration conditions (eq 2). 
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However, a few literature reports describing chemoselective hydroboration of β,γ-
unsaturated esters, without concomitant reduction of the ester were known.
321
 For example, 
hydroboration of dihydropyran 266 (Scheme 144, eq 1)
322
 under standard conditions gave 
the desired β-hydroxy ester 267 in good yield upon oxidative work-up, whilst 
hydroboration of the norbornenyl ester 268 (Scheme 144, eq 2)
323
 with diborane afforded a 
mixture of β- and γ-hydroxy esters 269a/269b in good yield. 
 
 
Scheme 144. Hydroboration reactions of β,γ-unsaturated esters. 
[a] Generated externally from addition of NaBH4 to BF3.OEt2 in DME. 
 
However, during the course of their synthesis of the natural product FR901483, Martin and 
co-workers
324
 reacted β,γ-unsaturated ester 270 with a variety of borane reagents (BMS, 
ThxBH2, Cy2BH, 9-BBN) and obtained a diastereomeric mixture of diol products 
271a/271b upon oxidative work-up (Scheme 145). Even the utilisation of the 
corresponding carboxylate acid salt of 270 did not prevent reduction of the carbonyl group. 
 
 




It was therefore anticipated that, in the absence of competing/concomitant ester reduction, 
hydroboration of β,γ-unsaturated ester 275 would afford an intermediate organoborane 
278, the enantiopurity of which could be readily verified following its oxidation to chiral 
β-hydroxy ester 276 (Scheme 146). Upon heating, isomerisation of 278 would occur to 
afford its corresponding α,β-unsaturated isomer 279, that would be unreactive towards the 




Scheme 146. Planned sequence of asymmetric hydroboration-isomerisation to afford γ-chiral α,β-unsaturated 
esters 279. 
 
The simple β,γ-unsaturated ester 275a was subsequently chosen as a test substrate and 
prepared via a literature route involving a Knoevenagel reaction between the enolate of 
malonic acid and 2-phenylpropionaldehyde which directly gave β,γ-unsaturated acid 
274a,
325
 that was then subjected to a straightforward Fisher esterification reaction with 
methanol (Scheme 147). 
 
 
Scheme 147. Synthesis of β,γ-unsaturated ester 275a via Knoevenagel reaction of 2-phenylpropionaldehyde. 
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The mechanism of this reaction was not discussed in the original paper, however it is 
proposed that the exclusive formation of the β,γ-unsaturated isomer, and the high (E)-
selectivity observed, can be explained by the following mechanism (Scheme 148). Aldol 
reaction of a malonate enolate equivalent with 2-phenylpropionaldehyde affords an aldol 
product that ring closes to afford a β-lactone which then eliminates CO2 from a cyclic 
transition state. This cyclic transition state positions its methyl group anti to the β-lactone 
group thus favouring formation of an (E)-alkene. 
 
Scheme 148. Proposed mechanism of the Knoevenagel reaction between malonic acid and 2-
phenylpropionaldehyde to afford β,γ-unsaturated carboxylic acid 274a  
 
The β,γ-unsaturated ester 275a was subsequently treated with BMS in diglyme, over a 
period of 16 hours, and the reaction mixture oxidised under mild conditions 
(H2O2/NaHCO3(aq) to avoid hydrolysis of the ester).
326
 Diglyme was removed from the 
reaction mixture by dilution with ether and washing with water, and the crude product 




C NMR spectra from this reaction revealed 
the presence of one compound, containing no resonances corresponding to the presence of 
a methoxy group. Upon closer inspection it was clear that diol 277a had been formed via 
hydroboration and a concomitant reduction of the ester group of 275a, with none of the 
expected anti-β-hydroxy ester 276a being present. 
 
 
Scheme 149. Attempted hydroboration-oxidation of β,γ-unsaturated ester 275a with BMS. 
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This result clearly implied that it was going to be difficult to carry out our proposed 
hydroboration/isomerisation protocol on this class of substrate. However, there is currently 
much interest in developing tandem synthetic protocols in which two or more 
transformations occur consecutively in a single reaction vessel. Consequently, it was 
decided to determine the scope and limitation of this reaction for the one-pot asymmetric 
synthesis of new types of chiral diols containing γ-stereocentres. Therefore, ester 275a was 
reacted with both one and two equivalents of (–)-IpcBH2 and oxidised under the same mild 
conditions (H2O2/NaHCO3(aq)). Treatment of 275a with one equivalent of the chiral borane 
resulted in the formation of a ~1:1 mixture of the original, unreacted ester 275a and β-
hydroxy ester 276a, with isopinocampheol 258 and minor amounts of unidentified 
products also present (Scheme 150, eq 1). When two equivalents of chiral borane were 
used, the hydroboration reaction proceeded to completion with complete reduction of the 




Scheme 150. Treatment of ester 275a with one (eq 1) or two (eq 2) equivalents of (–)-IpcBH2 results in 
different mixtures of products. 
 
Following isolation, the enantiomeric excess of (+)-277a was determined to be 82% by a 
1
H NMR chiral derivatisation method previously reported by the Bull and James groups.
327
 
Therefore, two samples of chiral diol 277a were treated with (2-formyl)phenylboronic acid 
280 and either racemic or enantiopure α-methylbenzylamine 281 in CDCl3. The use of 
racemic amine served as a control, whilst the chiral diol treated with enantiopure amine 
results in formation of a pair of diastereomeric imine derivatives (R,S,S)-282a and (S,R,S)-
156 
 
282a (Scheme 151). The ratio of these two species, determined by integration of the imine 
resonances in their 500 MHz 
1
H NMR spectrum (Figure 10b), is a direct reflection of the 





Scheme 151. Derivatisation protocol for determination of enantiopurity of diol 277a. 
 
 
Figure 10. 1H NMR spectra showing diagnostic signals corresponding to the imine resonances of the 
diastereoisomeric derivatives (S,R,S)-/(S,S,R)-282a using (a) racemic α-methylbenzylamine (±)-281, and (b) 







4.6 Assignment of stereochemistry 
Unfortunately, diol 277a was a novel compound and so its configuration could not be 
assigned directly from the sign of its specific rotation. However, its configuration could be 
implied from the products obtained by Brown from the hydroboration-oxidation reactions 
of (E)- and (Z)-2-phenyl-2-butene (Scheme 152, eqs 1 and 2, respectively).
316
 When I 
performed an equivalent reaction using (Z)-3-(4-methoxyphenyl)-2-butene (245) and (–)-
IpcBH2 of known absolute configuration, the product alcohol also displayed a negative 
value for its specific rotation (Scheme 152, eq 3). Substitution of the aromatic rings of 
analogous compounds with a 4-methoxyl substituent has not been observed to alter the 
sign of rotation (see Experimental Section, compounds 277a and 277c). Furthermore, the 
results of Nichols and co-workers,
328
 whose assignment of both the absolute 
stereochemistry of product alcohol 284 and configuration of borane reagent were 
unambiguous, also correlate with these conclusions (Scheme 152, eq 4). Based upon these 
results, the stereochemical course for hydroboration reactions of (E)- or (Z)-trisubstituted 
arylalkenes using (–)-IpcBH2 can be reliably predicted. 
 
 




However, the presence of the potentially coordinating ester group in 275a could alter the 
enantiofacial selectivity of the hydroboration step. Therefore, the configuration of diol 
277a was established via its conversion to mono-tosylate 285, followed by reduction with 
LiAlH4 to secondary alcohol 286 (Scheme 153). The sign of the specific rotation of 286 
derived from diol 277a was found to be positive, whereas the literature value for the 
specific rotation of (2R,3S)-2-phenyl-3-pentanol (i.e. (–)-286) is negative (Figure 11).329 
This confirmed that diol 277a possessed the absolute stereochemistry which was predicted 
by comparison with products of known absolute configuration from previously reported 
asymmetric hydroboration reactions of simple (E)-trisubstituted alkenes (Scheme 152, eqs 
1, 2 and 4). 
 
 




Figure 11. Specific rotation and stereochemical assignments of 2-phenyl-3-pentanol (a) derived from diol 
277a, (b) literature value. 
 
Reaction of ester 275a with a single equivalent of (–)-IpcBH2 did not result in the 
formation of any unsaturated alcohol 287, which implies that hydroboration of the alkene 
occurs considerably faster than reduction of the ester under these conditions, in agreement 
with Brown’s results.
320
 This was confirmed by carrying out an independent synthesis of 
allylic alcohol 287 via reduction of ester 275a with LiAlH4 in ether (Scheme 154), that 
enabled us to determine it was not present in the 
1
H NMR spectrum of the crude 




Scheme 154. Synthesis of an authentic sample of alcohol 287. 
The fact that no reduction of the ester functionality is observed when one equivalent of 
borane was employed in the hydroboration reaction implies that a second equivalent of 
borane is likely to participate in the ester reduction step, with a hydride equivalent being 
potentially delivered in an intramolecular fashion. In order to ascertain whether the 
presence of an “internal” borane substituent is required to activate the ester, the saturated 
aliphatic ester methyl hexanoate 288 was reacted with two equivalents of (–)-IpcBH2, 
under otherwise identical conditions, resulting in complete consumption of starting 
material and formation of 1-hexanol (Scheme 155). This implies that (–)-IpcBH2 is indeed 
capable of reducing an isolated ester group to its corresponding alcohol when present in 
excess and does not depend upon an alkene moiety being present in the substrate. 
 
 
Scheme 155. Reduction of a saturated ester with (–)-IpcBH2. 
A plausible mechanism for the reduction of 275a is as follows (Scheme 156): addition of 
(–)-IpcBH2 to the alkene bond of 275a affords organoborane 289; intramolecular 
coordination of the ester’s acyl oxygen to boron increases the electrophilicity of the 
carbonyl carbon atom and facilitates hydride addition by a second molecule of (–)-IpcBH2 
to afford intermediate 290; the methoxy group then leaves to afford an oxonium species 
291 that is further reduced to afford organoborane 292, which affords diol 277a upon 
oxidation. 
 
Scheme 156. Proposed mechanism of the hydroboration-reduction of ester 275a by (–)-IpcBH2. 
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In order to establish the general applicability of this reaction, a series of analogues with 
different substituents in their aromatic ring were prepared. In contrast to 2-
arylpropionaldehydes, a large number of substituted acetophenones are commercially 
available, allowing rapid access to the desired aldehydes via a two-step Wittig C1-
homologation/enol ether hydrolysis protocol.
330,331
 In all cases, hydrolysis of the enol ether 
intermediates proceeded readily and the aldehydes 273b-g were isolated in unoptimised 
overall yields of approximately 50% (Table 30). 
 
Table 30. Synthesis of 2-arylpropionaldehydes from their corresponding acetophenones/acetonaphthones. 
 
Entry Ketone (272) Aldehyde (273) Isolated yield 
   
  1 
  
       
      60% 
       272b       273b  
   
  2 
  
       
      52% 
       272c       273c  
   
  3 
  
       
      60% 
       272d       273d  
   
  4 
  
       
      48% 
       272e       273e  
   
  5 
  
       
      55% 
       272f       273f  
   
  6 
  
       
      40% 
       272g       273g  
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All six aldehydes 273b-g were then reacted with malonic acid under the previously utilised 
Knoevenagel reaction conditions
325
 to afford their corresponding β,γ-unsaturated 
carboxylic acids 274b-g. Although the acids were formed as mixtures of (E)- and (Z)-
isomers, the (E):(Z) ratios were generally high. The subsequent esterification reactions then 
proceeded readily to afford, after chromatographic purification, five geometrically pure 
(E)-β,γ-unsaturated esters 275b-f (Table 31). Unfortunately, the geometric isomers of the 
1-naphthyl substituted ester 275g could not be completely separated. 
 
Table 31. Synthesis of β,γ-unsaturated carboxylic acid esters via Knoevenagel reactions between malonic 






isolated yield, (E):(Z) 
Methyl (E)-4-arylpent-3-
enoate 
(275), isolated yield 
 
 
1    




   




   




   




   




   
           273g        274g, 34%, 4:1      275g, 35%[a] 
[a] Methyl ester 275g was isolated as a mixture of alkene geometric isomers, (E):(Z) = 4:1. 
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Under the standard hydroboration reaction conditions using two equivalents of (–)-IpcBH2 
in THF at –20 to 0 °C, over 16 hours, each ester was hydroborated-reduced, followed by 
oxidation with NaHCO3/H2O2 to afford their corresponding chiral diols (Scheme 157). The 
enantiomeric excess of these diols was determined by NMR as described previously for the 
parent diol 277a via derivatisation of two separate samples with 2-formyl-phenylboronic 
acid 280 and either enantiopure or racemic α-methylbenzylamine ((–)-281 or (±)-281, 
respectively). 
 
Scheme 157. Asymmetric hydroboration of β,γ-unsaturated esters 275b-g to afford chiral diols 277b-g. 
 
The chiral diols 277b-g were obtained in generally good 67–85% ee’s, implying that the 
electronic nature of the aryl substituents did not appear to adversely affect the levels of 
enantioselectivity. However, ester 275e, which is substituted in the 2-position relative to 
the alkenyl substituent, afforded its respective diol 277e in a slightly lower 77% ee. The 
lowest ee was observed for the 1-naphthyl substituted ester 275g, which could be due to 
the smaller difference in steric environments between the enantiotopic faces of the alkene. 
Indeed, this was also the only substrate which was found to afford a detectable quantity of 





Scheme 158. Hydroboration of ester 275g with (–)-IpcBH2 affords a mixture of diol and β-hydroxy ester. 
 
Lastly, the disubstituted β,γ-unsaturated ester 275h was synthesised from 
phenylacetaldehyde using our standard Knoevenagel conditions (Scheme 159). 
Hydroboration of 275h under our standard conditions proceeded with poor regioselectivity, 
affording a 10:1 mixture of 1-phenyl-1,4-butanediol 293 and the expected 1,3-diol 277h. 
The enantiomeric excesses of these diols were again determined by NMR as described 
previously for the parent diol 277a and found to be 70% for 293 and 76% for the minor 
isomer 277h. The stereochemical assignments are based upon comparison to the literature 
values reported for these two diols and are consistent with the facial selectivity previously 
observed with the (–)-IpcBH2 reagent. Although the reduced enantioselectivity was 
expected and is clearly due to the lower steric demand of the disubstituted alkene bond, the 




Scheme 159. Synthesis and asymmetric hydroboration with (–)-IpcBH2 of a β,γ-unsaturated ester featuring a 
disubstituted alkene bond, to afford its corresponding 1,4- and 1,3-diol products. 
 
In an attempt to improve the enantioselectivity of the hydroboration reaction of the parent 
trisubstituted alkene ester 275a, its asymmetric hydroboration reaction was performed at a 
significantly lower reaction temperature. Therefore, the reaction was thus repeated as 
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previously described, with a THF solution containing two equivalents of borane cooled to 
–78 °C before addition of ester 275a. The reaction mixture was then allowed to warm 
gradually to 15 °C over a period of 42 hours, and oxidised (H2O2/NaHCO3) to afford the 
chiral diol 277a in a slightly improved 87% ee (Scheme 160, eq 1). Next, the 
hydroboration reaction of 275a was carried out at –25 °C for 48 hours and the excess 
borane quenched with methanol at –25 °C before carrying out an oxidative work-up. These 
conditions were found to result in a highly selective (and complete – no starting material 
remained) hydroboration, without concomitant reduction of the ester functionality having 
occurred, affording β-hydroxy ester 276a and isopinocampheol 258 as major products 
(Scheme 160, eq 2). Following reduction of ester 276a to the known diol 277a with 
LiAlH4, the ee was determined as previously described and found to be slightly reduced at 
75% ee. 
 
Scheme 160. Low-temperature asymmetric hydroborations of β,γ-unsaturated ester 275a. 
The asymmetric hydroboration of β,γ-unsaturated esters is thus a viable synthetic route to 
chiral diol products, whilst appropriate control of reaction temperature allows the 
formation of the corresponding aldol product, 276. The opposite enantiomer of a given 
product may be readily accessed upon utilisation of commercially available (–)-α-pinene to 
prepare the chiral borane reagent (+)-IpcBH2, whilst the alternative syn-aldol products 
would be available from reaction of trisubstituted (Z)-β,γ-unsaturated esters (Scheme 161). 
 
 




Although the Knoevenagel reaction of malonic acid to afford β,γ-unsaturated carboxylic 
acids is known to be applicable to aliphatic aldehydes, in the absence of either the steric 
bias imparted from a trisubstituted alkene bond or the electronic influence of an aromatic 
ring, hydroboration of these types of β,γ-unsaturated carboxylic acid derivatives is unlikely 
to proceed with 100% regioselectivity. Future work involving the screening of more 
sterically demanding hydroborating agents, such as 294 and 295, which are derived from 
the 2-isobutyl and 2-isopropyl homologues of (+)-α-pinene, may afford better 























4.7 Catalytic hydroboration of β,γ-unsaturated amides 
During the course of carrying out my studies into asymmetric hydroboration reactions of 
β,γ-unsaturated esters, Takacs333 reported on rhodium-catalysed asymmetric hydroboration 
of β,γ-unsaturated amides with pinacolborane to afford chiral boronic acid ester 
intermediates. Oxidation of the resultant boronic esters, with alkaline hydrogen peroxide, 
afforded their corresponding β-hydroxy amides in good yields and excellent levels of 
enantioselectivity. The closest example to my β,γ-unsaturated ester substrates (275a-g) was 
the trisubstituted β,γ-unsaturated amide (Z)-297, which afforded its corresponding β-
hydroxy amide 298 in 93% ee  (Scheme 162).
334
 Although this work is broadly resembles 
the asymmetric hydroboration reactions which I have investigated, my reaction is quite 
different as it can give tandem reduction to afford chiral diol products, or chiral β-hydroxy 
esters, depending upon the reaction temperature. 
 
 











My investigation into tandem asymmetric hydroboration-isomerisation reactions quickly 
revealed that the reversible nature of hydroboration is not compatible with preservation of 
stereochemical integrity. However, the subsequent attempt to realise this initial objective 
via utilisation of an alternative substrate led directly to the development of a novel 
application of asymmetric hydroboration reactions for the synthesis of chiral 1,3-diols, or 
β-hydroxy esters. The limitation of this methodology occurs with disubstituted alkenes, 
where the decreased steric requirement of the alkene bond results in significantly lower 















5.1 General procedures 
Proton magnetic resonance spectra were recorded at 300.22 MHz on a Bruker Avance 300 
spectrometer. Chemical shifts (δH) are quoted in parts per million and are referenced to the 
residual solvent peak. The multiplicities and general assignments of spectroscopic data are 
denoted as: singlet (s), doublet (d), triplet (t), quartet (q), doublet of doublets (dd), 
multiplet (m), broad (br), phenyl (Ph), aromatic (Ar) and apparent (app). Coupling 
constants are quoted to the nearest 0.1 Hz. 
Carbon magnetic resonance spectra were recorded at 75.5 MHz on a Bruker Avance 300 
spectrometer. Chemical shifts (δC) are quoted in parts per million and are referenced to the 
residual solvent peak. 
Infrared spectra (4000 cm
-1
 to 0 cm
-1
) were recorded on a Perkin Elmer 1605 FT 
spectrometer as thin films; only selected peaks are quoted in ν cm-1. 
Mass spectra were recorded on a micrOTOF electrospray time-of-flight (ESI-TOF) mass 
spectrometer (Bruker Daltonik GmbH, Bremen, Germany), using methanol as solvent. 
Optical rotations were recorded on an Optical Activity Ltd AA-10 automatic polarimeter 
with a path length of 1 dm; concentrations (c) are quoted in g/100 ml. 
Analytical thin layer chromatography was carried out using commercially available 
aluminium backed plates coated with Merck Kieselgel 60 GF254. Plates were visualised 
under UV light (254 nm) or by staining with potassium permanganate or phosphomolybdic 
acid followed by heating. Flash chromatography was performed under medium pressure 
using Merck 60 H silica gel (35–70 μm). Samples were loaded either neat or as saturated 
solutions in an appropriate solvent. 
Anhydrous tetrahydrofuran, diethyl ether, toluene and dichloromethane were obtained by 
passing through anhydrous alumina columns using an Innovative Technology Inc. PS-400-
7 solvent purification system. Petrol refers to the fraction of petroleum ether boiling at 40–
60 °C. Ether refers to diethyl ether. Solvents were evaporated on a Büchi Rotorvapor. All 
commercially available compounds were used as obtained from the chemical suppliers 
unless otherwise stated. Reactions requiring anhydrous conditions were performed under 
nitrogen in oven-dried apparatus. All temperatures quoted are external. 
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General procedure A: Synthesis of α-methylene aldehydes 
According to a literature procedure
282
 a mixture of the aldehyde (1.0 equiv.), 
dimethylamine hydrochloride (1.2 equiv.) and 37% aqueous formaldehyde (1.2 equiv.) was 
stirred at 70 °C for 24 h. After cooling to room temperature, an excess of saturated aqueous 
NaHCO3 was added, the aqueous phase separated and extracted with three portions of 
hexane. The combined organic phases were washed with water, dried (MgSO4) and the 
solvent evaporated under reduced pressure to afford the α-methylene aldehyde. 
 
General procedure B: Synthesis of exo-methylene allylic alcohols 
The appropriate alkyl halide (0.2 equiv.) was added in one portion to a stirred suspension 
of magnesium turnings (2.0 equiv.) in dry ether (2 ml.mmol
-1
) under nitrogen. The mixture 
was then heated to a gentle reflux and the remaining alkyl halide (1.8 equiv.), diluted with 
an equal volume of dry ether, was added at a rate sufficient to maintain the reflux. After 
formation of the Grignard reagent was complete, the solution was cooled to 0 °C in an 
ice/salt-water bath (water and saturated salt solution in an approximate ratio of 55:45). The 
appropriate α-methylene aldehyde was then added dropwise. When tlc analysis indicated 
complete consumption of the aldehyde, the reaction was quenched by the cautious addition 
of a 50:50 mixture of water and saturated aqueous NH4Cl solution. The solids were 
removed by filtration through celite, eluting with fresh ether, and the filtrate transferred to 
a separatory funnel. The aqueous layer was separated and the organic phase washed 
successively with 1.0 M aqueous HCl, brine and water, then dried (MgSO4). The solvent 
was removed under reduced pressure and the residue purified by column chromatography 
(SiO2) to afford the pure allylic alcohol. 
 
General procedure C: Preparation and use of pyridyl-Grignard reagents 
Using a modified literature procedure,
290
 the following were sequentially added to a dry 
round bottomed flask: 10 ml of an i-PrMgCl solution (2.0 M in THF, 20 mmol, 2.0 equiv.), 
an additional 10 ml of dry THF and the appropriate bromopyridine (20 mmol, 2.0 equiv.). 
The resulting mixture was stirred at room temperature for 2 hours and then cooled to 0 °C. 
2-Methylenebutanal (206, 10 mmol, 1.0 equiv.) was then added dropwise and stirring 
continued at this temperature for a further 4 hours. The reaction was quenched by the 
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addition of water (20 ml) and extracted with CH2Cl2 (3 × 20 ml). The combined organic 
phases were washed with water, dried (K2CO3) and the solvent removed under reduced 
pressure. The crude alcohol was then purified by column chromatography (SiO2). 
 
General procedure D: Oxidation of alcohols to aldehydes/ketones 
According to the original literature procedure,
335
 the alcohol (10 mmol in 10 ml of dry 
CH2Cl2) was added in one portion to a stirred suspension of pyridinium chlorochromate 
(1.5 equiv., 15 mmol, 3.23 g) in dry CH2Cl2 (20 ml) at room temperature. When tlc 
analysis indicated complete consumption of the alcohol (1 – 3 h), the reaction mixture was 
diluted with five volumes of ether and filtered through florisil, eluting with fresh ether. The 
solvent was then removed under reduced pressure to afford the aldehyde/ketone, which 
was used without further purification. 
 
General procedure E: Wittig methylenation of ketones 
A slightly modified version of a literature procedure
330
 was employed: A suspension of 
methyltriphenylphosphonium bromide (3.20 g, 9.0 mmol, 1.7 equiv.) in dry THF (30 ml) 
was cooled to 0 °C, followed by the dropwise addition of 3.6 ml BuLi solution (2.5 M in 
hexanes, 9.0 mmol, 1.7 equiv.). The flask was removed from the cooling bath and stirred at 
room temperature for two hours, then cooled to 0 °C. A 1.0 M solution of the appropriate 
ketone (5.3 mmol, 1.0 equiv.) in THF was then added dropwise, the reaction mixture 
stirred for a further 30 minutes at 0 °C, then removed from the cooling bath and stirred 
overnight (~16 hours). The reaction mixture was diluted with hexane (50 ml) and filtered 
through a plug of silica, eluting with a 50:50 mixture of hexane and ether (100 ml). The 







General procedure F: Palladium-catalysed isomerisation of 
exomethylenic allylic alcohols, O-allyl ethers, hydrocarbons, α,β-
unsaturated aldehydes and ketones  
The palladium catalyst, additive (if used) and 80% of the total solvent were placed into a 
dry Schlenk tube, which was fitted with a rubber septum, and stirred at the appropriate 
temperature. A balloon attached to a needle-equipped syringe barrel was filled with 
hydrogen gas and set aside. Vacuum was applied to the Schlenk tube and the tap opened 
until vigorous bubbling of the solvent was observed, then immediately closed. The 
hydrogen gas was then transferred to the evacuated tube through the rubber septum. This 
sequence was repeated twice more and then the appropriate substrate, dissolved in the 
remaining solvent, was added via syringe. The reaction mixture was then stirred for the 
required time before being filtered through celite and the solvent evaporated under reduced 





General procedure G: Hydroboration-oxidation of substituted 
arylalkenes using (–)-isopinocampheylborane 
According to a modified literature procedure,
306
 2IpcBH2.TMEDA (0.53 equiv., 2.0 mmol, 
0.83 g) was dissolved in dry THF (2.5 ml) and BF3.OEt2 (1.0 equiv., 3.8 mmol, 0.54 g, 
0.47 ml) was added dropwise. After stirring at room temperature for three hours, the 
mixture was cooled to –20 °C, a 0.3 M THF solution of the arylalkene (0.71 equiv., 2.7 
mmol) was added dropwise and stirring was continued at this temperature for 48 hours. 
The reaction mixture was then brought to room temperature, 3.0 M aqueous NaOH 
solution (1.2 ml) was added, followed by 30% aqueous H2O2 (1.0 ml) and the mixture 
heated to 55 °C for 1.5 hours. After cooling to room temperature, saturated Na2CO3 
solution was added and the mixture extracted with ether (3 × 20 ml). The combined 
organics were washed with water, dried (MgSO4) and the solvent removed to afford a 






General procedure H: Hydroboration-isomerisation-oxidation of 
substituted arylalkenes using (–)-isopinocampheylborane 
The reaction was initially carried out in an identical manner to General Procedure G; 
however, following completion of the hydroboration stage, the THF was removed under 
ambient temperature and pressure by a strong flow of nitrogen gas. An equivalent volume 
of anhydrous diglyme was then added and the mixture stirred thoroughly for one hour. A 
portion of the crude product mixture was then removed by syringe and oxidised with 
alkaline hydrogen peroxide, taking care to remove the high-boiling diglyme solvent by 
washing the ethereal extracts thoroughly with water, then worked-up and purified as 
previously described. The remainder was then heated at 140 °C for the required time, 
cooled to room temperature, and worked-up as previously described. 
 
General procedure I: Synthesis of 2-arylpropionaldehydes 
A slightly modified version of a literature procedure
330
 was employed: A suspension of 
methoxymethyltriphenylphosphonium chloride (1.7 equiv., 56.6 mmol, 3.07 g) in dry THF 
(190 ml) was cooled to 0 °C, followed by the dropwise addition of 22.6 ml n-BuLi solution 
(2.5 M in hexanes, 1.7 equiv., 56.6 mmol). The flask was removed from the cooling bath 
and stirred at room temperature for two hours, then cooled to 0 °C. A 1.0 M solution of the 
appropriate substituted acetophenone 272 (1.0 equiv., 33.3 mmol) in THF was then added 
dropwise, the reaction mixture stirred for a further 30 minutes at 0 °C, then removed from 
the cooling bath and stirred overnight (~16 hours). The reaction mixture was diluted with 
hexane (320 ml) and filtered through a plug of silica, eluting with a 50:50 mixture of 
hexane and ether (640 ml). The solvent was then evaporated under reduced pressure to 
afford the corresponding crude enol ether as an approximately 50:50 mixture of (E):(Z) 
isomers (as shown by 
1
H NMR spectroscopy), which was subsequently hydrolysed 
according to a literature procedure.
331
 A thoroughly stirred mixture of THF (68 ml) and 
concentrated aqueous HCl (5.5 ml) was added to the crude residue and the resulting 
mixture refluxed for three hours. After cooling to room temperature, sufficient saturated 
NaHCO3 solution was added to neutralise the acid, the organic layer was removed and the 
aqueous layer was extracted with ether (3 × 50 ml). The combined organic extracts were 
washed with water, dried (MgSO4) and the solvent evaporated. The residue was subjected 
to column chromatography (SiO2) to afford the pure 2-arylpropionaldehyde 273. 
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General procedure J: Synthesis of 4-arylpent-3-enoic acids 
According to a literature procedure,
325
 dry triethylamine (1.5 equiv., 27.5 mmol, 3.9 ml) 
and malonic acid (1.0 equiv., 18.3 mmol, 1.90 g) were added to the appropriate 2-
arylaldehyde 253 (1.0 equiv., 18.3 mmol), the resulting mixture was refluxed for 16 hours, 
cooled to room temperature, and then acidified to pH 1 by the addition of dilute aqueous 
HCl. The solution was extracted with ether (3 × 30 ml) and the combined organic phases 
were washed with water containing a little NaCl, dried (MgSO4) and the solvent 
evaporated under reduced pressure. The residue was dissolved in 0.1 M aqueous NaOH 
solution, washed with ether (2 × 30 ml), then transferred to a separatory funnel and 
acidified to pH 1 with dilute aqueous HCl. The precipitated acid was extracted with 
CH2Cl2 (4 × 30 ml), the combined extracts washed once with water containing a little 
NaCl, dried (MgSO4) and the solvent evaporated under reduced pressure to afford the 
crude 4-arylpent-3-enoic acid 274, which was used in the next step without further 
purification. 
 
General procedure K: Synthesis of 4-arylpent-3-enoic acid methyl esters 
The crude acid (274) was dissolved in methanol (0.5 M), 98% H2SO4 (0.5 equiv.) was 
added dropwise with rapid stirring and the resulting solution stirred at room temperature 
for 24 hours. The acid was neutralised by the addition of excess solid NaHCO3 and the 
majority of the methanol evaporated under reduced pressure (the release of dissolved CO2 
can cause extreme bumping at this stage). The residue was partitioned between water and 
CH2Cl2, the aqueous layer extracted with CH2Cl2, then the combined organics were dried 
(MgSO4) and evaporated under reduced pressure. The residue was purified via column 
chromatography (SiO2) to afford the respective (E)- and (Z)-isomers of the methyl 4-
arylpent-3-enoate 275. 
 
General procedure L: Asymmetric hydroboration of β,γ-unsaturated 
esters using (–)-isopinocampheylborane 
BF3.OEt2 (2.0 equiv., 5.26 mmol, 0.65 ml) was added dropwise to a solution of 
2IpcBH2.TMEDA 257 (1.05 equiv., 2.76 mmol, 1.15 g) in 3.8 ml of dry THF. The 
resulting mixture was stirred at room temperature for three hours and then cooled to 
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approximately  –17 °C in a mixture of methanol and crushed ice. The surface of the slurry 
was covered with tin foil, wrapped with cotton wool and then wrapped again with tin foil. 
A solution of the ester 275 (1.0 equiv., 2.63 mmol) in THF (1.0 ml) was then added 
dropwise and the reaction mixture allowed to warm slowly to 0 °C, over approximately 16 
hours. The intermediate organoboranes were then oxidised via treatment with 30% aqueous 
H2O2 (13.8 ml) and saturated NaHCO3 solution (84 ml) followed by stirring at room 
temperature for six hours. Then the mixture was extracted with ether, the combined 
organics washed with water, dried (MgSO4) and the solvent evaporated under reduced 
pressure to afford a mixture of isopinocampheol 258 and the corresponding diol 277, 
which was isolated via column chromatography (SiO2). 
 
General procedure M: Determination of the enantiomeric excesses of 
diols 277a-h and 293 via a chiral derivatisation protocol 
According to a literature procedure,
327
 two samples of the diol (1 – 40 mg, 1.0 equiv.) were 
placed in small sample vials. CDCl3 (0.8 ml) and 2-formylphenyl boronic acid 280 (1.1 
equiv.) were added to each vial, followed by either racemic α-methylbenzylamine or 
enantiomerically pure (S)-(–)-α-methylbenzylamine 281 (1.2 equiv.). A small quantity of 
MgSO4 was then added and the contents of each vial were mixed thoroughly. After being 
allowed to stand for 10 minutes, the resulting mixtures were filtered through cotton wool 
into NMR tubes and analysed by 500 MHz 
1
H NMR spectroscopy. The enantiomeric 
excess of the diol 277 was then determined via integration of the respective imine proton 











5.2 Synthesis of 2-methylene aldehydes 
2-Methyleneoctanal 197336 
 
General procedure A was followed, using n-octanal (10.0 ml, 8.20 g), to afford the title 
compound as a pale yellow oil (7.53 g, 84%); 
1
H NMR (300 MHz, CDCl3) δ 9.47 (1H, s, 
CHO), 6.19-6.16 (1H, m, C=CHAHB), 5.92-5.90 (1H, m, C=CHAHB), 2.21-2.12 (2H, m, 
C5H11CH2), 1.44-1.14 (8H, m, (CH2)4), 0.86-0.76 (3H, m, CH3); 
13
C NMR (75 MHz, 







General procedure A was followed, using n-butyraldehyde (20.0 ml, 16.0 g). The product 
was isolated via extraction of the quenched reaction mixture with ether, followed by 
fractional distillation to afford the title compound as a colourless oil (bp 91 °C, 8.40 g, 
45%); 
1
H NMR (300 MHz, CDCl3) δ 9.55 (1H, s, CHO), 6.22-6.27 (1H, m, C=CHAHB), 














General procedure A was followed, using isovaleraldehyde (20.0 ml, 16.06 g). The product 
was isolated via extraction of the quenched reaction mixture with ether, followed by 
fractional distillation to afford the title compound as a colourless oil (bp 109 °C, 10.25 g, 
56%); 
1
H NMR (300 MHz, CDCl3) δ 9.46 (1H, s, CHO), 6.17 (1H, d, J = 0.9 Hz, 
C=CHAHB), 5.88 (1H, s, C=CHAHB), 2.73 (septet of d, 1H, J = 6.8 and 0.9 Hz, (CH3)2CH), 
1.01 (6H, d, J = 6.8 Hz, (CH3)2CH); 
13
C NMR (75 MHz, CDCl3) δ 195.1, 156.9, 132.6, 







General procedure A was followed, using hydrocinnamaldehyde (10.0 ml, 10.19 g), to 
form the title compound as a pale yellow oil, (8.77 g, 79%); 1H NMR (300 MHz, CDCl3) δ 
9.53 (1H, s, CHO), 7.26-7.06 (5H, m, Ph), 6.04-6.01 (1H, m, C=CHAHB), 6.00-5.97 (1H, 
m, C=CHAHB), 3.49 (2H, s, PhCH2); 
13
C NMR (75 MHz, CDCl3) δ 194.4, 150.2, 138.5, 






General Procedure D was followed, using 4-phenyl-1-butanol (10.0 g) and PCC (21.52 g) 
to afford the title compound as a colourless oil (9.08 g, 92%) which was used without 
further purification; 
1
H NMR (300 MHz, CDCl3) δ 9.77 (1H, t, J = 1.6 Hz, CHO), 7.36-
7.13 (5H, m, Ph), 2.68 (2H, t, J = 7.6 Hz, PhCH2), 2.47 (2H, td, J = 7.3 and 1.5 Hz, 
CH2CHO), 1.98 (2H, tt, J = 7.6 and 7.3 Hz, CH2CH2CH2); 
13
C NMR (75 MHz, CDCl3) δ 






General procedure A was followed, using 4-phenylbutanal (211, 8.80 g), to form the title 
compound as a pale yellow oil (7.90 g, 83%); 
1
H NMR (300 MHz, CDCl3) δ 9.47 (1H, s, 
CHO), 7.24-7.04 (5H, m, Ph), 6.12-6.10 (1H, m, C=CHAHB), 5.92-5.90 (1H, m, 
C=CHAHB), 2.73-2.65 (2H, m, PhCH2), 2.54-2.45 (2H, m, PhCH2CH2); 
13
C NMR (75 
























5.3 Synthesis of exomethylenic allylic alcohols 
3-Methylenenonan-2-ol 198a340 
 
General procedure B was followed, using 2-methyleneoctanal (197, 5.00 g) and methyl 
iodide (10.12 g, 4.4 ml) to afford the title compound as a colourless oil (5.00 g, 79%); 
1
H 
NMR (300 MHz, CDCl3) δ 4.96 (1H, s, C=CHAHB), 4.75-4.72 (1H, m, C=CHAHB), 4.18 
(1H, q, J = 5.9 Hz, CH(OH)), 2.08-1.86 (2H, m, C5H11CH2), 1.51 (1H, br. s, OH), 1.46-
1.15 (11H, m, CH3(CH2)4 and CH(OH)CH3), 0.89-0.74 (3H, m, CH3CH2); 
13
C NMR (75 





General procedure B was followed, using 2-methyleneoctanal (197, 7.80 g) and isopropyl 
iodide (18.91 g, 11.1 ml) to afford the title compound as a colourless oil (5.23 g, 51%); 
1
H 
NMR (300 MHz, CDCl3) δ 4.91 (1H, s, C=CHAHB), 4.82-4.79 (1H, m, CCHAHB), 3.68 
(1H, d, J = 6.5 Hz, CH(OH)), 2.07-1.80 (2H, m, C5H11CH2), 1.80-1.66 (1H, m, CH(CH3)2), 
1.47-1.16 (8H, m, CH3(CH2)4), 0.86 (3H, d, J = 6.7 Hz, CH3CHCH3), 0.82 (3H, obs. t, 
CH3CH2), 0.81 (3H, d, J = 6.8 Hz, CH3CHCH3); 
13
C NMR (75 MHz, CDCl3) δ 151.7, 
110.5, 81.5, 32.2, 31.8, 31.5, 29.7, 28.3, 23.0, 20.1, 17.7, 14.5; IR (neat): 3394 (O–H) (cm
-
1
); HRMS (ES): m/z [C12H23O]
-











To a dry round bottom flask was added 72 ml of PhMgBr solution (1.0 M in THF, 72 
mmol, 2.0 equiv.), followed by an equal volume of dry THF. The resulting solution was 
cooled to 0 °C and 2-methyleneoctanal (197, 5.0 g, 35.6 mmol, 1.0 equiv.) was added 
dropwise via syringe. When tlc analysis indicated complete consumption of the aldehyde, 
saturated aqueous ammonium chloride solution (10 ml) was added and the mixture stirred 
at room temperature for 15 m followed by the addition of ether (150 ml). The whole 
mixture was transferred to a separatory funnel and the organic layer was washed 
successively with 1.0 M HCl(aq) (50 ml), brine (50 ml) and water (50 ml). The combined 
organic fractions were dried (MgSO4) and the solvent removed under reduced pressure. 
The crude product was purified by column chromatography to afford the title compound as 
a colourless oil (5.06 g, 65%); 
1
H NMR (300 MHz, CDCl3) δ 7.41-7.26 (5H, m, Ph), 5.27 
(1H, s, C=CHAHB), 5.15 (1H, s, C=CHAHB), 4.99 (1H, s, CH(OH)), 2.07-1.79 (3H, m, 
C5H11CH2 and OH), 1.48-1.15 (8H, m, CH3(CH2)4), 0.93-0.83 (3H, m, CH3); 
13
C NMR (75 
MHz, CDCl3) δ 151.6, 142.6, 128.8, 128.1, 127.1, 110.0, 77.8, 32.2, 32.1, 29.5, 28.2, 23.0, 
14.5; IR (neat): 3360 (O–H) (cm
-1
); HRMS (ES): m/z [C15H22NaO]
+





General Procedure C was followed, using 2-methylenebutanal (206, 0.84 g) and 2-
bromopyridine (3.16 g, 1.9 ml) to afford the title compound as a colourless oil (0.71 g, 
44%); 
1
H NMR (300 MHz, CDCl3) δ 8.41-8.47 (1H, m, Ar), 7.57 (1H, td, J = 7.7 and 1.7 
Hz, Ar), 7.19-7.24 (1H, m, Ar), 7.11 (1H, ddd, J = 7.4, 5.1 and 1.0 Hz, Ar), 5.12-5.15 (2H, 
m, C=CH2), 4.90-4.93 (1H, m, CH(OH)), 1.89-2.08 (1H, m, CH3CHAHB), 1.54-1.73 (1H, 
m, CH3CHAHB), 0.89 (3H, t, J = 7.4 Hz, CH3); 
13
C NMR (75 MHz, CDCl3) δ 160.4, 152.4, 
148.1, 137.1, 122.7, 121.3, 111.8, 77.5, 23.1, 12.3; IR (neat): 3412 (O–H) cm-1; HRMS 
(ES): m/z [C10H13NNaO]
+





3-Bromopyridine was purified by distillation under reduced pressure (bp 55 °C, 10 mmHg) 
and then General Procedure C was followed, using 2-methylenebutanal (206, 0.84 g) and 
3-bromopyridine (3.16 g, 1.9 ml) to afford the title compound as a colourless oil (0.97 g, 
60%); 
1
H NMR (300 MHz, CDCl3) δ 8.48 (1H, d, J = 1.8 Hz, Ar), 8.40 (1H, dd, J = 4.8 
and 1.5 Hz, Ar), 7.66 (1H, dtd, J = 7.9, 1.9 and 0.5 Hz, Ar), 7.20 (1H, ddd, J = 7.8, 4.9 and 
0.5 Hz, Ar), 5.21-5.19 (1H, m, C=CHAHB), 5.15 (1H, s, C=CHAHB), 4.96-4.93 (1H, m, 
CH(OH)), 3.18 (1H, br. s, OH), 2.00-1.71 (2H, m, CH3CH2), 0.93 (3H, t, J = 7.4 Hz, CH3); 
13
C NMR (75 MHz, CDCl3) δ 152.4, 148.8, 148.5, 138.4, 134.9, 123.8, 110.3, 75.6, 24.5, 
12.4; IR (neat): 3189 (O–H), 1024 (C–O) cm-1; HRMS (ES): m/z [C10H13NNaO]
+
 requires 




4-Bromopyridine hydrochloride (5.0 g) was dissolved in water, the resulting solution 
placed into a separatory funnel and the pH adjusted to around 10 with saturated Na2CO3 
solution. The solution was then extracted thoroughly with ether, dried (K2CO3) and the 
solvent removed under reduced pressure to afford the unstable 4-bromopyridine freebase 
(3.58 g). General Procedure C was then followed using 2-methylenebutanal (206, 0.84 g) 
and 4-bromopyridine (3.16 g) to afford the title compound as an off-white solid (0.55 g, 
34%); 
1
H NMR (300 MHz, CDCl3) δ 8.48-8.53 (2H, m, Ar), 7.30-7.35 (2H, m, Ar), 5.19-
5.25 (2H, m, C=CH2), 4.99-5.03 (1H, m, CH(OH)), 3.34 (1H, br. s, OH), 1.95-2.12 (1H, m, 
CH3CHAHB), 1.74-1.91 (1H, m, CH3CHAHB), 1.00 (3H, t, J = 7.3 Hz, CH3); 
13
C NMR (75 
MHz, CDCl3) δ 152.2, 152.1, 149.8, 121.9, 111.3, 76.9, 23.9, 12.3; IR (neat): 3075 (O–H), 
1063 (C–O) cm-1; HRMS (ES): m/z [C10H14NO]
+
 requires 164.1075, found 164.1070. 






General procedure B was followed, using 3-methyl-2-methylenebutanal (207, 5.0 g) and 
methyl iodide (14.46 g, 6.3 ml) to afford the title compound as a colourless oil (4.77 g, 
82%); 
1
H NMR (300 MHz, CDCl3) δ 5.01-4.97 (1H, m, C=CHAHB), 4.80 (1H, s, 
C=CHAHB), 4.22 (1H, q, J = 6.4 Hz, CH(OH)), 2.33-2.15 (1H, m, CH(CH3)2), 1.54 (1H, 
br. s, OH), 1.23 (3H, d, J = 6.4 Hz, CH3CH(OH), 1.00 (6H, app. t, J = 6.7 Hz, (CH3)2CH); 
1
H NMR (75 MHz, CDCl3) δ 160.8, 106.3, 70.5, 30.6, 23.5, 23.2, 23.0; IR (neat): 3352 
(O–H) (cm-1);  HRMS (ES): m/z [C7H14NaO]
+




General procedure B was followed, using 3-methyl-2-methylenebutanal (207, 5.0 g) and 
benzyl bromide (17.43 g, 12.1 ml) to afford the title compound as a colourless oil (7.17 g, 
74%); 
1
H NMR (300 MHz, CDCl3) δ 7.27-7.12 (5H, m, Ph), 5.05-5.03 (1H, m, 
C=CHAHB), 4.88 (1H, s, C=CHAHB), 4.22 (1H, dd, J = 8.8 and 3.7 Hz, CH(OH)), 2.87 
(1H, dd, J = 13.7 and 3.9 Hz, CHAHBPh), 2.65 (1H, dd, J = 13.7 and 8.8 Hz, CHAHBPh), 
2.32-2.17 (1H, m, CH(CH3)2), 1.55 (1H, br. s, OH), 1.03 (3H, d, J = 4.9 Hz, CH3CHCH3), 
1.01 (3H, d, J = 4.9 Hz, CH3CHCH3); 
13
C NMR (75 MHz, CDCl3) δ  158.8, 139.0, 129.8, 
128.9, 126.9, 107.8, 75.2, 43.9, 31.2, 23.5, 22.8; IR (neat): 3402 (O–H) (cm-1); HRMS 
(ES): m/z [C13H18NaO]
+











General procedure B was followed, using 2-benzylacrylaldehyde (208, 5.0 g) and methyl 
iodide (9.71 g, 4.3 ml) to afford the title compound as a colourless oil (4.66 g, 84%); 
1
H 
NMR (300 MHz, CDCl3) δ 7.35-7.19 (5H, m, Ph), 5.17 (1H, s, C=CHAHB), 4.78-4.75 (1H, 
m, C=CHAHB), 4.26 (1H, q, J = 6.5 Hz, CH(OH)), 3.49 (1H, d, J = 15.5 Hz, PhCHAHB), 
3.37 (1H, d, J = 15.5 Hz, PhCHAHB), 1.74 (1H, br. s, OH), 1.32 (3H, d, J = 6.5 Hz, CH3); 
13
C NMR (75 MHz, CDCl3) δ 153.0, 139.9, 129.6, 128.8, 126.6, 111.3, 70.6, 39.4, 22.6; IR 
(neat): 3350 (O–H) (cm-1); HRMS (ES): m/z [C11H14NaO]
+





General procedure B was followed, using 2-benzylacrylaldehyde (208, 5.0 g) and isopropyl 
iodide (11.63 g, 6.8 ml) to afford the title compound as a colourless oil (4.82 g, 74%); 
1
H 
NMR (300 MHz, CDCl3) δ 7.25-7.08 (5H, m, Ph), 5.00 (1H, s, CCHAHB), 4.67-4.64 (1H, 
m, CCHAHB), 3.71 (1H, d, J = 6.5 Hz, CH(OH)), 3.37 (1H, d, J = 15.7 Hz, CHAHBPh), 
3.18 (1H, d, J = 15.7 Hz, CHAHBPh), 1.87-1.71 (1H, m, CH(CH3)2), 1.48 (1H, br. s, OH), 
0.87 (3H, d, J = 6.7 Hz, CH3CHCH3), 0.82 (3H, d, J = 6.8 Hz, CH3CHCH3); 
13
C NMR (75 
MHz, CDCl3) δ 151.0, 139.8, 129.7, 128.8, 126.6, 113.4, 80.8, 39.0, 31.6, 20.0, 17.7; IR 
(neat): 3402 (O–H) (cm-1); HRMS (ES): m/z [C13H18NaO]
+










General procedure B was followed, using 2-methylene-4-phenylbutanal (212, 3.0 g) and 
methyl iodide (5.32 g, 2.3 ml) to afford the title compound as a colourless oil (2.64 g, 
80%); 
1
H NMR (300 MHz, CDCl3) δ 7.26-7.06 (5H, m, Ph), 5.05-4.98 (1H, m, 
C=CHAHB), 4.84-4.77 (1H, m, C=CHAHB), 4.19 (1H, q, J = 6.4 Hz, CH(OH)), 2.76-2.68 
(2H, m, PhCH2), 2.41-2.18 (2H, m, PhCH2CH2), 1.52 (1H, br. s, OH), 6.43 (3H, d, J = 6.4 
Hz, CH3); 
13
C NMR (75 MHz, CDCl3) δ 153.1, 142.4, 128.8, 126.3, 109.2, 71.5, 35.0, 
33.7, 22.6; IR (neat): 3351 (O–H) (cm-1); HRMS (ES): m/z [C12H16NaO]
+
 requires 




General procedure B was followed, using 2-methylene-4-phenylbutanal (212, 4.0 g) and 
isopropyl iodide (8.49 g, 5.0 ml) to afford the title compound as a colourless oil (3.01 g, 
59%); 
1
H NMR (300 MHz, CDCl3) δ 7.23-7.04 (5H, m, Ph), 4.97 (1H, s, C=CHAHB), 4.91-
4.87 (1H, m, C=CHAHB), 3.67 (1H, d, J = 6.9 Hz, CH(OH)), 2.76-2.69 (2H, m, PhCH2), 
2.40-2.26 (1H, m, PhCH2CHAHB), 2.25-2.10 (1H, m, PhCH2CHACHB), 1.81-1.63 (1H, m, 
(CH3)2CH), 1.50 (1H, br. s, OH), 0.85 (3H, d, J = 6.6 Hz, CH3CHCH3), 0.79 (3H, d, J = 
6.8 Hz, CH3CHCH3); 
13
C NMR (75 MHz, CDCl3) δ 150.9, 142.5, 128.8, 126.3, 111.4, 
81.7, 34.8, 33.4, 31.7, 20.1, 17.9; IR (neat): 3410 (O–H) (cm-1); HRMS (ES): m/z 
[C14H20NaO]
+










General procedure B was followed, using 2-methyleneoctanal (197, 5.0 g) and benzyl 
bromide (12.2 g, 8.5 ml), to form the title compound as a colourless oil (5.88 g, 71%); 
1
H 
NMR (300 MHz, CDCl3) δ 7.37-7.20 (5H, m, Ph), 5.07 (1H, s, C=CHAHB), 4.92-4.88 (1H, 
m, CCHAHB), 4.30 (1H, dd, J = 8.8 and 4.1 Hz, CH(OH)), 2.96 (1H, dd, J = 13.7 and 4.2 
Hz, CHAHBPh), 2.76 (1H, dd, J = 13.7 and 8.8 Hz, CHAHBPh), 2.24-2.01 (2H, m, 
C5H11CH2), 1.67 (1H, br. s, OH), 1.60-1.26 (8H, m, CH3(CH2)4), 0.97-0.84 (3H, m, CH3); 
13
C NMR (75 MHz, CDCl3) δ 151.9, 138.9, 129.8, 128.9, 126.9, 109.9, 76.3, 43.2, 32.5, 
32.2, 29.7, 28.4, 23.1, 14.5; IR (neat): 3401 (O–H) (cm
-1
); HRMS (ES): m/z [C16H24NaO]
+
 




A solution of of 2-methyleneoctanal (197, 10.0 g, 71.3 mmol) in dry ether (60 ml) was 
added dropwise to a stirred suspension of LiAlH4 (1.46 g, 38.5 mmol) in dry ether (120 ml) 
at 0 °C. The mixture was stirred for 2 h at 5 °C, then 1.5 ml water, 1.5 ml 15% aqueous 
NaOH and 4.5 ml water were slowly added in succession. The inorganic salts were filtered 
off, the aqueous phase was extracted with ether and the combined organic fractions were 
washed with brine and water, dried (MgSO4) and the solvent removed under reduced 
pressure. The residue was purified by column chromatography (SiO2) to afford the title 
compound as a colourless oil (7.81 g, 77%); 
1
H NMR (300 MHz, CDCl3) δ 4.95-4.92 (1H, 
m, C=CHAHB), 4.81-4.77 (1H, m, C=CHAHB), 4.00 (2H, d, J = 5.8 Hz, CH2OH), 2.02-1.94 
(2H, m, C5H11CH2), 1.54 (1H, t, J = 5.8 Hz, OH), 1.44-1.14 (8H, m, CH3(CH2)4), 0.87-0.74 
(3H, m, CH3); 
13
C NMR (75 MHz, CDCl3) δ 149.7, 109.3, 66.3, 33.4, 32.1, 29.5, 28.1, 







To a solution of 2-methyleneoctan-1-ol (198n, 1.0 g, 7.0 mmol) in CH2Cl2 (72 ml), 
dihydropyran (0.71 ml, 7.74 mmol) was added, followed by pyridinium para-
toluenesulphonate (0.177 g, 0.70 mmol) and the reaction mixture was stirred at room 
temperature overnight. After addition of a saturated NaHCO3 solution the reaction mixture 
was diluted with CH2Cl2, the organic layer washed with water, dried (MgSO4), the solvent 
removed under reduced pressure and the residue purified by column chromatography 
(SiO2) to afford the title compound as a colourless oil (1.27 g, 80%); 
1
H NMR (300 MHz, 
CDCl3) δ 4.96 (1H, s, CCHAHB), 4.82 (1H, s, CCHAHB), 4.59-4.52 (1H, m,), 4.14-4.06 
(1H, m,), 3.88-3.75 (2H, m,), 3.50-3.40 (1H, m,), 2.04-1.93 (2H, m,), 1.87-1.31 (8H, m,), 
1.31-1.17 (6H, m,), 0.86-0.75 (3H, m,); 
13
C NMR (75 MHz, CDCl3) δ 146.7, 111.1, 98.1, 
70.1, 62.5, 33.7, 32.1, 31.0, 29.5, 28.0, 25.9, 23.0, 19.8, 14.5; IR (neat): 1036 (O–C–O) 
(cm
-1
); HMRS (ES): m/z [C14H26NaO2]
+




To a solution of 2-methyleneoctan-1-ol (198n, 1.0 g, 7.0 mmol) in CH2Cl2 (72 ml) were 
added imidazole (1.46 g, 21.4 mmol) and DMAP (0.13 g, 1.1 mmol), followed by (tert-
butyldimethyl)silyl chloride (2.15 g, 14.3 mmol) in CH2Cl2 (5 ml). After stirring for 24 
hours, the reaction mixture was partitioned between saturated aqueous NaHCO3 and 
CH2Cl2. The organic layer was separated, washed with water and dried (MgSO4). The 
solvent was removed under reduced pressure and the residue purified by column 
chromatography to afford the title compound as a colourless oil (1.53 g, 85%); 
1
H NMR 
(300 MHz, CDCl3) δ 4.97-4.91 (1H, m, C=CHAHB), 4.75-4.71 (1H, m, C=CHAHB), 3.99 
(2H, s, CH2O), 1.97-1.88 (2H, m, C5H11CH2), 1.43-1.14 (8H, m, CH3(CH2)4), 0.89-0.77 
(12H, m, CH3CH2 and (CH3)3C), 0.00 (6H, s, Si(CH3)2); 
13
C NMR (75 MHz, CDCl3) δ 
149.3, 108.6, 66.3, 33.2, 32.1, 29.5, 28.2, 26.3, 23.0, 18.8, 14.5, -4.5; IR (neat): 1252 (Si–







General Procedure D was followed, using 3-methylenenonan-2-ol (198a, 4.0 g) and PCC 
(5.52 g), to afford the title compound as a pale yellow oil (2.92 g, 74%) which was used 
without further purification; 
1
H NMR (300 MHz, CDCl3) δ 5.98 (1H, s, C=CHAHB), 5.76-
5.71 (1H, m, C=CHAHB), 2.32 (3H, s, CH3CO), 2.28-2.20 (2H, m, C5H11CH2), 1.45-1.20 
(8H, m, CH3(CH2)4), 0.94-0.80 (3H, m, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 200.3, 






General procedure B was followed, using 3-methylenenonan-2-one (201a, 2.0 g) and 
methyl iodide (3.68 g, 1.6 ml) to afford the title compound as a colourless oil (1.83 g, 
83%); 
1
H NMR (300 MHz, CDCl3) δ 5.12-5.09 (1H, m, C=CHAHB), 4.79-4.76 (1H, m, 
C=CHAHB), 2.11-2.02 (2H, m, C5H11CH2), 1.57-1.22 (15H, m, CH3(CH2)4, C(CH3)2 and 
OH), 0.94-0.83 (3H, m, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 156.7, 106.9, 73.9, 32.2, 












5.4 Synthesis of exomethylenic hydrocarbons 
Undecan-3-ol 220b348 
 
A 0.5 M solution of EtMgBr in ether (116.4 ml, 58.2 mmol) was prepared via dilution of 
the commercially available reagent and cooled to 0 °C, followed by the dropwise addition 
of nonanal (4.14 g, 5.0 ml, 29.1 mmol, 0.5 equiv.). After stirring for one hour, the reaction 
was quenched by the cautious addition of 50% saturated NH4Cl solution and transferred to 
a separatory funnel. Sufficient 1.0 M HCl and water were added to dissolve the 
precipitated salts, the organic layer was separated and the aqueous fraction extracted with 
ether (3 × 50 ml). The combined organics were washed successively with saturated 
NaHCO3 solution (50 ml) and water (50 ml), dried (MgSO4) and the solvent evaporated to 
afford the title compound as a colourless oil (4.61 g, 92%); 
1
H NMR (300 MHz, CDCl3) δ 
3.46-3.58 (1H, m, CH(OH)), 1.19-1.56 (16H, m, (CH2)7 and CH(OH)CH2CH3), 0.93 (3H, 
t, J = 7.4 Hz, CH(OH)CH2CH3), 0.84-0.90 (3H, m, CH3CH2CH2); 
13
C NMR (75 MHz, 
CDCl3) δ 73.4, 37.0, 31.9, 30.2, 29.7, 29.6, 29.3, 25.7, 22.7, 14.1, 9.9 ; IR (neat): 3345 (O–




To 82.2 ml of dry ether was added 34.2 ml of a commercially available t-BuLi solution 
(1.7 M in pentane, 58.1 mmol) to afford a final concentration of ~0.5 M. The resul ting 
solution was cooled to 0 °C, followed by the dropwise addition of nonanal (4.14 g, 5.0 ml, 
29.1 mmol, 0.5 equiv.). The reaction mixture was stirred for one hour and worked up as 
described above for 220b to afford the title compound as a colourless oil (5.13 g, 88%); 
1
H 
NMR (300 MHz, CDCl3) δ 3.19 (1H, app. d, J = 10.0 Hz, CH(OH)), 1.18-1.66 (14H, m, 
(CH2)7), 0.80-0.97 (12H, m, CH3CH2 and C(CH3)3); 
13
C NMR (75 MHz, CDCl3) δ 80.0, 






According to General Procedure D, undecan-3-ol (220b, 4.0 g) was oxidised with PCC 
(7.51 g) to afford the title compound as a colourless oil (2.65 g, 67%) which was used 
without further purification; 
1
H NMR (300 MHz, CDCl3) δ 2.30-2.43 (4H, m, 
CH2C(O)CH2), 1.45-1.59 (2H, m, CH2CH2C(O)), 1.14-1.32 (10H, m, (CH2)5), 1.00 (3H, t, 
J = 7.3 Hz, CH3CH2C(O)), 0.78-0.87 (3H, m, CH3(CH2)7); 
13
C NMR (75 MHz, CDCl3) δ 




According to General Procedure D, 2,2-dimethylundecan-3-ol (220c, 5.0 g) was oxidised 
with PCC (8.08 g) to afford the title compound as a colourless oil (3.07 g, 62%) which was 
used without further purification; 
1
H NMR (300 MHz, CDCl3) δ 2.47 (2H, t, J = 7.3 Hz, 
CH2CO), 1.47-1.62 (2H, m, CH2CH2CO), 1.19-1.37 (10H, m, alkyl), 1.12 (9H, s, 
(CH3)3C), 0.94-0.83 (3H, m, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 216.3, 44.1, 36.5, 




According to General Procedure E, 2-decanone (1.65 g, 2.0 ml) was methylenated to afford 
the title compound as a colourless oil (0.93 g, 57%) which was used without further 
purification; 
1
H NMR (300 MHz, CDCl3) δ 4.68 (1H, s, C=CHAHB), 4.66 (1H, s, 
C=CHAHB), 2.00 (2H, t, J = 7.5 Hz, CH2C), 1.71 (3H, s, CH3C), 1.22-1.48 (12H, m, 
(CH2)6), 0.84-0.92 (3H, m, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 146.4, 109.5, 37.9, 








According to General Procedure E, 3-undecanone (221b, 2.50 g) was methylenated to 
afford the title compound as a colourless oil (1.31 g, 53%) which was used without further 
purification; 
1
H NMR (300 MHz, CDCl3) δ 4.68-4.72 (2H, m, C=CH2), 1.97-2.08 (4H, m, 
CH2C(=CH2)CH2), 1.19-1.50 (12H, m, (CH2)6), 1.03 (3H, t, J = 7.5 Hz, CH3CH2C), 0.85-
0.94 (3H, m, CH3(CH2)7); 
13
C NMR (75 MHz, CDCl3) δ 151.9, 107.2, 36.3, 31.9, 29.6, 







A slight variation of General Procedure E was employed. Following the addition of a THF 
solution of 2,2-dimethyl-3-undecanone (221c, 2.80 g) to the phosphorus ylide, the reaction 
mixture was first stirred at 0 °C for 30 minutes and then refluxed overnight (~16 h). After 
cooling to room temperature, the reaction mixture was worked up as described in the 
General Procedure. The solvent was then evaporated under reduced pressure and the 
residue purified by column chromatography (SiO2) to afford the title compound as a 
colourless oil (1.25 g, 45%); 
1
H NMR (300 MHz, CDCl3) δ 4.85 (1H, s, C=CHAHB), 4.69 
(1H, s, C=CHAHB), 1.98-2.07 (2H, m, CH2C), 1.20-1.54 (12H, m, (CH2)6), 1.07 (9H, s, 
C(CH3)3), 0.85-0.94 (3H, m, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 158.4, 105.5, 36.2, 












5.5 Palladium-catalysed isomerisation reactions 
3-Methylnon-3-en-2-ol 199a352 
 
General Procedure F was followed, using 3-methylenenonan-2-ol (198a, 0.156 g), 
Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile at 0 °C, to afford 
the title compound as a clear oil in 90% yield (determined by 
1
H NMR spectroscopy); 
(E):(Z) ratio = 21:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 5.33 (1H, t, J = 6.2 Hz, 
C=CH), 4.13 (1H, q, J = 6.4 Hz, CH(OH)), 1.88-1.99 (2H, m, CH2CH=C), 1.53-1.56 (3H, 
m, CH3C=CH), 1.14-1.32 (9H, m, CH3CH(OH) and CH3(CH2)3), 0.82 (3H, t, J = 6.8 Hz, 
CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 138.7, 125.8, 73.9, 31.9, 29.6, 27.7, 23.1, 22.0, 
21.6, 14.4, 11.8; HRMS (ES): m/z [C10H20NaO]
+




General Procedure F was followed, using 2-methyl-4-methylenedecan-3-ol (198b, 0.184 g) 
and Pd(OH)2/C (8.5% Pd w/w, 0.125 g) in acetonitrile, to afford the title compound as a 
clear oil in 96% yield (determined by 
1
H NMR spectroscopy); (E):(Z) ratio = 17:1; (E)-
isomer: 
1
H NMR (300 MHz, CDCl3) δ 5.39 (1H, t, J = 6.2 Hz, C=CH), 3.60 (1H, d, J = 6.4 
Hz, CH(OH)), 1.99-2.11 (2H, m, CH2CH=C), 1.69-1.90 (1H, m, CH(CH3)2), 1.60-1.65 
(3H, m, CH3C=CH), 1.22-1.51 (6H, m, CH3(CH2)3), 1.02 (3H, d, J = 3.8 Hz, CH3CH), 
0.85-1.00 (3H, m, CH3CH2), 0.79 (3H, d, J = 3.6 Hz, CH3CH); 
13
C NMR (75 MHz, 
CDCl3) δ 136.6, 128.5, 84.7, 31.9, 31.5, 29.6, 27.8, 22.9, 19.8, 19.1, 14.5, 11.6; HRMS 
(ES): m/z [C10H20NaO]
+









General Procedure F was followed, using 2-methylene-1-phenyloctan-1-ol (198c, 0.218 g), 
Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile, to afford the title 
compound as a clear oil in 87% yield (determined by 
1
H NMR spectroscopy); (E):(Z) ratio 
= 8:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.14-7.31 (5H, m, Ph), 5.66 (1H, t, J = 
6.3 Hz, C=CH), 5.05 (1H, s, CH(OH)), 1.95-2.03 (2H, m, CH2CH=C),  1.39-1.42 (3H, m, 
CH3C=CH), 1.09-1.37 (6H, m, CH3(CH2)3), 0.82 (3H, t, J = 7.0 Hz, CH3CH2); 
13
C NMR 





Unoptimised palladium-catalysed isomerisation reactions of 2-methylene-1-phenyloctan-1-
ol (198c) resulted in the title compound being isolated by column chromatography (SiO2) 
as a clear oil in 6 – 22% yields; 1H NMR (300 MHz, CDCl3) δ 7.04-7.25 (5H, m, Ph), 2.58 
(1H, dd, J = 13.1 and 3.9 Hz, PhCHAHB), 2.28 (1H, dd, J = 13.1 and 8.1 Hz, PhCHAHB), 
1.58-1.72 (1H, m, CHCH2Ph),  1.02-1.36 (10H, m, (CH2)5), 0.72-0.89 (6H, m, CH3CH2 
and CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 142.1, 129.6, 128.4, 125.9, 44.1, 37.2, 35.4, 














General Procedure F was followed, using 2-methylene-1-(pyridin-3-yl)butan-1-ol (198d, 
0.161 g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in isopropanol,  to 
afford a crude mixture containing the title compound in 27% yield (determined by 
1
H 
NMR spectroscopy); (E):(Z) ratio = 13:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 8.44-
8.51 (1H, m, Ar), 7.56-7.67 (1H, m, Ar), 7.08-7.20 (2H, m, Ar), 5.69 (1H, qq, J = 6.6 and 
1.4 Hz, CH3CH), 5.03 (1H, s, CH(OH)), 1.62 (3H, dq, J = 6.7 and 1.0 Hz, CH3CH), 1.30-




General Procedure F was followed, using 2-methylene-1-(pyridin-3-yl)butan-1-ol (198e, 
0.161 g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in isopropanol,  to 
afford the title compound as a clear oil in 83% yield (determined by 
1
H NMR 
spectroscopy); (E):(Z) ratio = 10:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 8.35-8.52 
(2H, m, Ar), 7.57-7.70 (1H, m, Ar), 7.14-7.24 (1H, m, Ar), 5.67 (1H, q, J = 6.7 Hz, 
CH3CH), 5.11 (1H, s, CH(OH)), 2.52 (1H, br. s, OH), 1.60 (3H, d, J = 6.5 Hz, CH3CH), 
1.42 (3H, s, CH3C=CH); 
13
C NMR (75 MHz, CDCl3) δ 148.7, 148.5, 138.3, 137.5, 134.3, 











General Procedure F was followed, using 2-methylene-1-(pyridin-4-yl)butan-1-ol (198f, 
0.161 g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in isopropanol, to 
afford the title compound as a clear oil in 83% yield (determined by 
1
H NMR 
spectroscopy); (E):(Z) ratio = 10:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 8.39-8.47 
(2H, m, Ar), 7.20-7.26 (2H, m, Ar), 5.64 (1H, q, J = 6.4 Hz, CH3CH), 5.07 (1H, s, 
CH(OH)), 2.83 (1H, br. s, OH), 1.60 (3H, d, J = 6.4 Hz, CH3CH), 1.39 (3H, s, CH3C=CH); 
13




General Procedure F was followed, using 4-methyl-3-methylenepentan-2-ol (199g, 0.114 
g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile, to afford the 
title compound as a clear oil in 61% yield (determined by 
1
H NMR spectroscopy); 
1
H 
NMR (300 MHz, CDCl3) δ 4.79 (1H, q, J = 6.5 Hz, C=CH), 1.65-1.61 (3H, m, CH3CCH3), 
1.59 (3H, s, CH3CCH3), 1.55-1.58 (3H, m, CH3CCH(OH)), 1.13 (3H, d, J = 6.5 Hz, 
CH3CH(OH)); 
13












General Procedure F was followed, using 4-methyl-3-methylene-1-phenylpentan-2-ol 
(198h, 0.190 g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile, 





H NMR (300 MHz, CDCl3) δ 7.17-7.39 (5H, m, Ph), 4.84 (1H, dd, J = 8.1 
and 5.7 Hz, CH(OH)), 2.97 (1H, dd, J = 13.5 and 3.9 Hz, PhCHAHB), 2.88 (1H, dd, J = 
13.5 and 7.1 Hz, PhCHAHB), 1.71-1.76 (3H, m, CH3CCH3), 1.66 (3H, s, CH3CCH3), 1.3-
1.59 (3H, m, CH3CCH(OH)); 
13
C NMR (75 MHz, CDCl3) δ 158.8, 139.1, 129.8, 129.0, 




General Procedure F was followed, using 3-benzylbut-3-en-2-ol (198i , 0.162 g), 
Pd(OH)2/C (8.5% Pd w/w, 0.250 g) and Cs2CO3 (0.326 g) in acetonitrile, to afford the title 
compound as a clear oil in 13% yield (determined by 
1
H NMR spectroscopy); (E):(Z) ratio 
= 2:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.38-7.19 (5H, m, Ph), 6.57 (1H, s, 













General Procedure F was followed, using 3-methylene-5-phenylpentan-2-ol (198k, 0.176 
g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile at 0 °C, to 
afford the title compound as a clear oil in 55% yield (determined by 
1
H NMR 
spectroscopy); (E):(Z) ratio = 6:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.15-7.33 
(5H, m, Ph), 5.59-5.67 (1H, m, C=CH), 4.27 (1H, q, J = 6.4 Hz, CH(OH)), 3.40 (2H, d, J =  
5.9 Hz, PhCH2), 1.78 (3H, s, CH3C=CH), 1.30 (3H, d, J = 6.0 Hz, CH3CH(OH)); 
13
C NMR 




General Procedure F was followed, using 2-methyl-4-methylene-6-phenylhexan-3-ol (198l, 
0.204 g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile, to 
afford the title compound as a clear oil in 75% yield (determined by 
1
H NMR 
spectroscopy); (E):(Z) ratio = 8:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.13-7.35 
(5H, m, Ph), 5.59 (1H, tdq, J = 7.1, 1.4 and 0.8 Hz, C=CH), 3.65 (1H, d, J = 8.0 Hz, 
CH(OH)), 3.45 (2H, d, J =  5.8 Hz, PhCH2), 1.71-1.74 (3H, m, CH3C=CH), 1.44-1.54 (1H, 
m, CH(CH3)2), 1.01 (3H, d, J = 6.7 Hz, CH3CH), 0.84 (3H, d, J = 6.8 Hz, CH3CH); 
13
C 
NMR (75 MHz, CDCl3) δ 143.3, 141.5, 138.0, 128.7, 126.5, 126.3, 77.0, 33.9, 31.6, 19.9, 
19.0, 11.9; HRMS (ES): m/z [C14H20NaO]
+











General Procedure F was followed, using 3-methylene-1-phenylnonan-2-ol (198m, 0.232 
g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile at 0 °C, to 
afford the title compound as a clear oil in 80% yield (determined by 
1
H NMR 
spectroscopy); (E):(Z) ratio = 7:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.18-7.35 
(5H, m, Ph), 5.41-5.33 (1H, m, C=CH), 4.23 (1H, dd, J = 7.6 and 5.7 Hz, CH(OH)), 2.78-
2.88 (2H, m, PhCH2), 2.06-1.96 (2H, m, CH2CH=C),  1.72-1.69 (3H, m, CH3C=CH), 1.39-
1.16 (6H, m, CH3(CH2)3), 0.89 (3H, t, J = 7.0 Hz, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 




General Procedure F was followed, using 2-methyleneoctan-1-ol (198n, 0.142 g), 
Pd(OH)2/C (8.5% Pd w/w, 0.188 g) and Cs2CO3 (0.326 g) in acetonitrile, to afford the title 
compound as a clear oil in 65% yield (determined by 
1
H NMR spectroscopy); (E):(Z) ratio 
= 4:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 5.35 (1H, t, J = 6.4 Hz, C=CH), 3.93 
(2H, s, CH2(OH)), 1.89-2.02 (2H, m, CH2CH=C), 1.57-1.61 (3H, m, CH3C=CH), 1.14-
1.35 (6H, m, CH3(CH2)3), 0.81 (3H, t, J = 5.5 Hz, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 
134.9, 127.1, 69.5, 33.5, 30.9, 28.0, 23.0, 14.5, 14.4; HRMS (ES): m/z [C10H20NaO]
+
 











General Procedure F was followed, using 2-((2-methyleneoctyl)oxy)tetrahydro-2H-pyran 
(198o, 0.226 g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile at 
0 °C, to afford the title compound as a clear oil in 70% yield (determined by 
1
H NMR 
spectroscopy); (E):(Z) ratio = 4:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 5.39 (1H, t, 
CH=C, J = 6.2 Hz), 4.44-4.59 (1H, m, OCHO), 3.99-4.10 (1H, m, CH2CHAHBO), 3.88-
3.75 (2H, m, CCH2O), 3.35-3.56 (1H, m, CH2CHAHBO), 1.91-2.05 (2H, m, CH2CH=C), 




General Procedure F was followed, using tert-butyldimethyl((2-methyleneoctyl)oxy)silane 
(198p, 0.257 g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in ethyl acetate, 
to afford the title compound as a clear oil in 70% yield (determined by 
1
H NMR 
spectroscopy); (E):(Z) ratio = 4:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 5.33 (1H, tq, 
J = 7.2 and 1.4 Hz, CH=C), 3.95 (2H, s, CH2O), 1.88-2.01 (2H, m, CH2CH), 1.53 (3H, m, 
CH3C=CH), 1.14-1.33 (6H, m, CH3(CH2)3), 0.75-0.89 (3H, m, CH3CH2), 0.84 (9H, s, 













General Procedure F was followed, using 2-methyl-3-methylenenonan-2-ol (198q, 0.170 
g), Pd(OH)2/C (8.5% Pd w/w, 0.125 g) and Cs2CO3 (0.326 g) in acetonitrile, to afford a 
crude mixture containing the title compound in 36% yield (determined by 
1
H NMR 
spectroscopy); (E):(Z) ratio = 3:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 5.51 (1H, t, J 
= 6.2 Hz, C=CH), 1.98-2.06 (2H, m, CH2=CH), 1.64-1.70 (3H, m, CH3C=CH), 1.19-1.47 




General Procedure F was followed, using 3-methylenenonan-2-one (201a, 0.154 g) and 
Pd(OAc)2 (0.022 g) in acetonitrile, to afford a crude mixture containing the title compound 
in 46% yield; 
1
H NMR (300 MHz, CDCl3) δ 6.68 (1H, t, J = 7.0 Hz, C=CH), 2.39 (3H, s, 
CH3CO), 2.20-2.28 (2H, m, CH2CH), 1.79 (3H, s, CH3C), 1.45-1.20 (6H, m, CH3(CH2)3), 




General procedure F was followed, using 2-methyleneoctanal (197, 0.140 g) and Pd(OAc)2 
(0.022 g) in acetonitrile, to afford a crude mixture containing the title compound in 9% 
yield; 
1
H NMR (300 MHz, CDCl3) δ 9.35 (1H, s, CHO), 6.34 (1H, t, J = 7.0 Hz, C=CH), 








General Procedure F was followed, using 2-methyldec-1-ene (222a, 0.154 g) and 
Pd(OH)2/C (8.5% Pd w/w, 0.125 g) in isopropanol, to afford the title compound as a clear 
oil in 63% yield (determined by 
1
H NMR spectroscopy); 
1
H NMR (300 MHz, CDCl3) δ 
5.09 (1H, t, J = 14.0 Hz), 1.84-1.93 (2H, m, CH2C), 1.61 (3H, s, CH3C), 1.56 (3H, s, 
CH3C), 1.08-1.32 (10H, m, (CH2)5), 0.77-0.89 (3H, m, CH3CH2); 
13
C NMR (75 MHz, 




General Procedure F was followed, using 3-methyleneundecane (222b, 0.168 g) and 
Pd(OH)2/C (8.5% Pd w/w, 0.125 g) in isopropanol, to afford the title compound as a clear 
oil in 36% yield (determined by 
1
H NMR spectroscopy); (E):(Z) ratio = 1.6:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 5.15 (1H, q, J = 5.0 Hz, CH3=CH), 2.32-2.41 (2H, m, 
CH2C=CH), 1,84-2.00 (3H, m, CH3CH), 1.51 (3H, s, CH3C), 1.10-1.39 (12H, m, (CH2)6), 
1.03 (3H, t, J = 7.5 Hz, CH3CH2), 0.75-0.89 (3H, m, CH3CH2); 
13
C NMR (75 MHz, 





General Procedure F was followed, using 2,2-dimethyl-3-methyleneundecane (222b, 0.196 
g) and Pd(OH)2/C (8.5% Pd w/w, 0.125 g) in isopropanol, to afford the title compound as a 
clear oil in 45% yield (determined by 
1
H NMR spectroscopy); (E):(Z) ratio = 9:1; (E)-
isomer: 
1
H NMR (300 MHz, CDCl3) δ 5.11 (1H, t, J = 5.2 Hz, CH=C), 1.86-2.01 (2H, m, 
CH2CH), 1.53 (3H, s, CH3C=CH), 1.14-1.49 (10H, m, (CH2)5), 0.98 (9H, s, C(CH3)3), 
0.81-0.90 (3H, m, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 142.9, 121.2, 43.0, 33.0, 31.9, 
29.9, 29.8, 29.1, 28.6, 28.2, 25.7, 15.6. 
200 
 





According to a literature procedure,
306
 33.0 ml dry ether and 5.17 ml (52 mmol approx.) 
neat borane-methyl sulphide were placed into a two-necked 250 ml round bottom flask, 
fitted with a condenser. To the stirred mixture was added 18.4 ml (115 mmol) (+)-α-pinene 
(Aldrich, 91% ee) at a rate sufficient to maintain a gentle reflux. After the addition was 
complete, the reaction mixture was refluxed (external temperature 45 °C) for an additional 
30 m, then the flask was removed from the oil bath and allowed to cool to room 
temperature while stirring was continued. Following the dropwise addition of 3.77 ml (25 
mmol) TMEDA, the solution was refluxed for a further 30 m, the stirring discontinued and 
the mixture was allowed to cool to room temperature. Crystallisation could be induced by 
inserting a needle into the solution, withdrawing a couple of millilitres and squirting it 
back in rapidly, then allowing the solution to stand undisturbed at room temperature, under 
nitrogen. When crystallisation was clearly underway the solution was refrigerated 
overnight, then filtered (in a fume cupboard) and washed thoroughly  with freezer-cold 
pentane, to afford 2IpcBH2.TMEDA as a white solid (4.0 g, 70%); [α]
26
D +60.90 (c 1.02, 




B NMR (96 MHz, CDCl3) δ 4.35 (br. s); 
1
H NMR (300 MHz, CDCl3) δ 3.06-3.33 (4H, m, NCH2CH2N), 2.62 (6H, s, NCH3), 2.59 
(6H, s, NCH3), 2.14-2.26 (2H, m, CHAHBCHB), 2.00-2.13 (2H, m, CHAHBCHB), 1.68-
1.89 (10H, m, CHCH2CH and CHCH3), 1.48-1.62 (4H, m, BH2), 1.15 (6H, s, CH3CCH3), 
1.08 (6H, s, CH3CCH3), 0.99 (6H, d, J = 7.0 Hz, CH3CH), 0.58-0.72 (2H, m, CHB); 
13
C 
NMR (75 MHz, CDCl3) δ 57.2, 51.0, 50.8, 48.6, 43.0, 42.3, 39.0, 38.0, 34.1, 28.4, 22.9, 









To a solution of 2IpcBH2.TMEDA 257 (0.416 g, 1.0 equiv.) in dry THF (2.0 ml) was 
added BF3.OEt2 (0.278 g, 0.24 ml, 1.96 equiv.) dropwise, and the resulting mixture was 
stirred at room temperature for 3 hours. The liberated monoalkylborane was treated with 
aqueous 3.0 M NaOH solution (0.7 ml) and 30% aqueous hydrogen peroxide (0.55 ml), 
heated to 55 °C for 1 hour and then cooled to room temperature. Ether (10 ml) and water 
(10 ml) were added to the flask and the resulting mixture was transferred to a separatory 
funnel. The aqueous phase was subsequently extracted with ether (3 × 10 ml) and the 
combined organics washed with water (20 ml), dried (MgSO4) and evaporated under 
reduced pressure to afford the title compound as a white solid (0.302 g, 96%); 
1
H NMR 
(300 MHz, CDCl3) δ 4.02-4.11 (1H, m, CH(OH)), 2.45-2.58 (1H, m, CHAHBCH(OH)), 
2.32-2.42 (1H, m, CHAHBCH(OH)), 1.86-2.01 (2H, m, CHC(CH3)2CH), 1.80 (1H, app. td, 
J = 6.0 and 1.9 Hz, CHCH3), 1.65-1.76 (2H, m, CHCH2CH), 1.22 (3H, s, CH3CCH3), 1.13 
(3H, d, J = 7.3 Hz, CHCH3), 0.92 (3H, s, CH3CCH3); 
13
C NMR (75 MHz, CDCl3) δ 71.7, 














5.7 Synthesis and asymmetric hydroboration reactions of 
alkene (Z)-245  
2-(4-Methoxyphenyl)butan-2-ol 244360 
 
A 0.5 M solution of EtMgBr in ether (16.64 mmol, prepared via dilution of the 
commercially available reagent) was cooled to 0 °C, followed by the dropwise addition of 
4'-methoxyacetophenone (1.00 g, 6.66 mmol). The resulting mixture was stirred overnight, 
whilst slowly warming to room temperature, and then quenched by the cautious addition of 
saturated NH4Cl solution. Additional water and 1.0 M HCl were added to dissolve the 
precipitated salts and the mixture was transferred to a separatory funnel. The organic phase 
was removed and the aqueous layer extracted with ether (3 × 10 ml). The combined 
organics were washed with saturated NaHCO3 solution and water, dried (MgSO4) and the 
solvent removed under reduced pressure to afford the title compound as a colourless oil 
(1.12 g, 93%) which was used in the next step without further purification; 
1
H NMR (300 
MHz, CDCl3) δ 7.33-7.40 (2H, m, Ar), 6.85-6.92 (2H, m, Ar), 3.82 (3H, s, OMe), 1.83 
(2H, qd, J = 7.5 and 2.6 Hz, CH3CH2), 1.70 (1H, br. s, OH), 1.54 (3H, s, CH3C), 0.80 (3H, 
t, J = 7.5 Hz, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 158.2, 139.9, 126.1, 113.4, 74.7, 












 (E)-1-(4-Methoxyphenyl)-2-methylbut-2-en-1-ol (E)-246 
 
According to a modified literature procedure,
312
 4-methoxy-1-bromobenzene (39.6 mmol), 
dry THF (15 ml) and dry toluene (60 ml) were added to a round bottomed flask and the 
resulting mixture cooled to –78 °C. n-BuLi solution (2.5 M in hexanes, 15 ml, 37.5 mmol) 
was then added dropwise and stirring continued at this temperature for four hours. Tiglic 
aldehyde (2-methyl-but-2-enal, 43.6 mmol) was then added dropwise and the reaction 
mixture left in the cooling bath overnight, thus warming slowly to room temperature. The 
reaction was quenched by the addition of 50% saturated aqueous NH4Cl solution, the 
organic layer separated and the aqueous fraction extracted with ether (3 × 50 ml). The 
combined organics were washed with water, dried (MgSO4) and the solvent evaporated 
under reduced pressure to afford a residue which was purified by column chromatography 
(SiO2) to afford the title compound as a colourless oil (4.49 g, 59%); 
1
H NMR (300 MHz, 
CDCl3) δ 7.24-7.31 (2H, m, Ar), 6.85-6.91 (2H, m, Ar), 5.71 (q app. pentets, J = 6.7 and 
1.3 Hz, C=CHMe), 5.09 (1H, s, CH(OH)), 3.81 (3H, s, OMe), 1.65-1.70 (3H, m, CH3CH), 
1.48-1.51 (3H, m, CH3C); 
13
C NMR (75 MHz, CDCl3) δ 158.8, 137.7, 134.7, 127.5, 120.7, 
113.6, 78.9, 55.3, 13.2, 11.9; IR (neat): 3409 (O–H), 1611 (C=C), 1509 (C=C), 1244 (C–
O), 1170 (C–O) cm-1; HRMS (ES): m/z [C12H16NaO2]
+













 (Z)-1-(4-Methoxyphenyl)-2-methylbut-2-en-1-ol (Z)-246 
 
Allylic alcohol (Z)-246 was also isolated from the above reaction (0.23 g, 3%); 
1
H NMR 
(300 MHz, CDCl3) δ 7.20-7.26 (2H, m, Ar), 6.83-6.92 (2H, m, Ar), 6.38 (1H, s, CH(OH)), 
4.38 (1H, q, J = 6.4 Hz, CH3CH), 3.82 (3H, s, OMe), 1.89 (3H, d, J = 1.3 Hz, CH3C), 1.37 
(3H, d, J = 6.4 Hz, CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 158.1, 140.0, 130.2, 130.2, 
124.0, 113.6, 73.9, 55.3, 21.8, 13.3; IR (neat): 3376 (O–H), 1607 (C=C), 1509 (C=C), 
1245 (C–O), 1176 (C–O) cm-1; HRMS (ES): m/z [C12H16NaO2]
+






According to a literature procedure,
313
 allylic alcohol (E)-246 (1.92 g, 10 mmol) was 
dissolved in dry DME (20 ml) and to this solution was added NBS (2.14 g, 12 mmol), in 
one portion. The resulting mixture was stirred at room temperature until tlc analysis 
indicated complete consumption of the alcohol. Following the addition of a further 10 ml 
of dry DME, solid NaOH powder (10.0 g, 250 mmol) was then added to the reaction 
mixture, in small portions, under vigorous stirring. Stirring was subsequently continued for 
24 hours, whereupon the reaction mixture was diluted with water (50 ml) and thoroughly 
extracted with ether (5 × 40 ml). The combined organic extracts were washed with water, 
dried (MgSO4) and the solvent evaporated under reduced pressure to afford the title 
compound as a clear oil (1.04 g, 64%) which was used without further purification;
 1
H 
NMR (300 MHz, CDCl3) δ 7.13-7.19 (2H, m, Ar), 6.87-6.93 (2H, Ar, m), 5.55 (1H, qq, J = 
6.9 and 1.5 Hz, CH3CH), 3.83 (3H, s, OMe), 2.02 (3H, app. pentet, J = 1.5 Hz, CH3C), 
1.63 (3H, dq, J = 6.9 and 1.5 Hz, CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 158.1, 136.2, 







 (–)-(2S,3S)-3-(4-Methoxyphenyl)butan-2-ol 247361 
 
(Z)-1-(But-2-en-2-yl)-4-methoxybenzene (245, 0.324 g) was treated according to General 
Procedure G and the title compound isolated by column chromatography (SiO2) in 54% 
yield (0.195 g) and >99% ee, which was determined by chiral HPLC (OD-H, 0.3 ml/min, 
95:5 hexane-IPA, 215 nm, tmajor = 28.443, tminor = 29.060); [α]
26
D –6.19 (c 0.49, EtOH); 
1
H 
NMR (300 MHz, CDCl3) δ 7.10-7.17 (2H, m, Ar), 6.84-6.90 (2H, m, Ar), 3.85 (1H, app. 
pentet, J = 6.2 Hz, CH3CH(OH)), 3.81 (3H, s, OMe), 2.71 (1H, app. pentet, J = 6.8 Hz, 
ArCH), 1.49 (1H, br. s, OH), 1.31 (3H, d, J = 7.0 Hz, ArCHCH3), 1.09 (3H, d, J = 6.3 Hz, 
CH3CH(OH)); 
13





(Z)-1-(But-2-en-2-yl)-4-methoxybenzene (245, 0.324 g) was treated according to General 
Procedure H and the title compound isolated by column chromatography (SiO2) in 34% 
yield (0.123 g) and 5% ee, which was determined by chiral HPLC (OD-H, 0.5 ml/min, 
95:5 hexane-IPA, 215 nm, tmajor = 27.877, tminor = 29.570); [α]
26
D –0.60 (c 0.54, EtOH); lit. 




H NMR (300 MHz, CDCl3) δ 7.10-7.17 
(2H, m, Ar), 6.82-6.89 (2H, m, Ar), 3.80 (3H, s, OMe), 3.49-3.64 (2H, m, CH2OH), 2.78-
2.92 (1H, m, CH3CH), 1.78-1.88 (2H, m, CH2CH2OH), 1.40 (1H, br. s, OH), 1.26 (3H, d, J 
= 7.0 Hz, CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 157.9, 138.9, 127.8, 113.9, 61.3, 55.3, 









The title compound was also isolated from the previously described reaction (0.043 g, 
12%); 
1
H NMR (300 MHz, CDCl3) δ 7.11-7.17 (2H, m, Ar), 6.86-6.92 (2H, m, Ar), 3.81 
(3H, s, OMe), 3.76 (1H, dd, J = 10.7 and 5.8 Hz, CHAHB(OH)), 3.68 (1H, dd, J = 10.7 and 
8.0 Hz, CHAHB(OH)), 2.56-2.77 (1H, m, CH2CH), 1.65-1.81 (1H, m, CH3CHAHB), 1.48-
1.63 (1H, m, CH3CHAHB), 0.84 (3H, t, J = 7.3 Hz, CH3CH2); 
13
C NMR (75 MHz, CDCl3) 





















5.8 Synthesis of 2-arylpropionaldehydes 
2-(p-Tolyl)propanal 273b365 
 
4'-Methylacetophenone (272b, 37.45 mmol, 5.025 g, 5.0 ml) was treated according to 
General Procedure I to afford the title compound as a colourless oil (3.33 g, 60%); 
1
H 
NMR (300 MHz, CDCl3) δ 9.67 (1H, d, J = 1.4 Hz, CHO), 7.20 (2H, d, J = 8.1 Hz, Ar), 
7.10 (2H, d, J = 8.1 Hz, Ar), 3.60 (1H, qd, J = 7.0 and 1.2 Hz, CHCH3), 2.35 (3H, s, 
ArCH3), 1.43 (3H, d, J = 7.0 Hz, CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 201.2, 137.3, 
134.7, 129.8, 128.2, 52.6, 21.1, 14.6; IR (neat): 1722 (C=O) cm
-1
; HRMS (ES): m/z 
[C10H12NaO]
+




4'-Methoxyacetophenone (272c, 33.3 mmol, 5.00 g) was treated according to General 
Procedure I to afford the title compound as a colourless oil (2.84 g, 52%); 
1
H NMR (300 
MHz, CDCl3) δ 9.65 (1H, d, J = 1.5 Hz, CHO), 7.11-7.17 (2H, m, Ar), 6.89-6.95 (2H, m, 
Ar), 3.81 (3H, s, OCH3), 3.59 (1H, qd, J = 7.0 and 1.5 Hz, CHCH3), 1.42 (3H, d, J = 7.0 
Hz, CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 201.2, 159.0, 129.6, 129.4, 114.5, 55.3, 52.1, 
14.7; IR (neat): 1717 (C=O) cm
-1
; HRMS (ES): m/z [C10H12NaO2]
+












4'-Bromoacetophenone (272d, 25.1 mmol, 5.00 g) was treated according to General 
Procedure I to afford the title compound as a clear yellow oil (3.21 g, 60%); 
1
H NMR (300 
MHz, CDCl3) δ 9.67 (1H, d, J = 1.2 Hz, CHO), 7.48-7.54 (2H, m, Ar), 7.07-7.13 (2H, m, 
Ar), 3.62 (1H, qd, J = 7.2 and 1.2 Hz, CHCH3), 1.44 (3H, d, J = 7.2 Hz, CH3CH); 
13
C 







2'-Methoxyacetophenone (272e, 36.3 mmol, 5.045 g, 5.0 ml) was treated according to 
General Procedure I to afford the title compound as a colourless oil (2.86 g, 48%); 
1
H 
NMR (300 MHz, CDCl3) δ 9.67 (1H, s, CHO), 7.25-7.33 (1H, m, Ar), 7.12 (1H, dd, J = 
7.5 and 1.7 Hz, Ar), 6.98 (1H, app. td, J = 7.4 and 1.0 Hz, Ar), 6.92 (1H, d, J = 8.3 Hz, 
Ar), 3.87 (1H, q, J = 7.1 Hz, CHCH3), 3.82 (3H, s, OCH3), 1.39 (3H, d, J = 7.1 Hz, 
CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 202.1, 157.1, 129.2, 128.7, 127.0, 121.0, 110.8, 
55.4, 47.4, 13.4; IR (neat): 1722 (C=O) cm
-1
; HRMS (ES): m/z [C10H12NaO2]
+
 requires 












2-Acetonaphthone (272f, 29.4 mmol, 5.0 g) was treated according to General Procedure I 
to afford the title compound as a white solid (2.98 g, 55%); 
1
H NMR (300 MHz, CDCl3) δ 
9.69 (1H, d, J = 1.4 Hz, CHO), 7.71-7.82 (3H, m, Ar), 7.60 (1H, s, Ar), 7.37-7.47 (2H, m, 
Ar), 7.24 (1H, dd, J = 8.4 and 1.8 Hz, Ar), 3.73 (1H, qd, J = 7.0 and 1.1 Hz, CHCH3), 1.46 
(3H, d, J = 7.0 Hz, CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 201.1, 135.1, 133.6, 132.7, 
128.9, 127.7 (2), 127.2, 126.5, 126.2, 126.2, 53.2, 14.7; IR (neat): 1719 (C=O) cm
-1
; 
HRMS (ES): m/z [C13H12NaO]
+




1-Acetonaphthone (272g, 32.9 mmol, 5.60 g, 5.0 ml) was treated according to General 
Procedure I to afford the title compound as a colourless oil (2.42 g, 40%); 
1
H NMR (300 
MHz, CDCl3) δ 9.77 (1H, d, J = 1.0 Hz, CHO), 7.99-8.06 (1H, m, Ar), 7.89-7.95 (1H, m, 
Ar), 7.80-7.87 (1H, m, Ar), 7.45-7.62 (3H, m, Ar), 7.27-7.34 (1H, m, Ar), 4.39 (1H, qd, J = 
7.0 and 1.0 Hz, CHCH3), 1.59 (3H, d, J = 7.0 Hz, CH3CH); 
13
C NMR (75 MHz, CDCl3) δ 
201.3, 134.2, 134.2, 131.8, 129.2, 128.3, 126.7, 126.0, 125.7, 125.7, 123.0, 48.9, 14.7; IR 
(neat): 1720 (C=O) cm
-1
; HRMS (ES): m/z [C13H12NaO]
+















2-Phenylpropionaldehyde (149.4 mmol, 20.04 g, 20.0 ml) was treated according to General 
Procedure J to afford the title compound as a highly aromatic, waxy white solid (10.27 g, 
39%); (E):(Z) ~15:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.15-7.44 (5H, m, Ph), 
5.94 (1H, t, J = 7.2 Hz, C=CH), 3.32 (2H, d, J = 7.2 Hz, CHCH2), 2.08 (3H, s, Me); 
13
C 
NMR (75 MHz, CDCl3) δ 178.2, 142.9, 138.7, 128.3, 127.7, 125.8, 118.4, 34.2, 16.3; IR 
(neat): 2951 (O–H), 1695 (C=O) cm-1. 
 
4-(p-Tolyl)pent-3-enoic acid 274b 
 
2-(p-Tolyl)propanal (273b, 3.30 g, 22.3 mmol) was treated according to General Procedure 
J to afford the title compound as a waxy white solid (1.82 g, 43%); (E):(Z) ~10:1; (E)-
isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.30 (2H, d, J = 8.0 Hz, Ar), 7.10 (2H, d, J = 8.0 
Hz, Ar), 5.90 (1H, t, J = 7.3 Hz, CHCH2), 3.30 (2H, d, J = 7.3 Hz, CHCH2), 2.34 (3H, s, 
ArCH3), 2.05 (3H, s, CH3CAr); 
13
C NMR (75 MHz, CDCl3) δ 177.9, 140.0, 138.5, 136.9, 














2-(4-Methoxyphenyl)propanal (273c, 2.80 g, 17.1 mmol) was treated according to General 
Procedure J to afford the title compound as a waxy white solid (1.20 g, 34%); (E):(Z) 
~10:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.33-7.39 (2H, m, Ar), 6.83-6.91 (2H, 
m, Ar), 5.87 (1H, tq, J = 7.2 and 1.3 Hz, CHCH2), 3.82 (3H, s, OCH3), 3.30 (2H, d, J = 7.2 
Hz, CHCH2), 2.04-2.07 (3H, m, CH3C); 
13
C NMR (75 MHz, CDCl3) δ 178.3, 158.9, 138.0, 
135.4, 128.7, 116.8, 113.6, 55.3, 34.2, 16.3. 
 
4-(4-Bromophenyl)pent-3-enoic acid 274d 
 
2-(4-Bromophenyl)propanal (273d, 3.10 g, 14.5 mmol) was treated according to General 
Procedure J to afford the title compound as a waxy white solid (1.22 g, 33%); (E):(Z) ~7:1; 
(E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.42-7.48 (2H, m, Ar), 7.25-7.30 (2H, m, Ar), 
5.93 (1H, tq, J = 7.1 and 1.2 Hz, CHCH2), 3.31 (2H, dd, J = 7.1 and 0.6 Hz, CHCH2), 2.05 
(3H, d, J = 1.2 Hz, CH3); 
13
C NMR (75 MHz, CDCl3) δ 177.6, 141.7, 137.7, 131.3, 127.5, 
121.2, 119.0, 34.0, 16.2. 
 
4-(2-Methoxyphenyl)pent-3-enoic acid 274e 
 
2-(2-Methoxyphenyl)propanal (273e, 2.80 g, 17.1 mmol) was treated according to General 
Procedure J to afford the title compound as a waxy white solid (1.23 g, 35%); (E):(Z) ~5:1; 
(E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.13-7.30 (2H, m, Ar), 6.83-7.01 (2H, m, Ar), 
5.66 (1H, tq, J = 7.0 and 1.4 Hz, CHCH2), 3.61 (3H, s, OMe), 3.10 (2H, dd, J = 7.0 and 0.6 
Hz, CHCH2), 1.79-1.82 (3H, m, CH3C); 
13
C NMR (75 MHz, CDCl3) δ 178.2, 156.5, 139.0, 
133.8, 129.7, 128.1, 120.6, 120.1, 110.7, 55.3, 33.8, 17.5. 
212 
 
4-(Naphthalen-2-yl)pent-3-enoic acid 274f 
 
2-(Naphthalen-2-yl)propanal (273f, 2.90 g, 15.7 mmol) was treated according to General 
Procedure J to afford the title compound as a waxy white solid (1.64 g, 46%); (E):(Z) ~8:1; 
(E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.77-7.89 (4H, m, Ar), 7.61 (1H, dd, J = 8.6 and 
1.8 Hz, Ar), 7.44-7.50 (2H, m, Ar), 6.12 (1H, tq, J = 7.1 and 1.4 Hz, CHCH2), 3.39 (2H, 
dd, J = 7.1 and 0.8 Hz, CHCH2), 2.18-2.21 (3H, m, CH3); 
13
C NMR (75 MHz, CDCl3) δ 
178.6, 140.1, 138.6, 133.4, 132.7, 128.2, 127.8, 127.5, 126.2, 126.0, 125.8, 124.5, 124.3, 
34.3, 16.3. 
 
4-(Naphthalen-1-yl)pent-3-enoic acid 274g 
 
2-(Naphthalen-1-yl)propanal (273g, 2.40 g, 13.0 mmol) was treated according to General 
Procedure J to afford the title compound as a waxy white solid (1.00 g, 34%); (E):(Z) ~4:1; 
(E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.93-8.02 (1H, m, Ar), 7.71-7.91 (2H, m, Ar), 
7.38-7.53 (3H, m, Ar), 7.23-7.33 (1H, m, Ar), 5.71 (1H, t, J = 7.2 Hz, CHCH2), 3.41 (2H, 
d, J = 7.2 Hz, CHCH2), 2.14 (3H, s, CH3); 
13
C NMR (75 MHz, CDCl3) δ 178.1, 142.9, 
139.4, 133.8, 131.1, 128.3, 127.3, 125.9, 125.7, 125.4, 125.1, 124.9, 121.2, 34.5, 19.4. 
 
(E)-4-Phenylbut-3-enoic acid 274h368 
 
Phenylacetaldehyde (42.7 mmol, 5.14 g, 5.0 ml) was treated according to General 
Procedure J to afford the title compound as a colourless oil (3.88 g, 56%); 
1
H NMR (300 
MHz, CDCl3) δ 7.12-7.48 (5H, m, Ph), 6.53 (1H, d, J = 16.0 Hz, PhCH), 6.30 (1H, dt, J = 
16.0 and 7.1 Hz, PhCH=CH), 3.31 (2H, dd, J = 7.1 and 1.4 Hz, CH2); 
13
C NMR (75 MHz, 
CDCl3) δ 177.8, 136.7, 134.0, 128.6, 127.7, 126.4, 120.9, 38.0. 
213 
 
5.10 Synthesis of methyl 4-arylpent-3-enoate esters 
(E)-Methyl 4-phenylpent-3-enoate (E)-275a369 
 
4-Phenylpent-3-enoic acid (274a, 10.0 g, 56.8 mmol) was treated according to General 
Procedure K to afford the title compound as a colourless oil (8.31 g, 77%); 
1
H NMR (300 
MHz, CDCl3) δ 7.21-7.44 (5H, m, Ph), 5.95 (1H, tq, J = 7.1 and 1.4 Hz, CHCH2), 3.72 
(3H, s, OCH3), 3.27 (2H, d, J = 7.1 Hz, CH2), 2.05-2.08 (3H, m, CH3C); 
13
C NMR (75 
MHz, CDCl3) δ 172.4, 143.1, 138.1, 128.3, 127.1, 125.8, 119.2, 52.0, 34.3, 16.2. 
 
(Z)-Methyl 4-phenylpent-3-enoate (Z)-275a 
 
The title compound was also isolated from the above reaction as a colourless oil (0.54 g, 
5%); 
1
H NMR (300 MHz, CDCl3) δ 7.13-7.40 (5H, m, Ph), 5.65 (1H, t, J = 7.3 Hz, 
CHCH2), 3.67 (3H, s, OCH3), 3.02 (2H, d, J = 7.3 Hz, CH2), 2.08 (3H, s, CH3C); 
13
C NMR 













 (E)-Methyl 4-(p-tolyl)pent-3-enoate (E)-275b 
 
4-(p-Tolyl)pent-3-enoic acid (274b, 1.80 g, 9.46 mmol) was treated according to General 
Procedure K to afford the title compound as a colourless oil (1.53 g, 79%); 
1
H NMR (300 
MHz, CDCl3) δ 7.30 (2H, d, J = 8.1 Hz, Ar), 7.13 (2H, d, J = 8.1 Hz, Ar), 5.92 (1H, tq, J = 
7.2 and 1.4 Hz, CHCH2), 3.72 (3H, s, OCH3), 3.26 (2H, dd, J = 7.1 and 0.6 Hz, CHCH2), 
2.34 (3H, s, CH3Ar), 2.03-2.06 (3H, m, CH3CAr); 
13
C NMR (75 MHz, CDCl3) δ 172.5, 
140.2, 137.9, 136.8, 128.9, 125.7, 118.4, 51.9, 34.3, 21.1, 16.2; IR (neat): 1737 (C=O), 
1160 (C–O), 802 (C–H) cm-1; HRMS (ES): m/z [C13H17O2]
+
 requires 205.1229, found 
205.1242. 
 
 (Z)-Methyl 4-(p-tolyl)pent-3-enoate (Z)-275b 
 
The title compound was also isolated from the above reaction as a colourless oil (0.116 g, 
6%); 
1
H NMR (300 MHz, CDCl3) δ 7.17 (2H, d, J = 8.0 Hz, Ar), 7.08 (2H, d, J = 8.0 Hz, 
Ar), 5.63 (1H, tq, J = 7.4 and 1.5 Hz, CHCH2), 3.68 (3H, s, OCH3), 3.04 (2H, dd, J = 7.4 
and 1.1 Hz, CHCH2), 2.36 (3H, s, CH3Ar), 2.06-2.10 (3H, m, CH3CAr); 
13
C NMR (75 











(E)-Methyl 4-(4-methoxyphenyl)pent-3-enoate (E)-275c 
 
4-(4-Methoxyphenyl)pent-3-enoic acid (274c, 1.19 g, 5.57 mmol) was treated according to 
General Procedure K to afford the title compound as a colourless oil (1.02 g, 83%); 
1
H 
NMR (300 MHz, CDCl3) δ 7.33-7.39 (2H, m, Ar), 6.84-6.90 (2H, m, Ar), 5.89 (1H, tq, J = 
7.2 and 1.3 Hz, CHCH2), 3.81 (3H, s, CH3OAr), 3.72 (3H, s, CO2CH3), 3.26 (2H, d, J = 
7.2 Hz, CHCH2), 2.02-2.06 (3H, m, CH3CAr); 
13
C NMR (75 MHz, CDCl3) δ 172.5, 158.8, 
153.4, 137.4, 135.6, 126.9, 117.6, 113.6, 55.3, 51.9, 34.3, 16.2; IR (neat): 1735 (C=O), 
1243 (C–O), 1160 (C–O), 821 (C–H) cm-1; HRMS (ES): m/z [C13H17O3]
+
 requires 
221.1178, found 221.1203. 
 
(Z)-Methyl 4-(4-methoxyphenyl)pent-3-enoate (Z)-275c 
 
The title compound was also isolated from the above reaction as a colourless oil (0.074 g, 
6%); 
1
H NMR (300 MHz, CDCl3) δ 7.10-7.16 (2H, m, Ar), 6.86-6.92 (2H, m, Ar), 5.61 
(1H, tq, J = 7.3 and 1.5 Hz, CHCH2), 3.82 (3H, s, CH3OAr), 3.68 (3H, s, CO2CH3), 3.04 
(2H, dd, J = 7.3 and 1.1 Hz, CHCH2), 2.05-2.08 (3H, m, CH3CAr); 
13
C NMR (75 MHz, 











 (E)-Methyl 4-(4-bromophenyl)pent-3-enoate (E)-275d 
 
4-(4-Bromophenyl)pent-3-enoic acid (274d, 1.20 g, 4.70 mmol) was treated according to 
General Procedure K to afford the title compound as a colourless oil (1.01 g, 80%); 
1
H 
NMR (300 MHz, CDCl3) δ 7.41-7.47 (2H, m, Ar), 7.25-7.30 (2H, m, Ar), 5.95 (1H, tq, J = 
7.1 and 1.4 Hz, CHCH2), 3.73 (3H, s, OCH3), 3.26 (2H, dd, J = 7.1 and 0.8 Hz, CHCH2), 
2.02-2.05 (3H, m, CH3C); 
13
C NMR (75 MHz, CDCl3) δ 172.2, 141.9, 137.1, 131.3, 127.5, 
121.0, 119.8, 52.0, 34.3, 16.1; IR (neat): 1735 (C=O), 1163 (C–O), 1076 (C–Br), 807 (C–
H) cm
-1
; HRMS (ES): m/z [C12H13BrNaO2]
+
 requires 290.9997, found 290.9988. 
 
(Z)-Methyl 4-(4-bromophenyl)pent-3-enoate (Z)-275d 
 
The title compound was also isolated from the above reaction (0.089 g, 7%); 
1
H NMR (300 
MHz, CDCl3) δ 7.48 (2H, d, J = 8.3 Hz, Ar), 7.06 (2H, d, J = 8.3 Hz, Ar), 5.67 (1H, t, J = 
7.3 Hz, CHCH2), 3.68 (3H, s, OCH3), 2.99 (2H, d, J = 7.3 Hz, CHCH2), 2.06 (3H, s, 
CH3C); 
13
C NMR (75 MHz, CDCl3) δ 172.5, 139.9, 139.2, 131.5, 129.6, 121.0, 119.1, 
51.9, 34.6, 25.4; IR (neat): 1736 (C=O), 1164 (C–O), 1075 (C–Br), 835 (C–H) cm-1; 
HRMS (ES): m/z [C12H13BrNaO2]
+











(E)-Methyl 4-(2-methoxyphenyl)pent-3-enoate (E)-275e 
 
4-(2-Methoxyphenyl)pent-3-enoic acid (274e, 1.20 g, 5.82 mmol) was treated according to 
General Procedure K to afford the title compound as a colourless oil (0.718 g, 56%); 
1
H 
NMR (300 MHz, CDCl3) δ 7.21-7.26 (1H, m, Ar), 7.13-7.18 (1H, m, Ar), 6.91-6.95 (1H, 
m, Ar), 6.84-6.90 (1H, m, Ar), 5.67 (1H, tq, J = 7.0 and 1.4 Hz, CHCH2), 3.83 (3H, s, 
CH3OAr), 3.72 (3H, s, CO2CH3), 3.25 (2H, dd, J = 7.0 and 0.6 Hz, CHCH2), 1.99-2.02 
(3H, m, CH3C); 
13
C NMR (75 MHz, CDCl3) δ 172.5, 156.6, 138.4, 134.0, 129.7, 128.3, 
120.8, 120.6, 110.7, 55.4, 51.8, 34.0, 17.4; IR (neat): 1736 (C=O), 1232 (C–O), 1160 (C–
O) cm
-1
; HRMS (ES): m/z [C13H17NaO3]
+
 requires 221.1178, found 221.1179. 
 
(E)-Methyl 4-(naphthalen-2-yl)pent-3-enoate (E)-275f 
 
4-(Naphthalen-2-yl)pent-3-enoic acid (274f, 1.60 g, 7.07 mmol) was treated according to 
General Procedure K to afford the title compound as a colourless oil (1.26 g, 74%); 
1
H 
NMR (300 MHz, CDCl3) δ 7.77-7.86 (4H, m, Ar), 7.60 (1H, dd, J = 8.6 and 1.8 Hz, Ar), 
7.41-7.51 (2H, m, Ar), 6.12 (1H, tq, J = 7.1 and 1.4 Hz, CHCH2), 3.75 (3H, s, OCH3), 3.34 
(2H, dd, J = 7.1 and 0.7 Hz, CH2), 2.17-2.20 (3H, m, CH3C); 
13
C NMR (75 MHz, CDCl3) δ 
172.4, 140.2, 138.0, 133.4, 132.6, 128.1, 127.7, 127.5, 126.1, 125.7, 124.4, 124.3, 119.8, 
52.0, 34.4, 16.3; IR (neat): 1735 (C=O), 1161 (C–O), 810 (C–H) cm-1; HRMS (ES): m/z 
[C16H17O2]
+









Methyl 4-(naphthalen-1-yl)pent-3-enoate 275g 
 
4-(Naphthalen-1-yl)pent-3-enoic acid (274g, 0.99 g, 4.38 mmol) was treated according to 
General Procedure K to afford the title compound as a colourless oil (0.368 g, 35%); 
(E):(Z) = 4:1; (E)-isomer: 
1
H NMR (300 MHz, CDCl3) δ 7.94-8.02 (1H, m, Ar), 7.82-7.90 
(1H, m, Ar), 7.73-7.80 (1H, m, Ar), 7.45-7.51 (1H, m, Ar), 7.29 (1H, dd, J = 7.0 and 1.3 
Hz, Ar), 5.72 (1H, tq, J = 7.2 and 1.4 Hz, CHCH2), 3.76 (3H, s, OCH3), 3.37 (2H, dd, J = 
7.2 and 0.7 Hz, CH2), 2.11-2.15 (3H, m, CH3C); 
13
C NMR (75 MHz, CDCl3) δ 172.3, 
143.0, 138.8, 133.8, 131.1, 128.3, 127.2, 125.8, 125.8, 125.6, 125.4, 124.9, 121.9, 51.9, 
34.1, 19.3; IR (neat): 1735 (C=O), 1162 (C–O), 800 (C–H) cm-1; HRMS (ES): m/z 
[C16H17O2]
+
 requires 241.1229, found 241.1225. 
 
(E)-Methyl 4-phenylbut-3-enoate 275h370 
 
(E)-4-Phenylbut-3-enoic acid (274h, 3.80 g, 23.4 mmol) was treated according to General 
Procedure K to afford the title compound as a colourless oil (2.81 g, 68%); 
1
H NMR (300 
MHz, CDCl3) δ 7.22-7.41 (5H, m, Ph), 6.50 (1H, d J = 15.8 Hz, PhCH), 6.30 (1H, dt, J = 
15.8 and 7.0 Hz, PhCH=CH), 3.72 (3H, s, OCH3), 3.26 (2H, d, J = 7.0 Hz); 
13
C NMR (75 















(E)-Methyl 4-phenylpent-3-enoate (275a, 0.50 g, 2.63 mmol) was treated according to a 
slight variation on General Procedure L (where the hydroboration reaction was carried out 
at a temperature of -78 °C to 17 °C, over 42 hours) to afford the title compound as a 
colourless oil (0.26 g, 55%) in 87% ee, which was determined by General Procedure M; 
[α]26D +6.35 (c 4.55, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 7.21-7.38 (5H, m, Ph), 3.77-
3.97 (3H, m, CH2(OH) and CH(OH)), 2.79 (app. p, J = 7.0 Hz, CH3CH), 2.17 (2H, br. s, 
OH), 1.82-1.95 (1H, m, CH(OH)CHAHB), 1.58-1.74 (1H, m, CH(OH)CHAHB), 1.28 (3H, 
d, J = 7.0 Hz); 
13
C NMR (75 MHz, CDCl3) δ 143.0, 128.8, 128.1, 126.9, 76.8, 61.9, 46.6, 
35.6, 17.6; IR (neat): 3350 (O–H), 1048 (C–O) cm
-1
; HRMS (ES): m/z [C11H16NaO2]
+
 


















(E)-Methyl 4-phenylpent-3-enoate (275a, 0.50 g, 2.63 mmol) was treated with two 
equivalents of (–)-IpcBH2 according to a slightly modified version of General Procedure L: 
the solution of (–)-IpcBH2 obtained upon treatment of 2IpcBH2.TMEDA with BF3.OEt2 
was cooled to –25 °C prior to addition of the ester 275a and the reaction mixture 
subsequently stirred at this temperature for 48 hours before the excess borane was 
quenched, at –25 °C, with methanol and the intermediate organoboranes oxidised with 
NaHCO3/H2O2 to afford a mixture of isopinocampheol 258 and the title compound, which 
was isolated as a colourless oil (0.246 g, 45%) via column chromatography (SiO2). A 
sample of the  ester was subsequently reduced with LiAlH4 in an identical manner to that 
described below for the synthesis of (E)-4-phenylpent-3-en-1-ol (287) to afford the diol 
277a, whereupon its ee was found to be 75% following application of General Procedure 
M; [α]26D –11.66 (c 3.86, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 7.13-7.30 (5H, m, Ph), 
4.11 (1H, ddd, J = 9.4, 6.2 and 3.0 Hz, CH(OH)), 3.61 (3H, s, OMe), 2.78 (1H, app. pentet, 
J = 7.0 Hz, CH3CH), 2.97 (1H, dd, J = 16.0 and 3.0 Hz, CHAHB), 2.29 (1H, dd, J = 16.0 
and 9.6 Hz, CHAHB), 1.25 (3H, d, J = 7.0 Hz); 
13
C NMR (75 MHz, CDCl3) δ 173.4, 142.6, 
128.5, 128.2, 126.8, 72.3, 51.8, 45.2, 38.8, 17.2; IR (neat): 3657 (O–H), 1727 (C=O), 1438 
(C=C), 1254 (C–O), 1162 (C–O) cm-1; HRMS (ES): m/z [C12H16NaO3]
+
 requires 














(E)-Methyl 4-(p-tolyl)pent-3-enoate (275b, 0.537 g, 2.63 mmol) was treated according to 
General Procedure L to afford the title compound as a colourless oil (0.337 g, 66%) in 78% 
ee, which was determined by General Procedure M; [α]26D +6.77 (c 3.70, CHCl3); 
1
H NMR 
(300 MHz, CDCl3) δ 7.10-7.19 (4H, m, Ar), 3.77-3.95 (3H, m, CH2(OH) and CH(OH)), 
2.76 (app. pentet, J = 7.2 Hz, CH3CH), 2.34 (3H, s, CH3Ar), 1.83-1.95 (1H, m, 
CH(OH)CHAHB), 1.62-1.73 (1H, m, CH(OH)CHAHB), 1.27 (3H, d, J = 7.2 Hz); 
13
C NMR 
(75 MHz, CDCl3) δ 139.9, 136.5, 129.5, 127.9, 76.9, 61.9, 46.2, 35.6, 21.0, 17.7; IR (neat): 
3373 (O–H), 1052 (C–O) cm
-1
; HRMS (ES): m/z [C12H18NaO2]
+





(E)-Methyl 4-(4-methoxyphenyl)pent-3-enoate (275c, 0.579 g, 2.63 mmol) was treated 
according to General Procedure L to afford the title compound as a colourless oil (0.426 g, 
77%) in 84% ee, which was determined according to General Procdeure M; [α]26D +8.39 (c 
9.39, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 7.15-7.21 (2H, m, Ar), 6.85-6.93 (2H, m, Ar), 
3.82-3.92 (3H, m, CH2(OH) and CH(OH)), 3.81 (3H, s, CH3O), 2.75 (app. pentet, J = 7.2 
Hz, CH3CH), 1.82-1.95 (1H, m, CH(OH)CHAHB), 1.93 (2H, br. s, OH), 1.58-1.73 (1H, m, 
CH(OH)CHAHB), 1.26 (3H, d, J = 7.2 Hz); 
13
C NMR (75 MHz, CDCl3) δ 158.5, 134.9, 
129.0, 114.1, 61.8, 55.3, 45.7, 35.6, 29.5, 17.8; IR (neat): 3391 (O–H), 1244 (C–O), 1025 
(C–O) cm
-1
; HRMS (ES): m/z [C12H18NaO3]
+









(E)-Methyl 4-(4-bromophenyl)pent-3-enoate (275d, 0.708 g, 2.63 mmol) was treated 
according to General Procedure L to afford the title compound as a white solid (0.395 g, 
58%) in 85% ee, which was determined according to General Procedure M; [α]26D +9.69 (c 
1.76, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 7.46 (2H, d, J = 8.3 Hz, Ar), 7.14 (2H, d, J = 
8.3 Hz, Ar), 3.77-3.96 (3H, m, CH(OH) and CH2(OH)), 2.77 (1H, app. pentet, J = 7.1 Hz, 
CH3CH), 1.96 (2H, br. s, OH), 1.77-1.89 (1H, m, CHAHB), 1.54-1.70 (1H, m, CHAHB), 
1.27 (3H, d, J = 7.1 Hz, CH3); 
13
C NMR (75 MHz, CDCl3) δ 142.2, 131.7, 129.9, 120.6, 









(E)-Methyl 4-(2-methoxyphenyl)pent-3-enoate (275e, 0.579 g, 2.63 mmol) was treated 
according to General Procedure L to afford the title compound as a colourless oil (0.249 g, 
45%) in 77% ee, which was determined according to General Procedure M; [α]26D –4.63 (c 
4.54, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 7.20-7.27 (2H, m, Ar), 6.85-7.02 (2H, m, Ar), 
4.01 (1H, ddd, J = 9.9, 7.2 and 2.6 Hz, CH2CH), 3.78-3.90 (2H, m, CH2(OH)), 3.85 (3H, s, 
OCH3), 3.31 (app. pentet, J = 7.1 Hz, CH3CH), 2.14 (2H, br. s, OH), 1.77-1.89 (1H, m, 
CH(OH)CHAHB), 1.56-1.70 (1H, m, CH(OH)CHAHB), 1.26 (3H, d, J = 7.1 Hz, CH3C); 
13
C 
NMR (75 MHz, CDCl3) δ 157.3, 131.2, 128.5, 127.7, 121.1, 110.9, 62.2, 55.5, 39.7, 36.0, 
29.7, 16.7; IR (neat): 3372 (O–H), 1239 (C–O), 1051 (C–O) cm
-1
; HRMS (ES): m/z 
[C12H18NaO3]
+








(E)-Methyl 4-(naphthalen-2-yl)pent-3-enoate (275f, 0.632 g, 2.63 mmol) was treated 
according to General Procedure L to afford the title compound as a white solid (0.376 g, 
62%) in 83% ee, which was determined according to General Procedure M; [α]26D +8.56 (c 
0.94, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 7.78-7.88 (3H, m, Ar), 7.68-7.73 (1H, m, Ar), 
7.44-7.52 (2H, m, Ar), 7.41 (1H, dd, J = 8.5 and 2.2 Hz, Ar), 4.04 (1H, ddd, J = 9.8, 7.6 
and 2.6 Hz, CH(OH)), 3.81-3.95 (2H, m, CH2(OH)), 2.98 (1H, app. pentet, J = 7.2 Hz, 
CH3CH), 1.88-2.00 (1H, m, CHAHB), 1.89 (2H, br. s, OH), 1.64-1.78 (1H, m, CHAHB), 
1.38 (3H, d, J = 7.0 Hz, CH3); 
13
C NMR (75 MHz, CDCl3) δ 140.5, 133.5, 132.6, 128.5, 
127.7, 126.9, 126.2, 126.1, 125.7, 77.2, 61.9, 46.8, 35.6, 17.7; IR (neat): 3330 (O–H), 1048 
(C–O) cm-1; HRMS (ES): m/z [C15H18NaO2]
+




A mixture of (Z)- and (E)-methyl 4-(naphthalen-1-yl)pent-3-enoate (275g, 0.31 g, 1.29 
mmol) was treated according to General Procedure L to afford the title compound as a 
colourless oil (0.122 g, 41%) in 67% ee, which was determined via General Procedure M; 
[α]26D –4.83 (c 3.11, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 8.20 (1H, d, J = 7.8 Hz, Ar), 
7.86-7.91 (1H, m, Ar), 7.73-7.81 (1H, m, Ar), 7.47-7.59 (4H, m, Ar), 4.21 (1H, ddd, J = 
9.8, 7.3 and 2.5 Hz, CH(OH)), 3.75-3.95 (3H, m, CH2OH and CH3CH), 2.21 (2H, br. s, 
OH), 1.88-1.99 (1H, m, CH(OH)CHAHB), 1.70-1.86 (1H, m, CH(OH)CHAHB), 1.40 (3H, 
d, J = 7.0 Hz, CH3); 
13
C NMR (75 MHz, CDCl3) δ 139.5, 134.1, 132.4, 129.0, 127.3, 
126.2, 125.7, 125.6, 123.8, 123.3, 76.8, 62.0, 40.2, 35.1, 17.4; IR (neat): 3334 (O–H), 1056 
(C–O) cm-1; HRMS (ES): m/z [C15H18NaO2]
+






(+)-(3S,4R)-Methyl 3-hydroxy-4-(naphthalen-1-yl)pentanoate 276g 
 
The title compound was also isolated from the above reaction as a colourless oil (0.037 g, 
11%); [α]
26
D –7.31 (c 2.60, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 8.12-8.21 (1H, m, Ar), 
7.86-7.92 (1H, m, Ar), 7.74-7.81 (1H, m, Ar), 7.40-7.60 (4H, m, Ar), 4.40-4.49 (1H, m, 
CH(OH)), 3.93 (1H, app. pentet, J = 6.5 Hz, CH3CH), 3.56 (3H, s, OMe), 2.48-2.54 (2H, 
m, CH2), 1.46 (3H, d, J = 7.0 Hz); 
13
C NMR (75 MHz, CDCl3) δ 173.6, 138.9, 134.0, 
132.2, 129.1, 127.3, 126.2, 125.6, 125.5, 124.1, 123.2, 71.8, 51.8, 38.7, 37.9, 16.2; IR 
(neat): 1725 (C=O), 1162 (C–O), 1072 (C–O) cm-1; HRMS (ES): m/z [C16H19O3]
+
 requires 




(E)-Methyl 4-phenylbut-3-enoate (275h, 0.463 g, 2.63 mmol) was treated according to 
General Procedure L to afford the title compound as a colourless solid (0.216 g, 48%) in 
70% ee, which was determined via General Procedure M; [α]26D +18.10 (c 1.74, CHCl3); 
lit. value for epimer: [α]
25




H NMR (300 MHz, CDCl3) δ 7.16-
7.37 (5H, m, Ph), 4.66 (1H, t, J = 6.2 Hz, CH(OH)), 3.54-3.72 (2H, m, CH2OH), 3.19 (2H, 
br. s, OH), 1.79-1.89 (2H, m, CH(OH)CH2), 1.59-1.72 (2H, m, CH2CH2OH); 
13
C NMR (75 











The title compound was also isolated from the above reaction as a colourless oil (0.018 g, 
4%) in 76% ee, which was determined via General Procedure M; [α]26D +14.47 (c 0.36, 
CHCl3); lit. value: [α]
20




H NMR (300 MHz, CDCl3) δ 7.12-7.31 
(5H, m, Ph), 3.96-4.09 (1H, m, CH(OH)), 3.72-3.88 (2H, m, CH2(OH)), 2.65-2.81 (2H, m, 
PhCH2), 1.65-1.76 (2H, m, CH2CH2OH), 1.54 (2H, br. s, OH); 
13
C NMR (75 MHz, CDCl3) 


























According to a literature procedure,
376
 (E)-methyl 4-phenylpent-3-enoate (275a, 1.00 g, 
5.26 mmol) was dissolved in a small volume of dry ether, added in one portion to a stirred 
suspension of LiAlH4 (0.420 g, 10.52 mmol, 95% purity) in dry ether (40 ml) and the 
resulting mixture refluxed for 18 hours. After cooling to room temperature, the excess 
hydride was quenched by cautious addition, down the condenser, of 1.0 M aqueous H2SO4 
(24 ml) with several additional outlet needles in order to ensure efficient dispersion of the 
hydrogen gas thus evolved. The aqueous layer was subsequently extracted with ether and 
the combined organics washed successively with saturated NaHCO3 solution and water, 
dried (MgSO4) and the solvent evaporated under reduced pressure to afford the title 
compound as a colourless oil in 90% yield; 
1
H NMR (300 MHz, CDCl3) δ 7.22-7.43 (5H, 
m, Ph), 5.79 (1H, tq, J = 7.3 and 1.3 Hz, MeC=CH), 3.76 (2H, t, J = 6.5 Hz, CH2OH), 2.51 
(2H, app. q, J = 6.9 Hz, CHCH2), 2.07-2.10 (3H, m, Me); 
13
C NMR (75 MHz, CDCl3) δ 
143.5, 137.8, 128.2, 126.9, 125.7, 123.7, 62.4, 32.4, 16.1. 
 
Methyl hexanoate 288377 
 
Hexanoic anhydride (2.0 ml, 1.86 g, 8.7 mmol) was added to a large excess of methanol 
(50 ml), followed by 98% H2SO4 (0.5 ml). After stirring for three days, an excess of solid 
NaHCO3 was added and the methanol removed under reduced pressure. Water and CH2Cl2 
were added to the residue and the aqueous layer re-extracted with CH2Cl2. The combined 
organic extracts were dried (MgSO4) and the solvent evaporated under reduced pressure to 
afford the title compound as a fragrant, volatile, colourless liquid (0.541 g, 48%); 
1
H NMR 
(300 MHz, CDCl3) δ 3.67 (3H, s, OCH3), 2.30 (2H, t, J = 7.5 Hz, CH2CO2 CH3), 1.57-1.69 
(2H, m, CH3(CH2)2CH2), 1.25-1.35 (4H, m, CH3(CH2)2), 0.89 (3H, t, J = 6.8 Hz, CH3CH2); 
13
C NMR (75 MHz, CDCl3) δ 174.4, 51.5, 34.1, 31.3, 24.7, 22.3, 13.9. 
227 
 




According to a literature procedure,
379
 (+)-(3S,4R)-4-phenylpentane-1,3-diol (277a, 87% 
ee, 0.106 g, 0.65 mmol) was dissolved in CH2Cl2 (2.5 ml) and cooled to 0 °C. To the 
stirring solution were added Et3N (0.132 g, 0.18 ml, 1.3 mmol, 2.0 equiv.), DMAP (0.008 
g, 0.065 mmol, 0.1 equiv.) and TsCl (0.187 g, 0.98 mmol, 1.5 equiv.). The reaction 
mixture was stirred overnight at room temperature, quenched by addition of saturated 
NaHCO3 solution (10 ml) and extracted with CH2Cl2 (3 × 10 ml). The combined organic 
layers were washed with water (10 ml), dried (MgSO4) and the solvent removed under 
reduced pressure to afford a crude tosylate 285 (0.166 g, 84%). Tosylate 285 (0.166 g, 0.5 
mmol) was then dissolved in dry THF (2 ml) and added slowly to a stirring suspension of 
LiAlH4 (0.019 g, 0.5 mmol, 1.0 equiv.) in dry THF (2 ml).
380
 After stirring for one hour, 
the reaction mixture was quenched by addition of a THF-water mixture (1:1 v/v, 10 ml) 
and diluted with ether (20 ml). The aqueous layer was separated and extracted with ether (3 
× 10 ml). The combined organic layers were washed once with water (10 ml), dried 
(MgSO4) and evaporated under reduced pressure to afford the title compound as a 
colourless oil (0.06 g, 56%); [α]26D +6.29 (c 1.59, CHCl3); 
1
H NMR (300 MHz, CDCl3) δ 
7.12-7.30 (5H, m, Ph), 3.52 (1H, ddd, J = 8.2, 7.1 and 3.5 Hz, CH(OH)), 2.69 (app. pentet, 
J = 7.1 Hz, CH3CH), 1.49-1.65 (1H, m, CHAHB), 1.44 (1H, br. s, OH), 1.24-1.38 (1H, m, 
CHAHB), 1.21 (3H, d, J = 7.1 Hz), 0.92 (3H, t, J = 7.3 Hz); 
13
C NMR (75 MHz, CDCl3) δ 
143.6, 128.6, 128.2, 126.7, 77.4, 45.7, 27.3, 18.0, 10.0; IR (neat): 3387 (O–H), 1602 
(C=C), 1494 (C=C), 1452 (C=C), cm
-1
; HRMS (ES): m/z [C11H16NaO]
+
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